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ABSTRACT OF THE DISSERTATION 
ELUCIDATING THE ROLE OF MIFS-MIFR TWO-COMPONENT SYSTEM IN 
REGULATING PSEUDOMONAS AERUGINOSA PATHOGENICITY  
by 
Gorakh Digambar Tatke 
Florida International University, 2016 
Miami, Florida 
Professor Kalai Mathee, Major Professor 
Pseudomonas aeruginosa is a Gram-negative, metabolically versatile, 
opportunistic pathogen that exhibits a multitude of virulence factors, and is 
extraordinarily resistant to a gamut of clinically significant antibiotics. This ability is 
in part mediated by two-component systems (TCS) that play a crucial role in 
regulating virulence mechanisms, metabolism and antibiotic resistance. Our 
sequence analysis of the P. aeruginosa PAO1 genome revealed the presence of 
two open reading frames, mifS and mifR, which encodes putative TCS proteins, a 
histidine sensor kinase MifS and a response regulator MifR, respectively. This two-
gene operon was found immediately upstream of the poxAB operon, where poxB 
encodes a chromosomal ß-lactamase, hinting at the role of MifSR TCS in 
regulating antibiotic resistance.  However, loss of mifSR had no effect on the 
antibiotic resistance profile when compared to P. aeruginosa parent PAO1 strain. 
Subsequently, our phenotypic microarray data (BioLOG) and growth profile studies 
indicated the inability of mifSR mutants to grow in α-ketoglutarate (α-KG), a key 
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tricarboxylic acid (TCA) cycle intermediate, as a sole carbon source. To date, very 
little is known about the physiology of P. aeruginosa when provided with α-KG as 
its sole carbon source and the role of MifS and MifR TCS in virulence. Importantly, 
in the recent years, α-KG has gained notoriety for its newly identified role as a 
signaling molecule in addition to its conventional role in metabolism. This led us to 
hypothesize that MifSR TCS is involved in α-KG utilization and virulence in P. 
aeruginosa. Using mifS, mifR and mifSR clean in-frame deletion strains, our study 
demonstrates that the MifSR TCS modulates the expression P. aeruginosa kgtP 
(PA5530) and pcaT (PA0229) genes encoding putative α-KG permeases. In 
addition, our study shows that the MifSR-regulation of these transporters requires 
functional sigma factor RpoN (σ54). Loss of mifSR in the presence of α-KG, resulted 
in differential regulation of P. aeruginosa key virulence determinants including 
biofilm formation, motility, cell cytoxicity and the production of pyocyanin and 
pyoverdine. Involvement of multiple regulators and transporters suggests the 
presence of an intricate circuitry in the transport of α-KG and its importance in P. 
aeruginosa survival.  This is further supported by the α-KG-dependent MifSR 
regulation of multiple virulence mechanisms. Simultaneous regulation of multiple 
mechanisms involved in P. aeruginosa pathogenesis suggests a complex 
mechanism of MifSR action.  Understanding the physiological cues and regulation 
would provide a better stratagem to fight often indomitable P. aeruginosa 
infections. 
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Introduction  
“Adaptation is the key to survival”, this is particularly true with bacterial cells 
as they are often exposed to an array of physiological and environmental changes 
during their lifecycle. The evolutionary success of bacteria is a testament to its 
intrinsic capability that helps them to keep pace with the frequently changing 
environmental conditions, by means of genetic and phenotypic changes. Although 
they are considered to be the simplest form of life, bacteria have evolved 
sophisticated molecular machinery that orchestrates multiple functions efficiently. 
Most bacteria, if not all, live in an extreme and/or dynamic environment, where an 
adaptive behavior mediated by quick response to ecological variations is a key to 
existence and proliferation. Bacterial cells achieved this by utilizing numerous 
signal transduction, information processing systems that incessantly monitor their 
surroundings for important changes in order to elicit an adaptive response.   
Adaptation to environmental stimuli in bacteria is arbitrated predominantly 
through the expression of transcriptional regulators that include serine-threonine 
protein kinases (Kalantari et al., 2015), extra-cytoplasmic function (ECF) sigma 
factors (Mascher, 2013), and two-component signal transduction systems (TCSs) 
(Stock et al., 2000). These regulators function as cellular interpreters where they 
directly or with the help of other sensory units, first recognize a specific 
environmental stimuli at the cell surface and then transmit that extracellular 
information to the cytoplasm with the help of efficient signaling cascade (mostly 
phosphorylation and de-phosphorylation reactions) in order to stimulate an 
adaptive response, mainly by regulating expression of the target genes (Parkinson, 
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1993, Goudreau & Stock, 1998, Cashin et al., 2006). Amongst these signaling 
devices, TCS is the predominant signaling mechanism that empowers bacteria 
with an ability to efficiently sense, respond, and adapt to a wide variety of 
environments, stressors, and growth conditions (Stock et al., 2000). 
Two Component Regulatory Systems 
Two-component systems (TCS) are sophisticated signaling mechanisms 
marked by a highly modular design that have been adapted and integrated into a 
wide variety of cellular signaling circuits. They are one of the primary means by 
which bacteria sense and respond to variations in their environments, both intra- 
and extracellular. The archetypical TCS is composed of a membrane integrated 
sensory histidine kinase (HK) and a cytoplasmic response regulator (RR) (Figure 
1.1). The HK contains a periplasmic N-terminal domain that detects specific stimuli 
(sensing domain) and a C-terminal cytoplasmic transmitter domain that is 
comprised of a dimerization domain, a conserved histidine, and an ATP catalytic 
domain (Raghavan & Groisman, 2010). HKs can have two or more transmembrane 
domains with little or no periplasmic domain while others are completely 
cytoplasmic. The cognate response regulator (RR) contains a conserved receiver 
domain and a variable output domain (Stock et al., 2000). Upon receiving a signal, 
two HK monomers dimerize and cross-phosphorylate at the conserved histidine 
residue, the phosphate subsequently being transferred to an aspartate residue in 
the receiver domain of the cognate RR. The phosphotransfer is catalyzed by the 
receiver domain and results in a conformational change that activates the output 
domain, which often binds DNA and modulates gene expression or enzymatic 
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activity (Stock et al., 2000, Mascher et al., 2006, Gooderham & Hancock, 2009). 
Variations to this model occur in phosphorelays where a sensor kinase first 
transfers the phosphoryl group to a RR that has no output domain. The P~RR then 
transfers the phosphoryl group to a histidine containing phosphotransfer protein 
(HPT), and this in turn serves as a phosphate donor to a terminal RR which has 
an output domain that mediates a cellular response.  In other cases the sensor 
kinase and the RR lacking an output domain are fused into one protein (hybrid 
sensor kinase) (Gao & Stock, 2010). Other variations include the TCS connectors, 
a group of proteins that modulate the phosphorylation state and activity of sensor 
HK and RR and establish regulatory links between otherwise independent signal 
transduction pathways (Mitrophanov & Groisman, 2008).  
In general, the mechanism of signal perception mediated by the archetypic 
bacterial two-component system in order to elicit an adaptive response can be 
summarized in four steps:      
1) Signal detection by HK                                                                                                    
2) ATP-dependent auto phosphorylation of the HK sensor at its C-terminal 
histidine residue (HK activation)                                         
3) Transfer of phosphoryl group to the aspartate residue of the response regulator 
in the receiver domain (phosphortransfer and RR activation) 
4) Regulation of target genes by the activated RR (response generation) 
TCSs enable bacterial to effectively control their physiological and cellular 
functions by responding appropriately to a wide range of stimuli such as osmolarity, 
nutrient availability, temperature, pH and oxidative stress (Albright et al., 1989). 
5	
	 	 	
 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Schematic representation of a prototypic two-component 
system mediated signal transduction. TCS activation is arbitrated through a 
series of phosphotransfer reactions which typically involves phosphorylation 
and de-phosphorylation of the sensor histidine kinase (HK) and response 
regulator (RR). A specific environmental stimulus is detected by the HK through 
its sensor domain which brings about a conformational change resulting in two 
HK monomers to dimerize and auto cross-phosphorylate (ATP-dependent) at 
the conserved histidine residue located at its C-terminal domain. The 
phosphorylated HK then serves as a phosphate donor for the RR receiver 
domain, resulting in phosphorylation of a conserved Aspartate residue. The 
phosphorylation of the aspartate residue subsequently results in the activation 
of the RR effector domain that mediates the cellular response, usually by 
differential expression of specific target genes. 
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P. aeruginosa and two-component systems 
Pseudomonas aeruginosa is a ubiquitous, Gram negative bacteria that 
exhibits extraordinary ability to colonize diverse ecological niches. Its metabolic 
versatility and adaptability has significantly contributed to its ubiquity (Ramos, 
2004). Furthermore, P. aeruginosa causes opportunistic infection in humans, and 
is the primary pathogen responsible for pulmonary exacerbations and mortality in 
patients with cystic fibrosis (Lyczak et al., 2002). Importantly, it is one of the most 
recalcitrant nosocomial pathogen, responsible for 10% of all the hospital acquired 
infections (Sievert et al., 2013). Beyond high infection rate, P. aeruginosa has one 
of the highest case fatality rate amongst all Gram-negative infections (Aliaga et al., 
2002).  P. aeruginosa expresses an arsenal of multi-determinant virulence factors, 
both cell surface associated (flagella, pili, LPS) and secretory (proteases, 
exotoxins, phenazines, haemolysins), that play a crucial role in regulating its 
pathogenicity (Balasubramanian et al., 2013). In addition, a major impediment in 
treating P. aeruginosa infections is its extraordinary intrinsic and acquired 
resistance to several clinically critical antibiotics (Fraimow & Nahra, 2013). These 
characteristics together ensures the success of P. aeruginosa as an intractable 
pathogen.   
Furthermore, successful infection and disease progression depends 
significantly on the ability of bacterial pathogens, including P. aeruginosa, to adapt 
efficiently to the host environment. P. aeruginosa has evolved complex signal 
transduction mechanisms that aid in its effective adaptation by regulating and 
coordinating the temporal expression of various genes, in response to both inter- 
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and intracellular signaling molecules and environmental cues (Hancock & Speert, 
2000, Rodrigue et al., 2000, Ventre et al., 2006, Gooderham & Hancock, 2009, 
Williams & Camara, 2009, Haussler, 2010, Jimenez et al., 2012). Amongst the 
gamut of signaling mechanisms identified in P. aeruginosa, TCS mediated signal 
perception play a predominant role in sensing diverse environmental stimuli and 
eliciting a pertinent and rapid adaptive response (Rodrigue et al., 2000, Stock et 
al., 2000).  
P. aeruginosa, genome encodes one of the largest group of TCS proteins 
identified in any in any microorganism thus far analyzed (Barakat et al., 2009, 
Winsor et al., 2011). To date, 62 HK and 73 RR TCS proteins have been identified 
in P. aeruginosa prototypic strain PAO1 (Winsor et al., 2011).  This provides the 
bacterium with a sophisticated capability to regulate diverse metabolic 
adaptations, virulence and antibiotic resistance processes that are hallmark of P. 
aeruginosa infections. What follows is a brief description of some prominent ones. 
PhoQ-PhoP 
PhoQ-PhoP is one of the most extensively studied TCS in the g-
proteobacterial species (Miller et al., 1989, Gooderham & Hancock, 2009). ).  It is 
composed of the inner membrane histidine sensor kinase (HK) PhoQ and the 
cytoplasmic response regulator (RR) PhoP (McPhee et al., 2006). This TCS was 
first identified in Salmonella enterica where it was reported to be involved in 
controlling the expression of non-specific acid phosphatase (Kier et al., 1979). 
Subsequently, a more profound role of the PhoPQ TCS was identified where it was 
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involve in regulating several cellular activities including virulence mechanisms, cell 
cytotoxicity, motility, transport of small molecules, acid tolerance, antibacterial 
peptide resistance and bacterial surface remodeling (Groisman, 2001, Prost et al., 
2008). The PhoQ-PhoP system has been identified as a major component of 
virulence in other Gram-negative bacteria including P. aeruginosa, Escherichia coli 
and S. enterica (Gooderham & Hancock, 2009). The PhoPQ TCS is one of the first 
reported sensory-response mechanism to use extracellular cations as a primary 
signal (Gooderham & Hancock, 2009).  
In P.aeruginosa, PhoQ-PhoP TCS has been reported to modulate cellular 
adaptations to Mg2+-limiting environments (McPhee et al., 2006). It is now well 
established that sub-micromolar concentrations of Mg2+ induce P.aeruginosa 
PhoP-mediated transcription, and millimolar concentrations of Mg2+ are known to 
repress their expression (Gooderham et al., 2009). Furthermore, it is well 
established that the PhoPQ TCS respond to limiting concentrations of cations and 
regulate resistance to polymyxin B and cationic antimicrobial peptides through the 
regulation of the arnBCDTEF-pmrE LPS modification operon (Macfarlane et al., 
2000, McPhee et al., 2006) Activation of the genes in the arnBCADTEF operon 
results in the addition of 4-aminoarabinose to the Lipid A moiety of the 
lipopolysaccharide (LPS). The amalgamation of 4-aminoarabinose and Lipid A is 
responsible for inducing cytotoxicity in Gram-negative bacteria, because of a 
reduction of the net negative charge of the LPS. This limits LPS interaction with 
cationic peptides and cationic antibacterial agents such as polymixin B (McPhee 
et al., 2003, Moskowitz et al., 2004). PhoQ is also involved in swarming and 
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twitching motility as well as in biofilm formation and it is required for virulence 
without affecting the T3SS or QS systems (Gooderham et al., 2009). It differs from 
the Salmonella PhoQ in that it is also involved in the regulation of transcription of 
genes outside the PhoP regulon, including pmrA, algU-mucABCD alginate 
production operon, Type II secretion proteins HxcQ and XqhA, the quinolone signal 
biosynthetic genes (pqsBCD), iron–scavenging-related genes and siderophore 
genes as well as energy-metabolism-related genes including nirO, nosR and 
cytochrome o ubiquinol oxidase operon (Gooderham et al., 2009). Interestingly, P. 
aeruginosa isolates from cystic fibrosis patients have been shown to contain a lipid 
A structure equivalent to that of those formed by the activation of PhoPQ, and to 
generate an inflammatory response, suggesting a role of this TCS in eliciting an 
immune response. Furthermore, HK-PhoQ has been reported to crosstalk with 
other TCS regulatory proteins (PmrA/PmrB) to modulate several cellular 
responses (McPhee et al., 2003). McPhee and coworkers have shown that HK-
PhoQ is able to activate the RR-PmrA independently of HK-PmrB suggesting an 
interaction between these TCSs (McPhee et al., 2003). In addition, increased 
resistance to antibiotics including polymyxin B, aminoglycosides and quinolones in 
phoQ mutants suggest crosstalk between PhoPQ and other TCS (Kwon & Lu, 
2006) 
GacS-GacA 
The sensor HK-GacS (PA0928) and the RR-GacA (PA2586) are members 
of a TCS that is present in a wide variety of Gram-negative bacteria (Heeb & Haas, 
2001). In P. aeruginosa, the GacSA TCS is central to the regulation of the 
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expression of virulence factors, secondary metabolites, biofilm formation and QS 
(Kitten et al., 1998, Pessi et al., 2001) and to the switch between acute and chronic 
infections, as seen in mouse models of cystic fibrosis infection (Rahme et al., 2000, 
Coleman et al., 2003). GacS is a hybrid sensor HK that contains a HK domain, a 
RR domain and a histidine phosphotransfer (Hpt) domain (Goodman et al., 2004, 
Gooderham & Hancock, 2009). The signal transduction pathway from GacA to 
individual virulence genes is complex. Phosphorylated GacA positively regulates 
the transcription of two small RNAs, rsmZ and rsmY, which block the negative 
regulator RNA-binding protein RsmA, allowing the expression of QS signals, 
swarming motility, rhamnolipid and lipid biosynthesis (Heeb & Haas, 2001, 
Wolfgang et al., 2003, Brencic & Lory, 2009). The GacSA TCS is also involved in 
antibiotic resistance to three different antibiotics: tobramycin, ciprofloxacin and 
tetracycline (Linares et al., 2006) apparently mediated also by RsmA/RsmZ. The 
mechanisms of resistance are poorly understood, and susceptibility to other 
antibiotics or antimicrobial peptides remains unaffected. 
RetS and LadS  
P. aeruginosa utilizes two orphan sensor kinases, RetS (regulator of 
exopolysaccharide and T3SS; PA4856) and LadS (lost adherence sensor, 
PA3974), to switch between acute and chronic infections and to regulate virulence 
mainly through the interaction with GacA-GacS (Goodman et al., 2004, Yahr & 
Greenberg, 2004). RetS contains one HK domain and two tandem RR receiver 
domain (Goodman et al., 2004). LadS domain organization is similar to that of 
RetS, but it does not contain the second C-terminal RR domain (Ventre et al., 
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2006). LadS regulates both early and late maturation stages of biofilm formation 
LadS and RetS are hybrid sensor kinases with a signaling domain consisting of a 
7-transmembrane region and a periplasmic sensor domain that mediates homo- 
and hetero-dimer formation (Goodman et al., 2004). RetS is required for T3SS 
activation, repression of biofilm formation, and colonization/dissemination in 
murine acute infection models (Goodman et al., 2004, Laskowski et al., 2004, 
Zolfaghar et al., 2005). Genes under RetS control are inversely regulated by two 
other sensor kinases: GacS and LadS, probably through the regulation of the small 
RNAs RsmZ and RsmA, as suggested by the demonstration that RetS can directly 
interact with GacS modulating the levels of RsmZ and RsmA (Ventre et al., 2006, 
Gooderham & Hancock, 2009). LadS regulates biofilm formation probably through 
the regulation of the pel exopolysaccharide operon (Ventre et al., 2006). In a rat 
model with chronic pulmonary infection, LadS and RetS have been reported to 
regulate the expression of HcpI secretion island I (required for chronic 
infection), thus are also thought to have an important role in chronic infection in 
CF by actively regulating HcpI secretion island I (Potvin et al., 2003).  LadS 
together with RetS and GacA/GacS/RsmZ forms a intricate and dynamic 
network that directs the expression of P. aeruginosa key virulence mechanisms 
resulting in acute infection (expression of Type III secretion) and chronic 
infections (biofilm formation) (Goodman et al., 2004, Yahr & Wolfgang, 2006, 
Gooderham & Hancock, 2009). However, the exact regulatory mechanism as 
to how LadS and RetS sensors bring about the cascade of signal transduction 
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by modulating the expression of  rsmZ and rsmY transcription is not known, but 
it is possible that other response regulators may be involved (Laskowski & 
Kazmierczak, 2006). 
NarL-NarX 
P. aeruginosa is often known to assume a biofilm mode of growth that is 
marked by a substantial metabolic alterations as a consequence of its genetic and 
phenotypic variations (Waite et al., 2006, Schreiber et al., 2007). The ability of P. 
aeruginosa to grow as biofilms can be largely attributed to its metabolic flexibility 
and adaptability that enables it to grow in a low nutrient and oxygen-limited 
environment, a characteristic of biofilms. In particular, anaerobic respiration by P. 
aeruginosa is considered to be a vital metabolic process during its growth as a 
biolfim in chronic pulmonary infections (Barraud et al., 2006, Palmer et al., 2007). 
Under anaerobic conditions, P. aeruginosa survives and supports its growth either 
by arginine fermentation or by denitrification (Palmer et al., 2005, Palmer et al., 
2007). NarX and NarL TCS pair in P. aeruginosa is known to be involved in 
regulating P. aeruginosa denitrification pathways (Schreiber et al., 2007). 
Denitrification pathways play an important role in anaerobic respiration, where, in 
the absence of oxygen organism respire nitrate (No3-) or nitrite (No2-). In 
P.aeruginosa, the Anr (PA1544), Dnr (PA0527) regulatory proteins in concert with 
NarL-NarX TCS control the expression of genes encoding proteins required for 
denitrification (Benkert et al., 2008). The NarX is a HK which contains a highly 
conserved nitrate recognition region. This region is termed as a P-box which 
recognizes environmental presence of nitrate to which NarX responds by 
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autophosphorylating a conserved histidine residue (Stewart & Bledsoe, 2008). 
Further, the transfer of high energy phosphate to the conserved aspartate residue 
of the response regulator NarL results in activation or repression of target operon 
(Stewart & Bledsoe, 2008). Nitrate metabolism has been linked to motility, biofilm 
formation and virulence. NarX-HK is reported to be required for swarming motility, 
although the swarming phenotype has been displayed in a narL mutant as a result 
of overproduction of rhamnolipids (Van Alst et al., 2007). Also, narLX double 
mutants displayed reduced swimming motility in comparison to individual narL and 
narX mutants which exhibited normal motility, suggesting that the flagella 
dependent movement requires both the sensor kinase and the response regulator 
(Van Alst et al., 2007). Thus, the NarX–NarL TCS is involved in regulation several 
P. aeruginosa virulence related phenotypes including motility and biofilm 
formation.  
Conclusion: 
The versatility of two-component regulatory systems in sensing different signals, 
both extracellular and intracellular, make them an appropriate system for 
regulating expression of virulence and metabolism. P. aeruginosa genome 
encodes one of the largest groups of TCSs proteins (135), in sequenced bacteria 
(Winsor et al., 2011). Amongst these only few have been extensively studied and 
characterized in detail, including  PhoP-PhoQ,  GacA-GacS, RetS, LadS, and 
NarL-NarX, that are reported to be responsible for regulating P. aeruginosa key 
virulence determinants. Furthermore, in most of the cases, the environmental 
signals that influence TCS pathways remains obscure. However, there are a 
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plethora of uncharacterized putative TCSs in P.aeruginosa. Taking into 
consideration the metabolic adaptability and the plethora of uncharacterized 
putative TCSs in P.aeruginosa, it is most likely that some of these putative systems 
may have important roles in virulence, antibiotic resistance and metabolism. 
Further research is required to characterize these role of these putative TCS by  
elucidate there activating signals, identifying their targets and also various 
regulatory networks into which TCS are integrated, since these systems can be 
appropriate drug targets for  effective antimicrobial therapeutics.  
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Pseudomonas aeruginosa MifS-MifR two-component system is specific for 
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Abstract  
Pseudomonas aeruginosa is a Gram-negative, metabolically versatile 
opportunistic pathogen that elaborates multitude of virulence factors, and is 
extraordinarily resistance to a gamut of clinically significant antibiotics. This ability, 
in part, is mediated by two-component regulatory systems (TCS) that play a crucial 
role in modulating virulence mechanisms and metabolism. MifS (PA5512) and 
MifR (PA5511) form one such TCS implicated in biofilm formation. MifS is a sensor 
kinase whereas MifR belongs to the NtrC superfamily of transcriptional regulators 
that interact with RpoN (σ54). In this study we demonstrate that the mifS and mifR 
genes form a two-gene operon. The close proximity of mifSR operon to poxB 
(PA5514) encoding a ß-lactamase hinted at the role of MifSR TCS in regulating 
antibiotic resistance. To better understand this TCS, clean in-frame deletions were 
made in P. aeruginosa PAO1 creating PAO∆mifS, PAO∆mifR and PAO∆mifSR. 
The loss of mifSR had no effect on the antibiotic resistance profile. Phenotypic 
microarray (BioLOG) analyses of PAO∆mifS and PAO∆mifR revealed that these 
mutants were unable to utilize C5-dicarboxylate α-ketoglutarate (α-KG), a key 
tricarboxylic acid cycle intermediate. This finding was confirmed using growth 
analyses, and the defect can be rescued by mifR or mifSR expressed in trans. 
These mifSR mutants were able to utilize all the other TCA cycle intermediates 
(citrate, succinate, fumarate, oxaloacetate or malate) and sugars (glucose or 
sucrose) except α-KG as the sole carbon source. We confirmed that the mifSR 
mutants have functional dehydrogenase complex suggesting a possible defect in 
α-KG transport. The inability of the mutants to utilize α-KG was rescued by 
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expressing PA5530, encoding C5-dicarboxylate transporter, under a regulatable 
promoter. In addition, we demonstrate that besides MifSR and PA5530, α-KG 
utilization requires functional RpoN. These data clearly suggests that P. 
aeruginosa MifSR TCS is involved in sensing α-KG and regulating its transport and 
subsequent metabolism.  
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Introduction  
Pseudomonas aeruginosa is a metabolically versatile, Gram-negative 
opportunistic pathogen that is well known for its extensive spatio-temporal 
distribution (Ramos, 2004). It is a dominant nosocomial pathogen capable of 
causing acute and chronic infections in immunocompromised and 
immunosuppressed patients (Ledizet et al., 2012, Turner et al., 2014). In particular, 
patients with AIDS, severe burn wounds, cystic fibrosis (Brencic et al.), chronic 
obstructive pulmonary disease (COPD), non-CF bronchiectasis and neutropenia 
are predisposed to P. aeruginosa infections (Lyczak et al., 2000, Manfredi et al., 
2000, Ramos, 2004, Furukawa et al., 2006, Valderrey et al., 2010). P. aeruginosa 
chronic pulmonary infections are characterized by intensive bronchial neutrophilic 
inflammation resulting in respiratory failure (Emerson et al., 2002, Cohen-
Cymberknoh et al., 2013), a major cause of fatality in CF patients (Lyczak et al., 
2002). Moreover, P. aeruginosa is associated with keratitis (Dart & Seal, 1988) and 
chronic suppurative otitis media (Yeo et al., 2007) leading to visual impairment and 
deafness (Prevatt et al., 2004, Sun et al., 2010). P. aeruginosa possess numerous 
virulence factors, both cell-surface associated and secretory, which significantly 
contribute to its pathogenesis (Balasubramanian et al., 2013). Effective treatment 
of P. aeruginosa infections is impeded by its extraordinary intrinsic and acquired 
resistance to numerous clinically important antibiotics (Fraimow & Nahra, 2013). 
Thus, antibiotic resistance and expression of multi-determinant virulence factors 
are two critical hallmarks in P. aeruginosa infections that make it an intimidating 
pathogen.  
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Successful infection and disease progression depends significantly on the 
ability of any pathogen to effectively utilize available nutrients that are essential for 
its growth and survival. P. aeruginosa is renowned for its extraordinary ability to 
utilize wide range of organic compounds such as carbohydrates, amino acids, fatty 
acids, mono- and polyalcohols, di- and tri-carboxylic acids as sources of carbon, 
nitrogen and energy (Ramos, 2004). However, unlike other bacteria where glucose 
is the preferred carbon source (Loomis & Magasanik, 1967, Stulke & Hillen, 2000), 
P. aeruginosa preferentially utilizes tricarboxylic acid (TCA) cycle intermediates 
(Wolff et al., 1991, Collier et al., 1996), specifically, C4-dicarboxylates of the TCA 
cycle such as malate, fumarate and succinate (Liu, 1952, Wolff et al., 1991, Collier 
et al., 1996).  
The TCA cycle is an amphibolic pathway that serves two main purposes: 
energy-generation in aerobic organisms (catabolism), and the generation of 
intermediates to serve as biosynthetic precursors for fatty acid, amino acid and 
carbohydrate synthesis (anabolism) (Owen et al., 2002). The metabolic 
intermediates of the TCA cycle consist of a group of organic anions that include 
C4-dicarboxylates (succinate, fumarate, malate and oxaloacetate), C5-
dicarboxylates (alpha-ketoglutarate (α-KG)) and C6-tricarboxylates (citrate, 
isocitrate) (Krebs, 1940, Frohman et al., 1951). However, the role of TCA cycle 
intermediates is not restricted to energy metabolism or to serve as biosynthetic 
precursors. In the recent years, TCA cycle intermediates, in-particular, succinate 
and/or α-KG have gained significant importance as biological signaling molecules 
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in variety of organisms including, bacteria (Ninfa & Jiang, 2005), animals (He et 
al., 2004) and plants (Feria Bourrellier et al., 2010).  
Sensing the available nutrients is a prerequisite for mobilizing the uptake 
systems. Bacterial two-component systems (TCSs), involving a membrane-bound 
histidine sensor kinase (HK) and a cytoplasmic response regulator (RR) play an 
integral part in bacteria’s ability to sense physiological cues. In response to stimuli, 
the sensor autophosporylates at a conserved histidine residue at the C-terminus, 
and subsequently the phosphate is transferred to an aspartate residue at the N-
terminus of the RR (Stock et al., 1989, Hoch & Silhavy, 1995, Asai et al., 2000). 
TCSs in Bacillus subtilis, Corynebacterium glutamicum, Escherichia coli, Klebsiella 
pneumoniae, Rhizobium meliloti and Rhizobium leguminosarum have been shown 
to regulate extracellular C4-dicarboxylates and tricarboxylates transport (Jiang et 
al., 1989, Bott et al., 1995, Reid & Poole, 1998, Golby et al., 1999, Asai et al., 
2000, Yamamoto et al., 2000, Brocker et al., 2009). Of these, DctB-DctD in R. 
meliloti is an extensively studied TCS, which in coordination with sigma factor 
RpoN(σ54) regulates the extracellular transport of C4-dicarboxylates succinate, 
fumarate and malate (Ronson et al., 1987, Watson, 1990).  
Three TCS protein pairs in P. aeruginosa namely, PA5165/PA5166 
(DctB/DctD), PA5512/PA5511 (MifS/MifR) and PA1336/PA1335 have been 
identified to be homologous to the Rhizobium C4-dicarboxylate transport regulatory 
DctB/DctD (Valentini et al., 2011). Amongst the three, very little is known of 
PA1336/PA1335. The PA5165/PA5166 (DctB/DctD) TCS has been demonstrated 
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to regulate the transport of C4-dicarboxylates, succinate, fumarate and malate in 
coordination with the sigma factor RpoN (σ54) (Valentini et al., 2011). The SK MifS 
(65.3 kDa) and RR MifR (49.6 kDa) share 51% and 69% sequence identity to the 
R. meliloti DctB and DctD, respectively (Stover et al., 2000). The RR MifR is 
involved in regulating the maturation stage of P. aeruginosa biofilm formation as 
mifR deficient mutants fail to form microcolonies (Petrova & Sauer, 2009). Later 
studies reported the interdependence of pyruvate fermentation and functional MifR 
in supporting microcolony formation (Petrova et al., 2012). However, the 
mechanism by which MifR is activated in this process remains obscure and no 
relation with HK MifS has been established. Using clean in-frame deletion mutants 
of the mifS, mifR and mifSR genes we show that MifSR TCS regulates P. 
aeruginosa α-KG transport and requires functional RpoN. 
Materials & Methods 
Strains, media and growth conditions 
P. aeruginosa wild-type PAO1 (Stover et al., 2000) and its derivatives 
PAO∆mifS, PAO∆mifR, PAO∆mifSR and PAO∆rpoN or Escherichia coli strain 
DH5α were used in this study (Table 2.1). Saccharomyces cerevisiae strain 
InvSC1 (Invitrogen, Life Technologies, Carlsbard, CA, USA) was used for in vivo 
homologous recombination (Bascom-Slack & Dawson, 1998). Briefly, all bacterial 
cultures were grown in Luria Bertani (LB) broth (5 g tryptone, 10 g sodium chloride, 
and 5 g yeast extract per liter) or agar (LB broth with 1.5% agar) (Difco, NJ, USA) 
or M9 minimal Media (64 g Na2HPO4-7H2O, 15 g KH2PO4, 2.5 g NaCl, 5.0 g NH4Cl, 
20 mM MgSO4, 1 mM CaCl2 per liter) (Sambrook & Russell, 2001) at 37οC, unless 
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specified otherwise. Yeast extract-peptone-dextrose media (YEPD: 20 g Bacto 
Peptone, 10 g yeast extract, 20 g dextrose per liter) was routinely used to culture 
S. cerevisiae and synthetic define agar-uracil media was used as selection media 
for pMQ30 yeast transformants (Shanks et al., 2006).  P. aeruginosa competent 
cells were prepared as previously described (Choi et al., 2006). For growth curve 
and complementation studies M9 minimal media supplemented with glucose, 
sucrose or TCA cycle intermediates including citrate, α-KG, succinate, fumarate, 
malate or oxaloacetate were used as a sole carbon source at 30 mM each unless 
specified otherwise. Motility assays were performed in LB media (Difco, NJ, USA). 
For pyocyanin and proverdine production strains were cultivated in King’s A 
medium (Difco, NJ, USA) and King’s B medium (King et al., 1954). Cation-adjusted 
Mueller Hinton broth and agar (Difco, NJ, USA) was used in MIC assays. For 
plasmid maintenance, antibiotics were added to growth media when appropriate, 
at the specified concentrations: E. coli: ampicillin (Ap) 100 μg/ml, gentamycin 
(Siegmund & Wagner) 15 μg/ml, kanamycin (Km) 20 μg/ml, P. aeruginosa: Gm 75 
μg/ml. 
Genetic manipulations  
Genetic manipulations were carried out using standard techniques 
(Sambrook & Russell, 2001). Primers were synthesized by Integrated DNA 
Technologies, Inc. (Coralville, IA, USA) and are listed in Table 2.2. Plasmid DNA 
isolation was carried out using PureLink Hipure Plasmid Miniprep Kit (Invitrogen, 
Life Technologies, Carlsbard, CA, USA) and agarose gel fragments were purified 
using Wizard SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA). 
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RNA and cDNA was made using RNeasy Mini Kit (Qiagen Inc. Venio, Limburg, 
Netherlands) and SuperScript III First-Strand Synthesis System (Invitrogen, Life 
Technologies, Carlsbard, CA, USA). Restriction endonucleases were from New 
England Biolabs (Ipswich, MA, USA) and DNA sequencing was carried out at 
Florida International University (FIU) DNA core and at GENEWIZ Inc (South 
Plainfield, NJ, USA). All other chemicals were purchased from SIGMA-ALDRICH 
(St. Louis, MO, USA), AMRESCO (Solon, OH, USA) and Fisher Scientific 
(Waltham, MA, USA). 
 
Table 2.1: Strains and plasmids used in this study. 
Strain ID Strain/Plasmid Background Relevant characteristics Source 
Escherichia coli 
DH5α E. coli 
F- Φ80lacZΔM15Δ 
(lacZYA-argF)U169 deoR 
recA1 endA1 hsdR17 (rk- 
mk+) phoA supE44 λ- thi-1 
gyrA96 relA1 
New England 
Biolabs 
Saccharomyces cerevisiae 
INVSc1 S. cerevisiae MATa his3D1 leu2 trp1-289 ura3-52 Invitrogen 
Pseudomonas aeruginosa 
PAO1  Prototypic wild type (Stover et al., 2000) 
PKM900 PAO1 ∆mifS (PA5512) PAO∆mifS; This study 
PKM901 PAO1 ∆mifR (PA5511) PAO∆mifR; This study 
PKM902 PAO1 ∆mifSR (PA5511-PA5512) PAO∆mifSR;This study 
PAOΔrpoN PAO1 ∆rpoN (PA4462) (Heurlier et al., 2003) 
PAO1ΔrpoN
::rpoN PAO1 
∆rpoN att Tn7::rpoN_ 
aacC1 
(Heurlier et al., 
2003) 
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Plasmids 
pCR2.1 
TOPO  
ApR, KmR; colE1 f1 ori 
lacZα Invitrogen 
pRK600  CmR; colE1  tra+RK2 mob+ (Kessler et al., 1992) 
pRK2013  KmR; colE1 tra+ RK2 mob+ (Figurski & Helinski, 1979) 
pEXG2  Gm
R; colE1, oriT mob+ 
sacB+  
(Rietsch et al., 
2005) 
pMQ30  GmR; colE1, oriT  (Shanks et al., 2006) 
pPSV37  Gm
R; colE1  oriT lacIq 
PlacUV5  
(Lee et al., 
2010) 
pGDT001 pCR2.1 TOPO 
ApR; A ~1.7-kb NheI-XbaI 
fragment containing mifS 
ORF (PA5512) amplified 
from PAO1 genome using 
HK_mifSF1 and 
HK_mifSR1 primers and 
cloned into pCR 2.1 TOPO 
This study 
pGDT002 pCR2.1 TOPO 
ApR; A ~1.3-kb NheI-SacI 
fragment containing mifR 
(PA5511) ORF amplified 
from PAO1 genome using 
GDT_mifRF1 and 
GDT_mifRR1 primers and 
cloned into pCR 2.1 TOPO 
This study 
pGDT003 pPSV37 
GmR; The mifS ORF 
subcloned from pGDT001 
as an NheI-XbaI fragment 
into pPSV37  
pMifS 
This study 
pGDT004 pPSV37 
GmR; The mifR ORF 
subcloned from pGDT002 
as an NheI-SacI fragment 
into pPSV37  
pMifR 
This study 
pGDT005 pPSV37 
GmR; A ~3.0-kb NheI-SacI 
fragment containing mifSR 
(PA5511-PA5512) ORFs 
amplified from PAO1 
genome using HK_mifSF1 
and GDT_mifRR1 primers 
and cloned directly into 
NheI-SacI-cut in pPSV37  
pMifSR 
This study 
pGDT006 pPSV37 Gm
R; A ~1.3-kb NheI-SacI 
fragmentcontaining 
pPA5530 This 
study 
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PA5530 ORF amplified 
from PAO1 genome using 
GDT_PA5530F1 and 
GDT_PA5530R1 primers 
and cloned directly into 
NheI-SacI-cut in pPSV37 
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Table 2.2. Primers used in this study. 
Primer Name Sequence 
HKmifSUF 
5’-
GGAATTGTGAGCGGATAACAATTTCACACAGGAA
ACAGCTTCAGCTCGACTCCGCCGTCG-3’ 
HKmifSUR 
5’-
GACGAAGATCACCTGGTCGCCTAGTTAGCTAGCA
TCGGCGGATCGAAACGGC-3’ 
HKmifSDF 
5’-
GCCGTTTCGATCCGCCGATGCTAGCTAACTAGGC
GACCAGGTGATCTTCGTC-3’ 
HKmifSDR 
5’-
CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCG
TTCTGATACCGCTCTCATGACCGAA-3’ 
mifRUF1 5’-TTTGAATTCGCCTGGTCGAGCAGCGCA-3’ 
mifRUR1 5’-TTTGCTAGCTCGCTCATGTCG-3’ 
mifRDF1 5’-TTTAAGCTTCTCGGCTTCGACGCCCAT  
mifRDR1 5’-TTTGCTAGCTCGCGAGGCGTC-3’ 
mifSRUF1 
5’- 
GGAATTGTGAGCGGATAACAATTTCACACAGGAA
ACAGCTGCGAGCACCAGCGCGCCACT-3’ 
mifSRUR1 
5’-
TCTCTGACGCCTCGCGAGGGCTGCTCTAGTTAGC
TAGCATCGGCGGATCGAAACGGCGGC-3’ 
mifSRDF1 
5’-
GCCGTTTCGATCCGCCGATGCTAGCTAACTAGAG
CAGCCCTCGCGAGGCGTCAGAGA-3’ 
mifSRDR1 
5’-
CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCG
TTCTGATTACGTGTTCAGCGCGCTG-3’ 
HK_mifSF1 
5’-
GCTAGCAGAAGGAGATATACCATGTCCTTGTCCC
GTCCGCTG-3’ 
HK_mifSR1 5’-TTTTCTAGATCATGTCGTTACGCTCGTGTC-3’ 
GDT_mifRF1 
5’-
GCTAGCAGAAGGAGATATACCATGAGCGACCAG
GTGATCTTCGTCGAC-3’ 
GDT_mifRR1 5’-TTTGAGCTCTGCTTCAGGCCGGCTCTTCGC-3’ 
GDT_PA5530F1 
5’-
GCTAGCAGAAGGAGATATACCATGGAAAGCGCCA
AC-3’ 
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qRT in the primer name indicates that the primer was designed for qPCR. Broken 
and continuous lines below the primer sequence indicate ribosome binding and 
restriction sites respectively.  
  
GDT_PA5530R1 
5’-
TTTGAGCTCTCAATCGGTCGTGATCTTCGAGTGC-
3’ 
GDT_cotransF1 5’-GGTGTTCAGCCTGATCCTGCCGG-3’ 
GDT_cotransR1 5’-CCGCTTCGCGGATCGTCGCTTC-3’  
GDT_cotransF2 5’-GGATCGTCCACGAACTCGGCGGC-3’ 
GDT_cotransR2 5’-CAGGCGCACCTCGAAGCCGGAC-3’  
GDT_p37_SeqF 5’-GACCCGTTTAGAGGCCCCAA-3’ 
GDT_p37_SeqR 5’-CGTGCTTTACACTTTATGCTTCCGG-3’ 
mifR_seqF 5’-TGGTGCTGGAGAACCGGC-3’ 
mifR_seqR 5’-GCAGTTCAGCGCCACGAAC-3’ 
mifS_SeqF 5’-ATCTGGAACGGCAGTGGAACC-3’ 
mifS_SeqF2 5’-ATCGACGGCGAGTTGCAGCA-3’ 
PA5530_seqF 5’-TCGCGGCATGGAAGAGAC-3’ 
PA5530_seqR 5’-CATGCCGCGACGCAG -3’ 
DBS_qRT_clpXF 5'- TGCGATTACGATGTGGAGA -3' 
DBS_qRT_clpXR 5'- CCCTCGATGAGCTTCAGCA -3' 
GDT_qRT_PA5530F 5'-CGCAACGCATCAAGTCGAT-3' 
GDT_qRT_PA5530R 5'-AGTCGTACCACTCGACCAGGTT-3' 
qRT_rpoNF 5'-AAATGCGAAAAAGCCATTGAG-3' 
qRT_rpoNR 5'-CCCTGTGCCTCCAGTAAACC-3' 
qRT_icdF 5'-GCGACCGGTGACAAAATCAC-3' 
qRT_icdR 5'-GGGTTCTTCGGTACGCTCAA-3' 
qRT_idhF 5'-GGCGATGATCCGCAACTC-3' 
qRT_idhR 5'-GCATTACCGCCTTGGTGTCT-3' 
qRT_sucAF 5'-CTGCAGCCAGCATCACATG-3' 
qRT_sucAR 5'-CGAGATTGAGGCCCTTCTTG-3' 
qRT_lpd3F 5'-CATGCGGCGGAGATGAAC-3' 
qRT_lpd3R 5'-ACTTCCGGCTGGGTGTAGATG-3' 
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Construction of P. aeruginosa ∆mifR mutant 
An unmarked mifR clean in-frame deletion mutant of P. aeruginosa was 
generated by gene splicing (Horton et al., 1990). Upstream and downstream 
flanking regions of mifR were amplified by PCR (GC Rich PCR System, Roche, 
Indianapolis, IN, USA), using primers listed in Table 2.2. A 754-bp P1 and a 720-
bp P2 were amplified using upstream primers mifRUF1-EcoRI and mifRUR1-NheI 
and the downstream primers mifRDF1-NheI and mifRDR1-HindIII (Table 2.2), 
respectively from PAO1 genomic DNA. After sequencing to ensure fidelity, P1 and 
P2 were spliced together to obtain a 1474-bp deletion fragment with a deletion of 
mifR containing stop codons at its junction (inserted as part of NheI site in the 
primer). This was then sequenced and subcloned into a P. aeruginosa non-
replicative plasmid pEXG2 (Rietsch et al., 2005) as a EcoRI-HindIII fragment and 
moved into the wild-type PAO1 strain by allelic replacement (Schweizer & Hoang, 
1995) using pRK600 and pRK2013 as the helper plasmids (Figurski & Helinski, 
1979, Kessler et al., 1992) . Clones were screened for Gm sensitivity (75 µg ml−1) 
and sucrose resistance (8 % sucrose) corresponding to a double cross-over 
recombination event and replacement of the target gene with the deletion product. 
The presence of the deletion in PAOΔmifR (PKM901) was confirmed by PCR 
amplification and sequencing of the deletion product (data not shown). 
Construction of P. aeruginosa ΔmifS and ΔmifSR mutants 
The unmarked mifS and mifSR deletion in PAO1 was generated by using 
the yeast system of double-stranded gap repair and homologous recombination 
(Shanks et al., 2009). Briefly, the mifS and mifSR upstream and downstream 
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flanking regions were amplified by PCR using primers listed in Table 2.2.  To create 
a mifSR deletion, an upstream 933-bp P1 and a downstream 1115-bp P2 were 
amplified using primer pairs mifSRUF1-mifSRDF1 and mifSRUR1-mifSRDR1, 
respectively. Similarly, to create mifS deletion, an upstream 703-bp P1 and a 
downstream 653-bp were amplified using primer pairs HKmifSUF-HKmifSDF and 
HKmifSUR-HKmifSDR, respectively.   HKmifSUF and mifSRUF1 primers had 
stretches of homologous DNA, 5’-
GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCT-3’ and 5’-
CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCGTTCTGAT-3’, respectively, 
to target recombination of the amplicons with pMQ30 vector. These primer pairs 
also had complementing sequences at the 3’ end to facilitate joining to create the 
P3 fragment, as well as stop codons (CTAGTTAGCTAG) to prevent any run off 
translation. The pMQ30 vector has double selection markers URA3 for yeast and 
gentamycin for E. coli (Shanks et al., 2006). Yeast cells were transformed with the 
P1, P2 and linearized pMQ30 (BamHI digested) using standard protocols  and 
(Shanks et al., 2009) colonies were selected on sucrose-uracil plates. 
The yeast colonies were checked for the presence of P3 constructs for mifS 
and mifSR deletions  by amplification using upstream forward (mifSRUF1 and 
HKmifSUF, respectively) and downstream reverse (mifSRDR1 and HKmifSDR, 
respectively) primers. Yeast DNA was isolated from the positive colonies as 
described earlier (Shanks et al., 2009). E. coli was transformed with the 
recombinant pMQ30 plasmids containing P3s and screened for gentamycin 
resistance. The amplified P3s from the recombinant plasmids were sequenced to 
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ensure fidelity. The constructs were then moved into PAO1 strain using tri-parental 
mating and screened for single and double crossovers using counter selection with 
sucrose and gentamycin as described earlier (Balasubramanian et al., 2012, 
Kumari et al., 2014). The presence of the gene deletions in all the mutants were 
confirmed using standard molecular methods (PCR and DNA sequencing of the 
locus). These strains are henceforth referred to as PAOΔmifS (PKM900) and 
PAOΔmifSR (PKM902). 
Construction of complementing plasmids  
DNA fragments from P. aeruginosa PAO1 with mifS (~1.77 kb) and mifR 
(~1.35 kb) were PCR amplified using primer pairs HK_mifSF1-HK_mifSF1R1, 
GDT_mifRF1-GDT_mifRR1, respectively. In order to ensure expression of the 
genes, the primers are designed such that the ORF will juxtapose against a strong 
ribosome binding site (Lehninger et al., 2013). The PCR amplified products were 
cloned into pCR2.1 TOPO (Invitrogen, Life Technologies, Carlsbard, CA, USA) 
using manufacturers protocol to generate plasmids pGDT001 and pGDT002, 
respectively. The fidelity of the PCR amplified product was confirmed by 
sequencing. The fragments carrying mifS and mifR were moved into a broad host 
range pPSV37-Gm plasmid (Lee et al., 2010) as a NheI-SacI fragments, 
downstream of an inducible PlacUV5 promoter to generate plasmids pGDT003 and 
pGDT004, respectively. Henceforth, these plasmids are referred to as pMifS and 
pMifR.  
 DNA fragments from PAO1 with mifSR (~3.12 kb) and PA5530 (~1.3 kb) 
were PCR amplified using primer pairs HK_mifSF1-GDT_mifRR1 and 
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GDT_PA5530F1-GDT_PA5530R1 (Table 2.2), respectively. The PCR amplified 
products were cloned directly into pPSV37-Gm plasmid as NheI-SacI fragments, 
downstream of an inducible PlacUV5 promoter to generate plasmids pGDT005 and 
pGDT006, respectively. Sequence fidelity was confirmed by sequencing using the 
primers GDT_p37_SeqF-R, mifR_seqF-R, mifS_seqF-F2 and PA5530_seqF-R 
(Table 2.2).  Henceforth, these plasmids are referred to as pMifSR and pPA5530.  
These expression plasmids were then introduced into wild-type PAO1, 
PAO∆mifS, PAO∆mifR, PAO∆mifSR and PAO∆rpoN deletion mutants by 
electroporation (Choi et al., 2006) and gentamycin resistant colonies were 
selected. 
Phenotypic microarray 
Comparative phenotypic microarray profiles of wild-type PAO1 with 
PAO∆mifR and PAO∆mifS mutant were performed at BioLOG Inc. (Hayward, CA, 
USA). Phenotypic profiling was carried out in triplicate and data analyses was done 
using OmniLog PM Software. 
Growth curves 
P. aeruginosa PAO1 and its derivatives were grown overnight at 37˚C in LB 
broth with or without antibiotics. Overnight cultures were washed with sterile 0.85% 
NaCl (wt/vol) solution to remove spent and residual media. Cultures were diluted 
in fresh M9 minimal media to obtain equal optical densities (OD600) of 0.025. 
Growth of the cultures was assessed in LB broth and in M9 minimal media 
supplemented with glucose (30 mM), sucrose (30 mM) or TCA cycle intermediates 
including citrate, α-KG, succinate, fumarate, malate or oxaloacetate (at 30 mM, 
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unless specified otherwise)  as a sole carbon source in 48 and 96 well plates 
(Falcon). Growth was monitored by determining absorbance at 600 nm using 
BioTek Synergy HT (Winooski, VT, USA) plate reader for 18-24 h at 37οC. All 
experiments were performed multiple times in triplicate.   
Pyocyanin and pyoverdine production 
Extracellular pyocyanin was quantified by extracting the pigment from 
culture supernatants using the chloroform-HCL method as described previously 
(Essar et al., 1990). Briefly, 5 ml culture supernatants from stationary-phase 
cultures (∼18 h) grown in King’s A medium was extracted with 3 ml chloroform. 
Pyocyanin was then re-extracted into 1 ml of 0.2 N HCl, resulting in a pink color, 
indicating the presence of pyocyanin that was read at 520 nm. The concentration 
is expressed as µg of pyocyanin produced per ml of culture (µg/ml), by multiplying 
the optical density OD520 by 17.072 (Essar et al., 1990). 
To measure pyoverdine production, cells were grown overnight at 37ᵒC in 
King’s B medium (King et al., 1954). Pyoverdine in the supernatant was read at 
405 nm and normalized to the initial cell density (OD600). Pyoverdine levels were 
expressed as a ratio of OD405/OD600 (Shen et al., 2002).  
Minimum Inhibitory Concentration 
 MICs were determined using the E-test as per the manufacturers protocol 
(BioMerieux, USA) and/or by standard broth microdilution method . The assays 
were performed in triplicate, each with technical triplicate, for each antibiotic in 
cation-adjusted Mueller Hinton broth. 
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RNA isolation, cDNA synthesis and qRT-PCR 
RNA was isolated from P. aeruginosa wild-type PAO1, PAO∆mifR, 
PAO∆mifS and PAO∆mifSR strains grown in LB broth followed by 1 h treatment 
with 30 mM α-KG. Briefly, overnight cultures grown in LB broth at 37˚C were 
washed with sterile 0.85% saline solution to remove spent media and were 
subcultured at 37˚C, 200 rpm in LB media. LB broth was used as a carbon source 
for initial growth of cultures since PAO∆mifR, PAO∆mifS, PAO∆mifSR and 
PAO∆rpoN strains exhibit growth defects in the presence of α-KG alone. When the 
cells reached an optical density at 600 nm (OD600) of 0.6-0.7 all the cultures were 
treated with 30 mM α-KG for 1 h. Post treatment, RNA was stabilized by addition 
of phenol-ethanol mixture (Brencic et al., 2009). Stabilized RNA was then isolated 
using RNeasy Mini Kit (Qiagen, Inc Venio, Limburg, Netherlands) as per 
manufacturer’s protocol. Residual genomic DNA contamination was removed 
using RQ1 Rnase-free DNase (Promega, Madison, WI, USA) and RNA was 
repurified using Rneasy Mini Kit (Qiagen, Inc Venio, Limburg, Netherlands). 
Quality of purified RNA was assessed on a denaturing agarose gel (NorthernMax 
Gly, Ambion, Life Technologies, Carlsbard, CA, USA) and quantified at 260 nm 
(BioTEK, Synergy HT, Winooski, VT, USA). cDNA was then synthesized by 
annealing NS5 random primers to total purified RNA and subsequent extension 
was carried out using SuperScript III reverse transcriptase (Invitrogen, Life 
Technologies, Carlsbard, CA, USA).  
qRT-PCR to study expression levels of PA5530 under α-KG induction was 
performed using Applied Biosystems Step One cycler and detection system with 
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PowerSYBR Green PCR MasterMix with ROX (Applied Biosystems, Life 
Technologies, Carlsbard, CA, USA). In addition RNA was isolated from PAO1, 
PAO∆mifR, PAO∆mifS and PAO∆mifSR strains grown in M9 Minimal media 
supplemented with citrate (30 mM) without α-KG treatment, as described 
previously. qRT-PCR to study expression levels of genes encoding sigma-54 rpoN 
(PA4462), iso-citrate dehydrogenase (idh (PA2623) and icd (PA2624)), α-KG 
dehydrogenase complex (sucA (PA1585) and lpd3 (PA4829)) were done 
essentially as described above. The cycling conditions used were 95˚C/2 minutes 
(holding); 40 cycles of 95˚C/15 sec, 60˚C/1 min (cycling); 95˚C/15 sec, 60˚C/1 min, 
95˚C/15 sec (0.6˚C ramp) (melt curve). Expression was normalized to clpX 
(PA1802), whose expression was determined to remain constant between the 
samples and conditions tested (Balasubramanian et al., 2012). 
Bioinformatic Analyses 
Sequence analyses and domain organization studies were performed using the 
Simple Modular Architecture Research Tool (SMART) (Schultz et al., 1998) and 
InterPro domain prediction database (Hunter et al., 2012). mifS (PmifS) and PA5530 
(PPA5530)  promoter analyses and motif search was done using the ensemble 
learning method SCOPE and GLAM2 (Gapped Local Alignment of Motifs) 
(Chakravarty et al., 2007, Frith et al., 2008). Multiple sequence alignment was 
generated using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) and 
www.pseudomonas.com (Winsor et al., 2011). 
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Statistical Analyses 
All data were analyzed for statistical significance using the Student’s t-test 
on GraphPad or Analysis of Variance (ANOVA) with post-hoc testing when 
appropriate, on IBM SPSS Statistics 22.0 statistical analysis software. Differences 
were considered to be significant at p- values < 0.05. 
Results 
mifS and mifR are a part of a two-gene operon 
In eubacteria, the genes that encode a HK and its cognate RR are often 
linked and are co-transcribed (Stock et al., 1989). Our sequence analysis of P. 
aeruginosa PAO1 genome revealed that mifS (PA5512) and mifR (PA5511) are 
adjacent to each other, in the same orientation. The predicted translation start site 
of mifR ORF overlaps with mifS translation termination codon indicating that they 
are cotranscribed (Figure 2.1A and 2.1B). To determine if these two genes form 
an operon, cDNA across the intergenic regions spanning mifS and mifR was 
amplified using GDT_cotransF1-R1 and GDT_cotransF2-R2 primers (see 
Materials and Methods)x. As expected, 200 bp and 100 bp products were detected 
when using primers that span the overlapping region (Figure 2.1C, Lane 3 and 
Lane 4). These results confirm that mifS and mifR are a part of a two-gene operon. 
As controls, the mifSR genes were also amplified (Figure 2.1C, Lane 2).  
Loss of mifS and mifR did not affect antibiotic resistance 
To identify the role of MifSR TCS, clean in-frame deletion mutants of mifS, 
mifR and mifSR were constructed in the prototypic P. aeruginosa PAO1. 
Henceforth they will be referred to as PAO∆mifS, PAO∆mifR and PAO∆mifSR, 
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respectively. For complementation studies, recombinant plasmids containing the 
entire mifR, mifS and mifSR genes were constructed. The complementing 
plasmids with the genes are called pMifS, pMifR and pMifSR. These plasmids were 
introduced into the respective mutant strains. 
 
37	
	 	 	
  
Figure 2.1: Genome organization of the mifSR gene locus. In P. aeruginosa 
PAO1 the mifR (PA5511) ORF has a translation start codon (Briard et al.) 
overlapping the mifS (PA5512) termination codon (TGA), denoted in red (B), 
suggesting that the mifS and mifR genes are physically linked. The cDNA 
amplification of the intergenic region spanning the mifS and mifR genes using 
GDT_cotrans F1-R1 and GDT_cotrans F2-R2 primers (Table 1) confirm that the 
two genes mifS and mifR are co-transcribed and form an operon (C).  
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Previous studies in our lab postulated that the MifSR TCS system, found 
81-bp upstream of the pox operon, may contribute to P. aeruginosa ß-lactam 
resistance (Kong et al., 2005) as the genes regulated by TCS tend to be co-located 
on the chromosome (Stock et al., 1989). However, MIC analyses using E-test and 
micro-dilution methods showed that the loss of these genes did not affect the 
antibiotic resistance profile when compared to the parent strain, P. aeruginosa 
PAO1(Data not shown). Further, qRT-PCR studies showed that deletion of mifS, 
mifR and mifSR had no effect on the expression of poxB compared to the parent 
PAO1 (Figure 2.2). 
 
 
 
 
 
 
 
 
 
Figure 2:2 Expression of poxB (PA5514) in mifSR mutants. Expression of 
poxB (PA5514) was tested in mifSR mutants relative to PAO1. Data was 
normalized to expression in PAO1. Bars above or below the line represents up- 
and down-regulation, respectively and the bars indicate standard errors. The 
clpX gene (PA1802) was used as the housekeeping control. There was no 
statistically significant difference (p-value > 0.05) between the wild type PAO1 
and mifSR mutant strains as determined by one-way ANOVA and student’s 
unpaired t test. 
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mifS, mifR and mifSR mutants failed to grow in the presence of α-KG 
The PAO∆mifS, PAO∆mifR and PAO∆mifSR mutants exhibited no 
discernible phenotype compared to the parent PAO1 when tested for growth, 
swimming, swarming, twitching motility (LB media), pyocyanin production (LB & 
King’s A media), pyoverdine production (LB & King’s B Media), congo red binding 
assay (CR media) and antibiotic resistance (MH media) (Data not shown). Hence, 
a comparative phenotypic microarray analysis was performed with the wild-type 
PAO1, PAO∆mifR and PAO∆mifS mutants (BioLOG Inc.). Out of approximately 
2000 metabolic and chemical sensitivity assays tested, PAO∆mifR exhibited four 
gain-of-function and 29 loss-of-function phenotypes whereas PAO∆mifS exhibited 
two gain-of-function and 23 loss-of-function phenotypes (Figure 2.3A). A single 
gain of function phenotype shared between PAO∆mifS and PAO∆mifR, was the 
ability to utilize L-methionine. When metabolism and chemical sensitivity were 
compared, the mutants appear more sensitive to various antibiotics (Figure 2.3B). 
However, none of these were reproducible in the lab in the MH media. The loss of 
mifS and mifR resulted in differential phenotype in the presence of six metabolites, 
amongst which, two were common to both mifS and mifR mutants (Figure 2.3B). 
The shared metabolic phenotypes involved the utilization of L-methionine and α-
KG (Figure 2.3C). Compared to the parent PAO1, the mutants did not exhibit any 
growth increase when provided with L-methionine (Figure 2.4). This could be 
simply due to the difference in culture conditions and BioLOG proprietary media.  
The inability to utilize α-KG by PAO∆mifS (Figure 2.5A) and PAO∆mifR 
(Figure 2.5B) in the BioLOG assay was reproduced in M9 minimal media 
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supplemented with 30 mM α-KG (Figure 2.5C). In fact, all three mutant strains, 
PAO∆mifR, PAO∆mifS and PAO∆mifSR failed to grow in the presence of α-KG 
(Figure 2.5C). To rule out potential toxicity, the wild-type P. aeruginosa PAO1 and 
the mutants were cultured in M9 minimal media with varying concentrations of α-
KG, ranging from 1 to 80 mM (Figure 2.6). The mutants exhibited no growth in the 
presence α-KG after 24 h at 37˚C, whereas the wild-type PAO1 exhibited an 
increase in growth that was proportional to α-KG concentration (Figure 2.6B). All 
subsequent experiments were done with 30 mM α-KG. The growth defect exhibited 
by PAO∆mifS, PAO∆mifR and PAO∆mifSR could be restored to the wild-type 
levels by introducing mifR and mifSR genes into the respective mutants (Figure 
2.5D and Figure 2.7A).  
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Figure 2.3: mifS and mifR dependent phenotypes. To identify the role of 
P. aeruginosa mifSR TCS, comparative phenotypic microarray of PAO∆mifS, 
PAO∆mifR mutants and wild-type PAO1 strain was performed at BioLOG Inc. 
(Hayward, CA, USA). Venn diagram of differentially regulated phenotypes of 
the mutants compared to their isogenic parent PAO1, showing gain of 
function or loss of function phenotypes (A). Phenotypic differences were 
further classified based on metabolic and chemical sensitivity properties (B). 
The phenotypes common to both mifS and mifR mutants are listed (C). 
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Figure 2.4: Growth curve analysis in the presence of methionine. Growth 
curves of P. aeruginosa wild-type PAO1 and mifSR mutants in M9 minimal 
media supplemented with glucose (30 mM) and methionine (5 mM) as carbon 
and nitrogen source. 
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Figure 2.5: Phenotypic microarrays of PAOΔmifS and PAOΔmifR mutants. 
The loss of mifS and mifR results in a growth deficient phenotype in the 
presence of α-KG as a sole carbon source, as depicted by BioLOG plate PM1, 
well D6 (A and B). Loss of growth phenotype was confirmed by growing PAO1, 
PAO∆mifS, PAO∆mifR and PAO∆mifSR  mutants in M9 minimal media with α-
KG (30 mM) for 18 to 24 h at 37ᵒC (C). The growth defect was rescued by 
expressing mifR and mifSR genes (D) and the gene encoding the α-KG specific 
transporter PA5530 (E) in trans. 
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mifSR mutants exhibit α-KG dependent growth defect 
α-KG is a key TCA cycle intermediate (Figure 2.8) and plays an important 
role in regulating carbon and nitrogen metabolism (Doucette et al., 2011). It has 
been previously shown that P. aeruginosa preferentially utilizes TCA cycle 
intermediates as a carbon source over other compounds (Liu, 1952, Wolff et al., 
1991, Suh et al., 2002). To test if the growth defect exhibited by the loss of mifS 
and mifR is restricted to α-KG utilization, the mutants and the complementing 
strains were grown in the presence of TCA cycle intermediates citrate, succinate, 
fumarate, malate and oxaloacetate at 30 mM each. No difference in growth was 
observed between wild type PAO1 and its isogenic mutants in the presence of 
other TCA cycle intermediates except for α-KG (Table 2.3). This is not surprising 
as P. aeruginosa can use the glyoxylate shunt pathway to bypass the need for α-
KG (Figure 2.8) (Campbell et al., 1953). Furthermore, no difference in the growth 
profile of the wild type PAO1 and mifSR mutants was observed when grown in the 
presence of sugars, glucose and sucrose (30 mM each) (Data not shown). To 
reconfirm that the presence of α-KG is not toxic, the cells were grown in the 
presence of citrate and succinate combined in equal concentration with α-KG. The 
mutants and the wild type shared similar early exponential growth (Figure 2.9).  
However, the mutants reached stationary phase earlier as compared to the parent 
strain PAO1.  This suggests that the presence of excess carbon source in the form 
of α-KG further contributes to the growth of PAO1. These analyses indicate that 
mifSR mutants are only defective in α-KG utilization. 
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Figure 2.8: Tricarboxylic acid (TCA) cycle and its related reactions. Enzymes 
converting iso-citrate to α-KG (iso-citrate dehydrogenase: Icd, Idh), α-KG to 
succinyl-coA (α-KG dehydrogenase complex: SucA, SucB, Lpd3) and those 
involved in the glyoxylate shunt (isocitrate lyase (AceA) and malate synthase G 
(GlnB)) are shown in bold. Green boxes indicate the amino acid biosynthetic 
precursors of α-KG involved in the anaplerotic reaction. 
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mifSR mutants are defective in α-KG transport 
The absence of growth in the presence of exogenous α-KG could be due to 
either failure to enter the cells or loss of the mutants’ ability to convert α-KG to 
succinate. The latter is likely if the mutants failed to express a functional α-KG 
dehydrogenase complex. The ability of mifSR mutants to grow effectively in the 
presence of citrate and succinate suggests that these mutants are likely to harbor 
a functional α-KG dehydrogenase complex, unless the mutants bypass it using the 
glyoxylate shunt (Figure 2.8). The former is likely as qPCR analysis of genes 
encoding isocitrate dehydrogenase (idh, icd) and α-KG dehydrogenase complex 
(sucA, sucB, lpd3) revealed no difference in the expression levels in the wild-type 
PAO1 and mifSR mutants (Figure 2.10).   
α-KG is a hub for anaplerotic reactions, a process for replenishing TCA 
cycle intermediates. In this process glutamate, glutamine, proline and arginine act 
as precursor molecules for α-KG synthesis (Kornberg, 1966). Growth studies in 
the presence of these amino acids would serve as another indirect measure to test 
the functionality of α-KG dehydrogenase complex in mifSR mutants. To test this 
hypothesis, PAO1, PAO∆mifR, PAO∆mifS and PAO∆mifSR mutants were cultured 
in the presence of glutamate, glutamine, proline and arginine (Table 2.4). The 
parent PAO1 and the isogenic mutants exhibited similar growth phenotype. From 
the expression studies and growth analyses we deduce that the mifSR mutants 
are impaired in α-KG transport.  
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Figure 2.10: Quantification of rpoN, acnA, idh, icd, sucA, and Ipd3 mRNA 
by qRT-PCR. RNA was isolated from cells grown in M9 minimal media 
supplemented with citrate (30 mM), reverse transcribed to cDNA and the 
presence of specific transcripts was analyzed by qPCR using gene-specific 
primers (Table 5). The expression of genes encoding aconitate hydratase 1 
(acnA (PA1562)) isocitrate dehydrogenase (idh (PA2623)) isocitrate 
dehydrogenase, α-KG dehydrogenase complex (icd (PA2623)), sucA (PA1585) 
and lpd3 (PA4829), and  σ54 (rpoN (PA4462)) were analyzed in mifSR mutants 
relative to PAO1 (log10 RQ = 1). Bars above or below the line represents up- 
and down-regulation, respectively and the bars are standard errors. The clpX 
(PA1802) gene was used as the housekeeping control. Statistically significant 
difference between the wild type and mutants as determined by one-way 
ANOVA with Bonferroni’s post-hoc test. Difference in the expression levels of 
genes is not statistically significant at p-value < 0.05.  
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mifSR TCS genes regulate extracellular α-KG transport  
In a recent study using transposon mutagenesis; PA5530 was identified as 
the functional α-KG transporter (Lundgren et al., 2014). To confirm the role of P. 
aeruginosa PA5530 in α-KG uptake and identify the role of mifSR genes, the gene 
was amplified and subcloned downstream of the inducible PlacUV5 promoter. The 
plasmid pPA5530 was introduced into PAO1 and the mifSR mutants. Expression 
of PA5530 in trans in PAO∆mifS, PAO∆mifR, PAO∆mifSR mutants restored their 
growth to a level similar to the wild-type PAO1 in M9 minimal media with α-KG (30 
mM) as the sole carbon source (Figure 2.7B). Expression of an extra copy of 
PA5530 gene in the wild-type PAO1 did not affect its growth (Figure 2.5E).  This 
finding suggests that expression of PA5530 is likely regulated by MifSR and/or α-
KG. In fact, expression of PA5530 is regulated by α-KG, as seen in qRT-PCR 
analysis when PAO1 was grown in M9 media with varying amounts α-KG (Figure 
2.11A). The loss of mifS, mifR and mifSR results in a significant decrease in 
PA5530 expression as compared to the wild type PAO1 in the presence of α-KG 
(Figure 2.11B). Thus, α-KG-dependent PA5530 expression requires MifSR. 
Table 2.4. Growth profile analysis of the mifSR mutants in presence of 
amino acids. 
Carbon Source PAO1 ∆mifR ∆mifS ∆mifSR 
Glutamate +++ +++ +++ +++ 
Glutamine +++ +++ +++ +++ 
Proline +++ +++ +++ +++ 
Arginine +++ +++ +++ +++ 
+++, growth; ---, no growth 
Cells were grown in the M9 minimal media with the indicated amino acids (30 
mM each). Data is represented in terms of growth and no growth phenotype. 
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RpoN (σ54) is required for α-KG utilization 
 The closest P. aeruginosa MifS and MifR homologs are R. meliloti DctB and 
DctD (Stover et al., 2000). In fact, MifR is 69% similar to R. meliloti DctD that 
belongs to the Sigma 54 (σ54) dependent NtrC family of transcriptional regulators 
(Stover et al., 2000, Valentini et al., 2011).  Thus, it is likely that MifR has the 
conserved domains found among NtrC family of regulators, an N-terminal 
regulatory, a central σ54 activation and a C-terminal DNA binding domains (Morett 
& Segovia, 1993, Osuna et al., 1997). MifR analysis using the simple modular 
architecture research tool (SMART) (Schultz et al., 1998) and InterPro (Hunter et 
al., 2012) revealed the presence of three domains: CheY-homologous 
receiver/regulatory, a central AAA+ region required for σ54 activation, and the DNA 
binding helix-turn-helix domains (Figure 2.12A). The central AAA+ domain contains 
seven conserved regions designated C1 to C7 (Morett & Segovia, 1993) that are 
characteristic of σ54-dependent transcriptional regulators. Sequence analysis of 
MifR revealed the presence of all the seven conserved regions in the AAA+ domain 
between amino acid residues 144 to 373 (Figure 2.12B).  
Since MifR exhibits high identity to σ54-dependent transcriptional regulators, 
we hypothesized that P. aeruginosa rpoN mutants should exhibit a α-KG-
dependent phenotype, similar to the mifSR mutants. To verify this hypothesis, we 
tested the ability of PAO∆rpoN mutant to grow in the presence of α-KG (30 mM) 
(Table 2.5). As expected, PAO∆rpoN failed to grow in the presence of α-KG (Table 
2.5). The growth of the rpoN mutant was restored in PAO∆rpoN::rpoN 
complementing strain. Further, in trans expression of mifR and mifSR in 
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PAO∆rpoN mutant failed to restore their growth in the presence of α-KG (Table 
2.5). This data confirms that MifR regulatory function requires functional RpoN 
(σ54).  
The small 81-bp mifSR promoter has no obvious RpoN sigma factor -12/-
24 consensus sequence: 5’-TGGCACG-N4-TTGCW-3’ in which W stands for 
either A or T (Figure 2.13A) (Barrios et al., 1999). In fact, it appears to have a 
potential -10 (consensus: TATAAT) but lacked -35 (consensus: TTGACA) for 
sigma-70 promoter (Figure 2.13A) (Paget & Helmann, 2003). On the other hand, 
the promoter region of PA5530 is 315-bp long with strong -12 and -24 boxes 
upstream of the predicted transcription start site (Figure 2.13B). We hypothesized 
that the inability of rpoN mutant to utilize α-KG can be rescued by expressing 
PA5530 under a regulatable promoter PlacUV5. As expected, the growth of the rpoN 
mutant was restored when the plasmid harboring the transporter PA5530 was 
expressed in trans (Table 2.5). This suggests that expression of PA5530 requires 
both MifSR TCS and RpoN.  
The presence of a common motif, GATCGGCGGATt/gTCC, in the PmifS and 
PPA5530 (Figure 2.13A and 2.13B) suggest that these two operons share some 
common regulatory mechanism. In addition, both promoters possess multiple 
motifs: PmifS has two sets of large overlapping inverted repeats, and PPA5530 has 
three sets of direct repeats (Figure 2.13A and 2.13B). However, the role of these 
motifs remains to be elucidated.  
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Figure 2.12: P. aeruginosa MifR domain organization and sequence 
alignment. (A) MifR domain organization determined using the Simple Modular 
Architecture Research Tool (SMART) (Schultz et al., 1998). MifR is a sigma-54 
dependent transcriptional activator (Winsor et al., 2011). There are three 
functional domains, N-terminal receiver with the conserved aspartate residue at 
position 53 (Asp-53) (Purple), central AAA+ ATPase, characteristic of sigma-54 
dependent activation proteins (Green), and the C-terminal helix-turn-helix 
(HTH) DNA binding  (Manfredi et al.) domains.  (B) Sequence alignment of MifR 
with P. aeruginosa DctD (PA5166), NtrC (PA5125) and R. meliloti DctD.  
Vertical bars indicate conserved residues, asterisk (*) indicate residues are 
identical at that position. Key residues of the central AAA+ domain (C1 to C7) 
are well conserved amongst sigma-54 dependent transcriptional activators. The 
horizontal arrow bars indicate HTH domain.  Asp-53 indicates the conserved 
phosphorylation site of P. aeruginosa MifR. The alignment was generated using 
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).  
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Table 2.5. Growth properties of PAO1ΔrpoN and its derivatives in the 
presence of α-KG and LB. 
Strain Plasmid α-KG LB 
PAO∆rpoN 
- --- +++ 
Vector --- +++ 
pRpoN +++ +++ 
pMifR --- +++ 
pMifSR --- +++ 
pPA5530 +++ +++ 
+++, growth; ---, no growth  
Growth of PAO1ΔrpoN mutant and its derivatives was tested in the M9 minimal 
media supplemented with α-KG (30 mM) and in the LB media at 37˚C for 24h.       	
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Figure 2.13: In silico analysis of mifS (PmifS) and PA5530 (PPA5530) promoter 
sequences. Motif search was done using the ensemble learning method 
SCOPE and GLAM2 (Gapped Local Alignment of Motifs) (Chakravarty et al., 
2007, Frith et al., 2008). (A) Sequence analysis of the 81-bp (PmifS) (black) 
indicates a putative σ70-dependent -10 consensus (TATAAT). However, it lacks 
the -35 consensus (TTGACA) for σ70 promoter (Potvin et al., 2008). Arrows 
represent the long 17-bp direct and inverted repeats in PmifS with a consensus 
GGAt/cAGCGACATCGGCG. (B) The 315-bp promoter region of PA5530 
showing strong -12 and -24 σ54-dependent promoter like element and the 
proposed transcription start site (+1). Dashed line (blue) depicts a common 
motif in PmifS and PPA5530 suggesting a common regulatory mechanism (A and 
B). The three pairs of direct repeats in PPA5530 are represented by green, blue 
and orange arrows.  PPA5530 possess the signature sequence (AAc/uAAc/uAA) 
for catabolite repression control (Crc) protein (brown box) (Sonnleitner et al., 
2009). The uncharacterized small antisense RNA (asRNA) identified in the 
PPA5530 region (Wurtzel et al., 2012) is indicated by marked line. 
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Figure 2.14: Proposed model for α-KG utilization in P. aeruginosa.  HK-
MifS senses the extracellular α-KG to undergo phosphorylation. The phosphate 
is transferred to the RR-MifR. The phosphorylated MifR in coordination with 
RpoN (σ54) activates the expression of α-KG specific transporter gene PA5530.  
PA5530 thus enables the influx of α-KG to meet the metabolic and energy 
demands of the cells. PA5530 promoter (PPA5530) region has a Crc binding site 
(Figure 2.13), suggesting that it is under the catabolite repression control by 
Crc/CrcZ.  The PPA5530 also shows the presence of another uncharacterized 
small non-coding asRNA indicating a multilayered and complex regulation of 
the α-KG transport system. 
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Discussion 
P. aeruginosa pathogenicity relies significantly on its metabolic flexibility. 
However, establishment of successful infection and its progression requires more 
than just meeting nutritional demands. Precision in sensing environmental signals 
concomitant with a quick and appropriate response is the key to efficient bacterial 
adaptation and survival. An arsenal of TCSs encoded in its genome has furnished 
P. aeruginosa with a sophisticated capability to regulate diverse metabolic and 
virulence processes, ensuring its success as a pathogen (Nishijyo et al., 2001, 
Gooderham & Hancock, 2009, Winsor et al., 2011). P. aeruginosa genome 
encodes one of the largest groups of TCS proteins identified in any sequenced 
bacterial species (Barakat et al., 2009, Winsor et al., 2011). Bacterial TCS’s sense 
and respond to a variety of external cues such as nutrient availability, osmolarity, 
redox state, temperature, and concentrations of other extracellular molecules 
(Stock et al., 2000). However, very few TCS signaling molecules have been 
identified to date. In this study we suggest that the P. aeruginosa MifSR TCS 
exclusively senses α-KG, a C5 dicarboxylate and a key component of TCA cycle.  
P. aeruginosa antibiotic resistance is independent of MifSR TCS 
A common feature of bacterial genomes is a close association between the 
functionally related genes and their location on the chromosome (Dandekar et al., 
1998, Overbeek et al., 1999). Typically, genes encoding functionally related HKs 
and RRs are often physically linked and are co-transcribed as an operon (Stock et 
al., 1989, Chen et al., 2004). Indeed, our in silico analysis (Figure 2.1A and 2.1B) 
and cDNA amplification (Figure 2.1C) reveled that mifS-mifR genes are co-
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transcribed and form an operon. This also suggests that HK-MifS and RR-MifR are 
functionally related and work as a TCS pair. In addition, TCS proteins are known 
to regulate expression of genes in their immediate vicinity (Stock et al., 1989). The 
mifSR genes are 81 bp upstream of the two-gene poxAB (PA5513-5514) operon. 
Due to the proximity of mifSR to poxB which encodes for a β-lactamase, we 
postulated that mifSR TCS regulates antibiotic resistance. However, our initial 
results nullified this hypothesis in which comparative MIC’s (Data not shown) and 
qRT-PCR data (Figure 2.2) showed no difference in antibiotic resistance profiles 
or poxB expression between the wild-type PAO1 and mifSR single and double 
deletion mutants. 
MifSR TCS regulates P. aeruginiosa α-KG utilization 
A previous transcriptome study of the wild-type PAO1 and a mifR deletion 
mutant cultivated under biofilm-specific conditions showed significant alteration in 
the expression of genes involved in regulating P. aeruginosa metabolism, small 
molecule transport and amino acid biosynthesis (Petrova et al., 2012). The majority 
of the changes observed in phenotypic microarrays of the mifS and mifR mutant 
strains cultivated under planktonic conditions were associated with chemical 
sensitivity and not with metabolism (Figure 2.3B). Only 12-16% of phenotypic 
changes were associated with metabolism. This confirms the significant metabolic 
differences in the rich planktonic versus anaerobic mode of biofilm growth in P. 
aeruginosa (Waite et al., 2006). 
Petrova et al. (2012) have also demonstrated that genes involved in energy 
metabolism, including anaerobic metabolism and fermentative pathways using 
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arginine (arcDABC) and pyruvate, were expressed significantly less in ∆mifR 
mutant biofilms as compared to its parent PAO1 (Petrova et al., 2012). Though 
pyruvate is needed for biofilm formation, it cannot compensate for the loss of mifR 
(Petrova et al., 2012). Interestingly, the biofilm phenotype associated with the loss 
of mifR can be complemented by ldhA encoding D-lactate dehydrogenase to wild 
type levels of biomass accumulation and microcolony formation (Petrova et al., 
2012). These findings suggest that MifR somehow regulates expression of ldhA, a 
second gene in a three-gene operon gacS-ldhA-PA0926 (Winsor et al., 2011). 
Importantly, analyses of the promoters reveal the presence of a shared motif in 
PmifS (GATCCGCCGATGTCC) and PPA5530 (GATCGGCGGATTTCC) (Figure 2.13) 
and PgacS (AATCCGCCGGGCTGC) suggesting a possible coordinate regulation, 
and that need to be verified. 
Our phenotypic microarray analyses and growth experiments suggested 
that P. aeruginosa α-KG utilization requires MifS and MifR (Figure 2.5 and 2.7A). 
The ability of PAOΔmifR, PAOΔmifS and PAOΔmifSR to grow in the presence of 
α-KG was restored by in trans expression of mifR and mifSR (Figure 2.7A). 
Interestingly, the PAO∆mifS was complemented by pMifR and pMifSR (Figure 
2.5D) but not by pMifS alone. To rule out that gene expression may have been 
compromised, the mifS gene was cloned downstream of the inducible PlacUV5 
promoter. Though the expression of stable protein was visible in a protein gel, it 
failed to complement PAO∆mifS mutant (data not shown). This suggests that cis-
expression of mifS and mifR is critical for MifS-function. Other researchers have 
encountered similar problems involving histidine kinases (Yeung et al., 2011). 
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Moreover, complementation of the PAO∆mifS with pMifR suggests that either 
phosphorylation is not required or there is a potential crosstalk between MifR and 
other non-cognate HKs. Alternatively, phosphorylation of MifR can occur through 
small molecule phosphor-donors, like acetyl phosphate, carbamoyl phosphate and 
phosphoramidate (Deretic et al., 1992). Such phenomenon is observed with other 
TCS RRs (Lukat et al., 1992, Wanner & Wilmes-Riesenberg, 1992, Varughese, 
2002).  However, this has to be verified. 
The C5-dicarboxylate α-KG is an important intermediate in the energy-
generating TCA cycle (Figure 2.8) and plays a key role in regulating carbon and 
nitrogen metabolism (Doucette et al., 2011). Similar to other bacteria (Janausch et 
al., 2002), TCS’s in P. aeruginosa have been reported to regulate transport and 
utilization of TCA cycle intermediates such as succinate, fumarate, malate and 
citrate (Nishijyo et al., 2001, Valentini et al., 2011). The R. meliloti DctB/DctD 
system is a well-characterized TCS that controls the transport of TCA cycle C4-
dicarboxylates succinate, fumarate and malate (Janausch et al., 2002). Though P. 
aeruginosa MifS/MifR proteins are homologous to R. meliloti DctB/DctD TCS 
proteins, the mifSR mutants efficiently utilized citrate, succinate, fumarate, malate, 
oxaloacetate, sucrose and glucose but exclusively failed to grow in the presence 
of α-KG (Table 2.3). This was further supported by another parallel study that 
shows that α-KG utilization requires MifR (Lundgren et al., 2014).  Thus, the P. 
aeruginosa MifSR TCS is specifically and uniquely involved in C5-dicarboxylate α-
KG utilization.  
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MifSR TCS modulates P. aeruginosa α-KG transport 
The inability to utilize α-KG suggested that the mifSR mutants either have 
a defective α-KG dehydrogenase complex (inability to convert α-KG to succinyl-
coA, Figure 2.8), or they are deficient in the transport of α-KG into the cell. The 
former was ruled based upon multiple findings: unchanged expression levels of 
genes encoding α-KG dehydrogenase, lpd3 (PA4829) and sucA (PA1585) (Figure 
2.10); the ability to use C4 and C6 dicarboxylates (Table 2.3) and C5 family of amino 
acids such as arginine, proline, glutamine, and histidine (Table 2.4). The C5 family 
of amino acids act as biosynthetic precursors of glutamate that ultimately are 
converted to α-KG by a transamination reaction or through the action of glutamate 
dehydrogenase (Lehninger et al., 2013). These findings strongly argued that the 
mifSR mutants were defective in their ability to transport α-KG into the cell.  
To date, among the identified carboxylate transporters, the C4-dicarboxylate 
transporters have been reasonably well characterized. Based on protein sequence 
similarity analysis, bacterial C4-dicarboxylate transporters are classified into five 
families, namely, dicarboxylate transport (DctA); dicarboxylate uptake (DcuAB), 
(DcuC) and (CitT) and the tripartite ATP-independent periplasmic (TRAP) families 
(Janausch et al., 2002). Amongst these, DctA transporters, a subgroup of the 
dicarboxylate/amino acid:cation symporter (DAACS) family (Busch & Saier, 2002, 
Busch & Saier, 2004, Saier et al., 2006), are extensively studied and are implicated 
in the transport of C4-dicarboxylates in Echerischia coli (Davies et al., 1999), 
Bacillus subtilis (Asai et al., 2000), Rhizobium meliloti (Yarosh et al., 1989, Watson, 
1990), Rhizobium leguminosarum (Finan et al., 1981, Ronson et al., 1987) and 
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Corynebacterium glutamicum (Youn et al., 2009). As we were trying to identify the 
MifSR-dependent transporter Lundgren et al., reported that PA5530 is involved in 
α-KG transport (Lundgren et al., 2014). As predicted, in trans expression of 
PA5530 was able to restore the ability of mifR, mifS and mifSR mutants to grow in 
α-KG (Figure 2.5E). This is further confirmed by the increase in PA5530 expression 
in PAO1 in the presence of α-KG (Figure 2.11A). PA5530 shares no homology with 
the P. aeruginosa C4-dicarboxylate transporter PA1183 (DctA). However, it does 
have conserved protein domain family PRK10406 implicated in α-KG transport and 
shares ~70% homology to E. coli and Erwinia spp. α-KG permease KgtP (Seol & 
Shatkin, 1991, Marchler-Bauer et al., 2015). A common feature in the transport of 
C4-dicarboxylates and other carbon sources in different bacteria is the involvement 
of TCS mediated regulatory mechanism. Involvement of TCSs, a stimulus-
response coupled mechanism, in the transport of C5-dicarboxylates suggests a 
more profound role of α-KG as a signaling molecule.   
P. aeruginosa α-KG transport requires functional RpoN (σ54) 
P. aeruginosa RpoN (σ54) is involved in a myriad of functions including 
expression of virulence factors and nutrient uptake (Potvin et al., 2008). Functional 
RpoN is reported to be critical for maintaining a carbon-nitrogen balance in 
Pseudomonads (Kohler et al., 1989, Nishijyo et al., 2001, Cases et al., 2003, Li & 
Lu, 2007, Zhang & Rainey, 2008). Sequence analysis of MifR indicated a 
requirement of functional RpoN in modulating P. aeruginosa α-KG utilization. Our 
study confirms that α-KG utilization in P. aeruginosa PAO1 requires functional 
RpoN (Table 2.5). This phenotype is not strain-specific as phenotypic microarray 
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profiling (BioLOG) of P. aeruginosa PA14 rpoN mutant exhibited a similar 
phenotype, a significant difference in the ability to utilize α-KG as a carbon source 
as compared to the wild-type PA14 (Behrends et al., 2013). An RpoN-dependent 
phenotype was also observed with citrate and 4-hydroxyphenylacetate utilization 
(Behrends et al., 2013). Similarly, utilization of C4-dicarboxylates succinate, 
fumarate and malate in R. meliloti and P. aeruginosa also requires the sigma factor 
RpoN (σ54) (Ronson et al., 1987, Ronson et al., 1987, Valentini et al., 2011). 
The need for RpoN (σ54) to utilize α-KG in P. aeruginosa can be bypassed 
by expressing PA5530 encoding for the transporter under a regulatable promoter 
but not MifS and MifR. Consistent with the need for RpoN (σ54), the promoter for 
PA5530 has the requisite signature sequences (Figure 2.13). Like most complex 
RpoN-dependent promoters (Merrick, 1993), the region is long with multiple motifs 
that include a signature sequence (AAc/uAAc/uAA) for catabolite repression 
control (Crc) protein, a post-transcriptional inhibitor that binds the mRNA 
preventing translation (Moreno et al., 2007, Sonnleitner et al., 2009, Browne et al., 
2010). Expression of crc is in-turn regulated by RpoN-dependent non-coding RNA 
CrcZ (Sonnleitner et al., 2009) whose absence in rpoN mutant can also lead to 
reduced expression of PA5530. Also, analysis of P. aeruginosa PA14 transcripts 
indicates that the PA5530 promotor is under a small non-coding antisense RNA 
(asRNA) regulation (Wurtzel et al., 2012). Though the role of Crc, CrcZ and the 
asRNA in α-KG transport has to be verified experimentally, it suggests an 
additional layer of regulation superimposed on the need for MifS and MifR on the 
expression of the C5-dicarboxylate transporter PA5530.  
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Conclusion 
In eukaryotic cells, the mitochondria serve as a hub and reservoir of the 
TCA cycle and its intermediates, respectively. Bacterial pathogens can be highly 
virulent intruders of the host tissue, causing significant damage leading to cellular 
aberrations and injury. Mitochondrial dysfunction, a consequence of cell injury, 
results in efflux of TCA cycle intermediates leading to an increase in their 
extracellular concentrations (Hebert, 2004). It is known that TCA cycle 
intermediates (C4, C5, and C6 dicarboxylates) are present at micromolar (μM) 
concentrations in blood that increase with tissues damaged (He et al., 2004, 
Hebert, 2004). α-KG can also act as a reactive oxygen species scavenger, 
especially for hydrogen peroxide, protecting both host and pathogen (Long & 
Halliwell, 2011). For pathogenic bacteria such as P. aeruginosa, efficient uptake 
of TCA intermediates from the host is crucial for its survival, especially when it is 
bombarded with host reactive oxygen species, and requires the activity of bacterial 
carboxylate transport proteins. The transport proteins could be specific for C4, C5, 
and C6 intermediates and may use a cognate TCS. This study suggests a complex 
regulatory cascade in modulating P. aeruginosa C5-dicarboxylate, α-KG uptake 
involving the PA5530 transporter, the MifS/MifR TCS and the sigma factor RpoN 
(Figure 2.14).  It appears that MifS senses the presence of α-KG and signals MifR. 
The activated MifR in concert with RpoN initiates the transcription of α-KG-specific 
transporter gene PA5530. Analyses of the published data suggests that the 
PA5530 promoter is under several layers of regulation including catabolite 
repression mediated by Crc/CrcZ (Sonnleitner et al., 2009) and the small non-
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coding asRNA (Wurtzel et al., 2012). Though the asRNA has been identified 
(Wurtzel et al., 2012), it has not been characterized. It is not surprising that the 
PA5530 expression is potentially regulated by Crc, as it would allow control of 
transporter(s) in response to the presence of carbon sources in the environment. 
In addition to MifSR (PA5512/PA5511), PA1336/PA1335 have been identified to 
be homologous to the Rhizobium C4-dicarboxylate transport regulatory DctB/DctD 
TCS (Stover et al., 2000, Valentini et al., 2011). However, the role of 
PA1336/PA1335 remains to be elucidated. The P. aeruginosa genome also 
encodes 19 other paralogs of PA5530 dicarboyxlate transporters, most of which 
have share less than 50% similarity except for PA0229 (PcaT). PA0229 and 
PA5530 have 73% similarity. Future studies will determine if the transporters are 
preferentially or hierarchically upregulated depending on the carbon source. It is 
also important to note that much of bacterial physiology, particularly of pathogens 
such as P. aeruginosa remains a mystery. Metabolic versatility, expression of 
virulence factors and antibiotic resistance together makes P. aeruginosa an 
portentous pathogen. Thus, understanding the physiological cues and regulation 
would provide a better stratagem to fight the often indomitable infections.  
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Abstract 
Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen responsible 
for causing incapacitating infections in individuals with impaired immunity. 
Successful infection and disease progression relies significantly on the ability of 
any pathogen to effectively utilize available nutrients that are essential for its 
growth and survival. Unlike other pathogenic bacteria where glucose is the 
preferred carbon source, P. aeruginosa preferentially utilizes tricarboxylic acid 
(TCA) cycle intermediates as carbon, nitrogen and energy sources. In P. 
aeruginosa, two-component system (TCS) signaling proteins have played an 
integral part in regulating the uptake of TCA cycle intermediates, specifically, C4-
dicarboxylates such as succinate, fumarate and malate. We recently identified a 
TCS protein pair PA5512/PA5511 (MifS/MifR) that in- tandem with the sigma factor 
RpoN (σ54) facilitate the uptake of extracellular C5-dicarboxylate α-ketoglutarate 
(α-KG) by activating the expression of P. aeruginosa α-KG-specific permease 
PA5530 (KgtP).  In the present study, we demonstrate that besides KgtP, P. 
aeruginosa genome encodes a second α-KG transporter PA0229 (PcaT) whose 
expression is independent of the MifSR TCS, suggesting an additional layer of 
regulation involved in P. aeruginosa α-KG uptake. Importantly, in the recent years, 
α-KG has become the focal point of research because of its newly identified role 
as a signaling molecule in-addition to its conventional role in metabolism. To date, 
very little is known of the physiology of P. aeruginosa when provided with α-KG as 
the sole carbon source and their role in pathogenesis. Using PAOΔmifS, 
PAOΔmifR and PAOΔmifSR mutants expressing the α-KG transport protein PcaT 
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in trans, we additionally investigated the role of MifSR TCS and α-KG in regulating 
P. aeruginosa virulence. Multiple virulence phenotypes were tested in the 
presence of α-KG, citrate and/or succinate, as a sole carbon source. In comparison 
to the wild-type PAO1 strain, mifSR deletion strains exhibited differential regulation 
of biofilm formation, pyocyanin and pyoverdine production, motility, and cell 
cytotoxicity in the presence of α-KG. Subsequently, mifSR mutant derivatives 
exhibited no discernible phenotypes compared to the parent PAO1 when α-KG 
was replaced with citrate and/or succinate, as the sole carbon source. Thus, MifSR 
TCS regulates the expression of P. aeruginosa’s key virulence determinants in α-
KG-dependent manner. Simultaneous regulation of multiple mechanisms involved 
in P. aeruginosa pathogenesis suggests a complex mechanism of MifSR action. 
Understanding the physiological cues and regulation would provide a better 
stratagem to fight the often indomitable P. aeruginosa infections.   
Introduction 
Despite continuous efforts in the development of new antimicrobial drugs, 
bacterial infections are frequently associated with high morbidity and mortality 
rates.  In particular, infections caused by the multidrug resistant bacteria, including, 
but not restricted to the so called “ESKAPE” pathogens (Enterococcus faecium, 
Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, 
Pseudomonas aeruginosa, and Enterobacter species)  (Rice, 2008), represent a 
major public health concern (Tommasi et al., 2015) and economic burden 
worldwide (Boucher et al., 2009). Amongst these organisms, P. aeruginosa is 
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frequently implicated in causing injurious infections (Rice, 2008),  and has gained 
significant attention over the years as one of the most portentous pathogen.  
P. aeruginosa is a Gram-negative, ϒ-proteobacteria that is widely 
distributed in nature (Green et al., 1974). It is well-known for its nutritional and 
ecological resilience, which enables it to endure and thrive in diverse 
environmental settings, both natural and artificial (Ramos, 2004). Although, P. 
aeruginosa is a multi-host pathogen infecting insects (Bulla, 1975), nematodes 
(Mahajan-Miklos et al., 1999), plants (Sing & Schroth, 1977, Rahme et al., 1995) 
and mammals  (Stevens et al., 1994), it is the epitome of opportunistic human 
infections (Ramos, 2004). It is one of the most feared nosocomial pathogen, 
accounting for 10% of all the hospital acquired infections (Hancock & Speert, 2000, 
Sievert et al., 2013). P. aeruginosa can colonize different tissue types leading to 
multifactorial clinical and pathological manifestations including pneumonia 
(Driscoll et al., 2007), urinary tract infection (Driscoll et al., 2007), gastrointestinal 
infection (Markou & Apidianakis, 2014), chronic suppurative otitis media (Yeo et 
al., 2007, Mittal et al., 2015), endocarditis (Fish et al., 1937, Sandre & Shafran, 
1996), osteomyelitis (Carek et al., 2001), keratitis (Dart & Seal, 1988), bacteremia 
(Kerby, 1947) and soft-tissue infection (Moet et al., 2007). The largest cohorts of 
P. aeruginosa infected patients are the ones with AIDS, severe burn wounds, 
cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), diabetes, 
cardiovascular disease, cancer and those with acquired or primitive immunological 
abnormalities  (Manfredi et al., 2000, Ramos, 2004, Driscoll et al., 2007, Vento et 
al., 2008, Valderrey et al., 2010). Also, beyond high infection rate, P. aeruginosa 
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has the highest case fatality rate of all Gram-negative infections (Aliaga et al., 
2002). P. aeruginosa is extensively armed with a set of multi-determinant virulence 
factors, both cell surface associated (flagella, pili, LPS) and secretory (proteases, 
exotoxins, phenazines, haemolysins), which modulates its pathogenic potential. In 
addition to its ability to dodge host immunity, a major setback in effectively treating 
P. aeruginosa infections is its extraordinary intrinsic and acquired resistance to a 
gamut of clinically critical antibiotics (Breidenstein et al., 2011). Expression of 
diverse virulence factors and antibiotic resistance together, makes P. aeruginosa 
an indomitable pathogen.  
Metabolic versatility is the key to bacterial pathogenesis and disease 
progression. In order to survive and multiply in the host systems, bacterial 
pathogens have developed mechanisms to regulate their metabolism according to 
the nutrient composition and availability (Silby et al., 2011). Carbon and nitrogen 
are the two major nutrients required by all living organisms to perform fundamental 
cellular activities. P. aeruginosa uses an eclectic range of organic compounds 
including carbohydrates, amino acids, fatty acids, mono- and polyalcohols, di- and 
tri-carboxylic acids as carbon, nitrogen and energy source (Ramos, 2004). 
Although efficiently metabolized via the Entner-Doudoroff pathway, sugars are less 
preferred carbon source (Entner & Doudoroff, 1952, Lessie & Phibbs, 1984). 
Instead, P. aeruginosa has a predilection for tricarboxylic acid (TCA) cycle 
intermediates, specifically, C4-dicarboxylates of the TCA cycle such as malate, 
fumarate and succinate (Liu, 1952, Collier et al., 1996).  
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The TCA cycle, classical (Krebs, 1940) or the modified form (Romano & 
Conway, 1996, Hugler et al., 2005, Zhang & Bryant, 2011), is one of the most 
important central metabolic pathway used by all organisms to generate energy. 
Essentially, the TCA cycle plays a dual role in cell metabolism: 1) it produces 
carbon dioxide and reduced electron carriers (NADH and FADH2) by oxidation of 
acetyl-CoA to generate energy (catabolism), and 2) provides cells with precursor 
metabolites as building blocks for the synthesis of carbohydrates, fatty acids, 
nucleic acids and amino acids (anabolism) (Owen et al., 2002). Because of its 
amphibolic nature and ubiquity, it is not surprising that different organisms use and 
modulate TCA cycle according to their metabolic requirements, thus giving rise to 
a considerable diversity in its way of operating. Moreover, it is becoming evident 
that the TCA cycle is embedded in a more complex network of metabolic pathways, 
and its intermediates, beyond their canonical function play a profound role as intra- 
and extracellular signals (Benit et al., 2014, Huergo & Dixon, 2015, Haas et al., 
2016). 
TCA cycle intermediates are organic acids, that based on the number of 
carbon atoms are classified into three groups C4-dicarboxylates (succinate, 
fumarate, malate and oxaloacetate), C5-dicarboxylate (α-Ketoglutarate (α-KG)) 
and C6-tricarboxylates (citrate and iso-citrate) (Krebs, 1940). Amongst these, the 
C5-dicarboxylate α-KG has gained significant attention because of its newly 
established role as a signaling molecule in-addition to its conventional role in 
metabolism.  There is mounting evidence that corroborates the role of α-KG as a 
signaling molecule in all three domains of life, archaea (Dodsworth et al., 2005), 
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bacteria (Ninfa & Jiang, 2005) and eukaryota (Lancien et al., 2000, He et al., 2004). 
Indeed, it is now known that α-KG plays a key role in many signaling pathways 
including, but not limited to, regulation of carbon/nitrogen metabolism (Doucette et 
al., 2011), cyclic AMP (cAMP) synthesis (Rabinowitz & Silhavy, 2013), paracrine 
mediator in regulating renal acid-base balance (Tokonami et al., 2013) and in 
epigenetic regulation mediated through histone modification (Letouze et al., 2013, 
Carey et al., 2015) and α-KG-dependent oxygenases (Loenarz & Schofield, 2008).  
In bacteria, intracellular levels of α-KG acts as a key indicator of the cellular 
C/N status (Doucette et al., 2011). α-KG provides the major carbon skeleton for 
nitrogen assimilation pathways (Commichau et al., 2006). High levels of 
intracellular α-KG signals nitrogen starvation, thereby activating the transcription 
of nitrogen assimilation genes (Leigh & Dodsworth, 2007). It is now well 
established that α-KG directly regulates nitrogen metabolism by binding and 
modulating the activity of either the nitrogen regulatory PII protein GlnB in E. coli 
(Ninfa & Jiang, 2005) and/or the transcription factor NtcA in cyanobacteria 
(Tanigawa et al., 2002, Vazquez-Bermudez et al., 2002). Signal perception 
mechanisms mediated by α-KG, nitrogen regulatory PII and NtcA proteins has 
been studied and reviewed extensively (Forchhammer, 2008, Forchhammer, 
2010, Huergo et al., 2013, Huergo & Dixon, 2015). Furthermore, endogenous α-
KG acts as a reactive oxygen species scavenger, particularly of hydrogen peroxide 
thus acting as a protectant against oxidative damage (Mailloux et al., 2009, Lemire 
et al., 2010) and cyanide poisoning (Kunz et al., 1998). Recent studies have 
reported the use of exogenous α-KG as a preferred carbon source during the 
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course of infection by pathogenic bacteria (Guo et al., 2012, Cai et al., 2013). This 
together suggests a more intricate and intense role of α-KG in regulating bacterial 
physiology and metabolism. 
Sensing the available nutrient is a prerequisite for bacterial growth and 
virulence. Bacteria have evolved various host-adapted nutrient acquisition 
strategies to modulate the uptake systems. One canonical mechanism by which 
most bacteria sense and respond to the available nutrient is the two-component 
systems (TCSs). TCSs are made of two signal transduction proteins, a membrane-
bound histidine sensor kinase (HK) and a cytoplasmic response regulator (RR), 
usually a DNA binding protein (Gross et al., 1989). In response to stimuli, the 
sensor autophosporylates at a conserved histidine residue at the C-terminus, and 
subsequently the phosphate is transferred to an aspartate residue at the N-
terminus of the RR (Stock et al., 1989, Stock et al., 2000). The phosphorylated RR 
then modulates the expression of various genes required to bring about the 
appropriate response (Bourret et al., 1989). Given the importance of TCA cycle 
intermediates as a preferred carbon source in numerous bacteria (Finan et al., 
1983, Collier et al., 1996, Tang et al., 2005), it is not surprising that the TCSs are 
involved in regulating their uptake. In both, Gram-negative and Gram-positive 
bacteria TCS proteins have been implicated in regulating the transport and 
utilization of TCA cycle intermediates, particularly the C4-dicarboxylates 
(succinate, fumarate and malate) and the C6-tricarboxylate (citrate) (Asai et al., 
2000, Janausch et al., 2002). However, not much is known about the assimilation 
of the C5-dicarboxylate α-KG. 
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The TCS proteins responsive to extracellular α-KG has been identified in 
limited number of bacterial species, including Escherichia coli (Cai et al., 2013), 
Rhizobium tropici (Batista et al., 2009) and most recently in P. aeruginosa (Tatke 
et al., 2015). In P. aeruginosa, a TCS protein pair PA5512/PA5511 (MifS/MifR) 
together with the sigma factor RpoN (σ54) regulates the transport of extracellular 
α-KG by activating the expression of the α-KG-specific permease PA5530, a Major 
Facilitator Superfamily (MFS) of secondary active transporter protein (Lundgren et 
al., 2014, Tatke et al., 2015). P. aeruginosa MifS/MifR pair is homologous to the 
Rhizobium meliloti C4-dicarboxylate transport regulatory DctB/DctD TCS (Winsor 
et al., 2011). No role of P. aeruginosa MifS and MifR in the utilization of TCA cycle 
C4-C6 di and tricarboxylates (succinate, fumarate, malate, oxaloacetate and citrate) 
has been established (Tatke et al., 2015). Thus, P. aeruginosa MifSR TCS is 
specifically and uniquely involved in α-KG utilization.  
Previously, the MifR protein has been identified to be essential for regulating 
P. aeruginosa biofilm formation (Petrova & Sauer, 2009) and pyruvate 
fermentation (Petrova et al., 2012). Additionally, in P. aeruginosa, nutritional cues 
such as individual carbon and nitrogen sources have been known to influence 
several clinically relevant virulence phenotypes such as motility, biofilm 
development, quorum sensing and pigment production (Kohler et al., 2000, 
Klausen et al., 2003(a), Palmer et al., 2005, Shrout et al., 2006, Palmer et al., 
2007). To date, very little is known about the physiology of P. aeruginosa when 
provided with α-KG as the sole carbon source. Here we show that, MifS/MifR TCS 
and the C5-dicarboxylate α-KG plays a perspicacious role in regulating P. 
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aeruginosa pathogenicity by modulating its key virulence traits, including, motility, 
pigment production, biofilm formation and cell cytotoxicity.  This study is one of the 
first to report a novel role of the regulatory mechanism exerted by MifSR TCS and 
significantly highlights the potential role of α-KG as a signaling molecule in P. 
aeruginosa. 
Materials & Methods 
Bacterial strains, media and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table 3.1. 
Briefly, strains of Pseudomonas aeruginosa and Escherichia coli were routinely 
cultured in Luria Bertani (LB) broth (5 g tryptone, 10 g sodium chloride, and 5 g 
yeast extract per liter) or agar (LB broth with 1.5% agar) (Difco, NJ, USA) or in M9 
minimal Media (64 g Na2HPO4-7H2O, 15 g KH2PO4, 2.5 g NaCl, 5.0 g NH4Cl, 20 
mM MgSO4, 1 mM CaCl2 per liter) (Sambrook & Russell, 2001) at 37οC, unless 
specified otherwise. P. aeruginosa competent cells were prepared using the 
sucrose (300 mM) method as previously described (Choi et al., 2006). Growth 
curves, complementation studies and phenotypic assays were performed in M9 
minimal media supplemented with TCA cycle intermediates, α-KG, succinate 
and/or citrate (at 30 mM each), as described previously (Tatke et al., 2015).  For 
selection and maintenance of plasmids, antibiotics when used, were at the 
following specified concentrations, unless specified otherwise: E. coli: ampicillin 
(Ap) 100 μg/ml, gentamycin 15 μg/ml, kanamycin (Km) 20 μg/ml, P. aeruginosa: 
Gm 75 μg/ml.  
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Cell culture and media 
A549, a human lung adenocarcinoma epithelial cell line was provided by 
Dr. Rahul Mittal (University of Miami, Miller School of medicine, Miami, FL). The 
J774 E-clone, a murine macrophage cell line, also a generous gift from Dr. Philip 
Stahl (Washington University Medical school, St Louis, MO) and the human 
epithelial adenocarcinoma cell line was obtained from ATCC (ATCC®CCL-2™). 
J774 E-clone cell lines were maintained under a 5% CO2 atmosphere in Dubelco’s 
Minimum Essential Medium (DMEM), supplemented with 10% heat-inactivated 
fetal calf serum (FCS), 2 mM L-glutamine, 100 Units/mL penicillin and 100 μg/mL 
of streptomycin. A549 cells were grown in Roswell Park Memorial Institute Medium 
(RPMI) 1640 (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal 
calf serum (FCS), 24 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 2 mM L-glutamine, 100 Units/mL penicillin, 100 μg/mL of streptomycin 
and incubated at 37°C in 5% CO2. HeLa cells were cultured in DMEM 
supplemented with 10% FCS and 2 mM L-glutamine and 1% non-essential amino 
acids in presence of 5% CO2 at 37°C. All chemicals and reagents were purchased 
from Sigma-Aldrich (St. Louis, MO), unless otherwise indicated. 
Genetic manipulations  
Genetic manipulations were carried out as previously described using 
standard techniques (Green et al., 2012). Polymerase Chain Reaction (PCR) 
amplification was performed using the AccuPrime high-fidelity Taq DNA 
Polymerase (Invitrogen, Life Technologies, Carlsbard, CA, USA). Primers for PCR 
and sequencing were synthesized by Integrated DNA Technologies, Inc. 
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(Coralville, IA, USA) and are listed in Table 3.2. DNA purification and plasmid DNA 
isolation was carried out using nucleic acid purification kits (Promega, Madison, 
WI, USA) and PureLink Hipure Plasmid Miniprep Kit (Invitrogen, Life Technologies, 
Carlsbard, CA, USA). Wizard® SV Gel and PCR Clean-Up System kits (Promega, 
Madison, WI, USA) were used for PCR product and agarose gel fragment 
purification. RNA extraction and cDNA synthesis was performed using RNeasy 
Mini Kit (Qiagen Inc. Venio, Limburg, Netherlands) and SuperScript III First-Strand 
Synthesis System (Invitrogen, Life Technologies, Carlsbad, CA, USA). Restriction 
enzymes were from New England Biolabs (Ipswich, MA, USA), and DNA 
sequencing was carried out at Florida International University (FIU) DNA core and 
at GENEWIZ Inc. (South Plainfield, NJ, USA). All other chemicals were purchased 
from Sigma-Aldrich (St. Louis, MO, USA), Amresco (Solon, OH, USA) and 
TheromoFisher Scientific (Waltham, MA, USA), unless otherwise specified. 
PCR amplification and cloning of pcaT  
DNA fragments from PAO1 with pcaT (~1.3 kb) and PA0703 (~1.3 kb) were 
PCR amplified using primer pairs GDT_pcaTF1-GDT_pcaTR1 (Table 3.2), 
respectively. The primers are designed such that the ORF is contiguous to a strong 
ribosome binding site (AGGAGA), to ensure expression of the genes (Lehninger 
et al., 2013). The PCR amplified pcaT was cloned directly into a broad host range 
pPSV37-Gm (Lee et al., 2010) plasmid as a NheI-SacI fragments, downstream of 
an inducible PlacUV5 promoter to generate plasmids pGDT007, respectively. The 
fidelity of the PCR product was confirmed by sequencing using the primers 
82	
	 	 	
GDT_p37_SeqF-R, pcaT_seqF-R and PA0703_seqF-R (Table 3.2).  Henceforth, 
this plasmid is referred to as pPcaT, respectively.  
The expression plasmid pPcaT was subsequently introduced by 
electroporation (Choi et al., 2006) into PAO1 and its isogenic mutants PAO∆mifS, 
PAO∆mifR, PAO∆mifSR and PAO∆rpoN.  
Growth curves 
Growth curves were performed as described previously (Tatke et al., 2015). Briefly, 
P. aeruginosa wild type PAO1 and its isogenic mutant derivatives were grown 
overnight in LB broth with or without antibiotics at 37°C. After overnight growth, 
spent and residual media was removed by centrifugation and the cultures were 
washed with sterile 0.85% NaCl (wt/vol) solution. Cultures were then diluted in 
fresh M9 minimal media supplemented with TCA cycle intermediates including α-
KG, succinate and/or citrate (at 30 mM each) as a sole carbon source to obtain 
equal optical densities (OD600) of 0.025. Growth was monitored in 48-96 well plates 
(Corning-Falcon, NY, USA) by determining absorbance at 600 nm using BioTek 
Synergy HT plate reader for 14-18 h at 37°C. The experiments were performed 
multiple times in triplicates.   
Motility assays 
Motility assays were examined on 0.3%, 0.6% and 1% (wt/vol) M9 minimal 
media agar plates as a described previously (Deziel et al., 2001). All cultures were 
grown overnight in LB media at 37°C. Overnight cultures were washed with sterile 
0.85% NaCl (wt/vol) solution and diluted to OD600 of 1. Swimming and swarming 
motilities were evaluated by spotting 1-2 μl cultures onto 0.3% and 0.6% (wt/vol) 
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M9 minimal media agar plates with α-KG or citrate (at 30 mM each) as a sole 
carbon source. Twitching motility was evaluated by stab inoculating OD600 
normalized cultures onto 1% (wt/vol) M9 minimal media agar plates with α-KG or 
citrate (at 30 mM each) as a sole carbon source. Plates were incubated at 37°C 
and motility patterns were assessed 24 to 48 h post-incubation. Diameters of the 
swim or twitch zones were measured in millimeter (mm) and swarming was 
assessed by determining the surface coverage on agar plates post incubation. 
Each form of motility was assessed multiple times with three replicates for each 
mutant. 
Rhamnolipid assay 
P. aeruginosa wildtype PAO1, PAO1(pPcaT), PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT) and PAOΔmifSR(pPcaT) strains were assayed for rhamnolipid 
production using the  cetyltrimethylammonium bromide (CTAB) methylene blue 
agar plate assay as described previously (Siegmund & Wagner, 1991). Briefly, all 
cultures were grown overnight at 37°C in LB broth.  Spent and residual media from 
the overnight culture was removed by centrifugation, and the cultures were washed 
with sterile 0.85% NaCl (wt/vol) solution. Rhamnolipd production was evaluated by 
spot inoculating OD600 normalized cultures on M9 minimal media supplemented 
with 30 mM α-KG (unless otherwise specified), 0.0005% (wt/vol) methylene blue 
and 0.02% (wt/vol) CTAB. Plates were incubated at 37°C for 24 h followed by 
incubation at room temperature for at least 48 h until a blue halo appeared around 
the colonies, indicating rhamnolipid production (Siegmund & Wagner, 1991). The 
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diameter of the blue halo (in millimeter (mm)) around the colonies was measured 
as a mark of rhamnolipid production. 
Pyocyanin production 
Pyocyanin produced was measured by extracting the pigment from culture 
supernatants using the chloroform-hydrochloric acid (HCL) method as described 
previously (Essar et al., 1990). Briefly, 5-ml culture supernatant from the 
stationary-phase cultures (∼18 h) grown in M9 minimal media supplemented with 
TCA cycle intermediates including α-KG, citrate and succinate (30 mM each) 
individually as a sole carbon source was mixed with 3 ml chloroform to extract 
pyocyanin into the organic phase. Pyocyanin from the organic phase was then re-
extracted into 1 ml of 0.2 N HCl. The resulting pink color formation, an indication 
of the presence of pyocyanin was read at 520 nm. The concentration is expressed 
as µg of pyocyanin produced per ml of culture (µg/ml), by multiplying the optical 
density OD520 by 17.072 (Essar et al., 1990). Absorption spectra analysis (250 nm 
to 800 nm) to detect pyocyanin from the cell free culture supernatants, was 
performed using the Beckman Coulter Inc., DU 800 spectrophotometer. 
Pyoverdine production 
To measure pyoverdine production, cells were grown overnight at 37°C in 
M9 minimal media supplemented with α-KG, succinate and/or citrate, individually 
(at 30 mM each) as a sole carbon source. Extracellular pyoverdine from the culture 
supernatant was read at 405 nm and normalized to the initial culture density 
(OD600). Pyoverdine levels were expressed as a ratio of OD405/OD600 (Shen et al., 
2002). Absorption spectra analysis (250 nm to 800 nm) to detect pyoverdine from 
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the cell free culture supernatants, was performed using the Beckman Coulter Inc., 
DU 800 spectrophotometer. 
Cytotoxicity assay 
P. aeruginosa wild-type PAO1 and its isogenic PAO∆mifR, PAO∆mifS, 
PAO∆mifSR, mutant strains and its derivatives were used for the cytotoxicity 
assay. Their cytotoxicity was assessed using a human lung adenocarcinoma 
epithelial cell line (A549), a murine macrophage cell line (J774 E-clone) and HeLa 
cells. Bacterial cytotoxicity was quantified by measuring the lactate 
dehydrogenase (LDH) enzyme activity from the culture supernatant post 24 h 
infection with P. aeruginosa strains (Hauser & Engel, 1999). Briefly, monolayers of 
J774 E-clone, A594 and HeLa cells (106 cells/mL) were incubated with bacterial 
suspension containing 108 CFU/mL of bacteria. Overnight bacterial cells were 
subcultured into M9 minimal media with α-KG (30 mM) to a final OD600 nm of 0.1. 
The infection was synchronized by centrifugation for 5 minutes at 1000 x g and 
incubated for 24 hours at 37°C in 5% CO2. Cell-free culture supernatant were then 
collected and the amount of lactate dehydrogenase (LDH) enzyme activity was 
assayed in a 96-well plate using the Sigma kit as per manufacturer’s instructions 
(Sigma Aldrich, St. Louis, MO). Triplicate wells were used for each test, and all 
tests were repeated at least three times. 
Biofilm formation  
Biofilm formation was assessed on 96-well polystyrene flat-bottomed 
(Costar, Corning NY) and/or on non-tissue culture-treated 96-well polyvinyl 
chloride (PVC) U-bottom (Falcon) microtiter plates, as described previously 
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(Friedman & Kolter, 2004, O'Toole, 2011). Briefly, PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT), PAOΔmifSR(pPcaT), PAO1 (pPcaT) as well as the control 
strains PAO1(wildtype), PAOΔretS (positive control, hyperbiofilm producer) and 
PAOΔpel∆psl∆algD (negative control, no biofilm producer) were grown in LB broth 
overnight at 37°C. Cultures were then diluted to an OD600 of 0.0025 in M9 minimal 
media supplemented with α-KG, succinate or citrate individually (at 30 mM each). 
The plates were incubated under static condition at room temperature for 24, 48 
and 72 hours. At each time point, the culture was decanted and the plates were 
washed by gently submerging them in a small water tub in order to remove the 
unattached cells, and the plates were dried for 10-15 minutes at room temperature. 
To stain the biofilm, 0.1% solution of crystal violet (St. Louis, MO, USA) in water 
was added to each well (200 µL). After 20-minute incubation at room temperature, 
crystal violet was decanted, and the plates were washed 7 to 8 times in a small 
water tub. Plates were then inverted and left to dry overnight. Quantification of the 
attached and stained cells was done after solubilization of the dye with absolute 
ethanol (200 µL). The optical density of the solution reflecting the relative biofilm 
formation was measured at 590 nm using BioTek Synergy HT (Winooski, VT, USA) 
and expressed as relative biofilm formation (OD590 mutant / OD590 wildtype) (Ueda 
& Wood, 2009). The experiments were performed multiple times in triplicates. 
RNA isolation and cDNA synthesis 
P. aeruginosa wild-type PAO1 and its isogenic PAO∆mifR, PAO∆mifS, 
PAO∆mifSR, PAO∆rpoN mutant strains and its derivatives were used for RNA 
extraction. Total RNA was extracted from cells grown to mid-exponential phase 
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with or without α-KG (at 30 mM) treatment. Briefly, cultures were grown overnight 
in LB broth at 37°C.  Post incubation overnight cultures were washed with sterile 
0.85% saline solution to remove spent media and were subcultured at 37°C, 200 
rpm in LB media. LB media was used as a preferred nutrient source for initial 
growth of cultures since PAO∆mifR, PAO∆mifS, PAO∆mifSR and PAO∆rpoN 
mutants exhibit growth defects in the presence of α-KG alone. When the cells 
reached an OD600 of 0.6-0.7, all the cultures were treated with 30 mM α-KG for 2 
h. Post treatment, the RNA was stabilized by adding phenol-ethanol mixture 
(Brencic et al., 2009). The stabilized RNA was then isolated using RNeasy Mini Kit 
(Qiagen Inc. Venio, Limburg, Netherlands) as per manufacturer’s protocol. 
Residual genomic DNA contamination was removed using RQ1 RNase-free 
DNase (Promega, Madison, WI, USA) and RNA was repurified using RNeasy Mini 
Kit (Qiagen Inc. Venio, Limburg, Netherlands). RNA quality was preliminarily 
checked on  a denaturing agarose gel (NorthernMax Gly, Ambion) followed by 
analysis on the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). 
Samples with RNA Integrity Numbers of 8.0 or above were subsequently used for 
cDNA synthesis. cDNA was synthesized by annealing NS5 random primers to total 
purified RNA and subsequent extension was carried out using SuperScript III 
reverse transcriptase, as per the manufacturers protocol (Invitrogen, Life 
Technologies, Carlsbard, CA, USA).  
Quantitative real-time PCR 
P. aeruginosa genes encoding α-KG transporter proteins (pcaT and 
PA5530 (kgtP)) and pyocyanin synthesis (phzA1, phzB1, phzA2, phzM and phzS) 
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were amplified (qRT-PCR) under α-KG induced condition at 30 mM, using the ABI 
7500 (Applied Biosystems, Life Technologies, Carlsbard, CA, USA) cycler with 
Power SYBR Green PCR MasterMix with ROX (Applied Biosystems, Life 
Technologies, Carlsbard, CA, USA). The gene-specific primers used to quantitate 
the expression levels of the transcript are listed in Table 3.2. Ten nanograms of 
cDNA was used per reaction well in the qRT-PCR assays. The cycling conditions 
used were 95˚C/2 minutes (holding); 40 cycles of 95˚C/15 sec, 60˚C/1 min 
(cycling); 95˚C/15 sec, 60˚C/1 min, 95˚C/15 sec (0.6˚C ramp) (melt curve). The 
reading was normalized to P. aeruginosa clpX (PA1802), whose expression was 
determined to remain constant between the samples and conditions tested. The 
qRT-PCR assays for each gene was repeated twice in triplicate, and the mean 
value of the quantification was calculated. Melting curves were determined to 
ensure primer specificity.  
Bioinformatic and statistical analyses 
Sequence analyses and multiple sequence alignments were generated 
using ClustalW2 http://www.ebi.ac.uk/Tools/msa/clustalw2/ and 
www.pseudomonas.com (Winsor et al., 2011). Student’s t-test or Analysis of 
Variance (ANOVA) with post-hoc testing, when applicable, was used to analyze 
statistical differences. The t-test and ANOVA were performed using GraphPad and 
IBM SPSS statistics 22.0 statistical analysis software. A p-value of < 0.05 was 
considered statistically significant. 
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Table 3.1: Strains and plasmids used in this study. 
Strain ID Strain/Plasmid Background Relevant characteristics Source 
Escherichia coli 
DH5α E. coli 
F- Φ80lacZΔM15Δ (lacZYA-
argF)U169 deoR recA1 
endA1 hsdR17 (rk- mk+) 
phoA supE44 λ- thi-1 gyrA96 
relA1 
New 
England 
Biolabs 
Pseudomonas aeruginosa 
PAO1  Prototypic wild type (Stover et al., 2000) 
PKM900 PAO1 ∆mifS (PA5512) 
PAOΔmifS 
(Tatke et al., 
2015) 
PKM901 PAO1 ∆mifR (PA5511) 
PAOΔmifR 
(Tatke et al., 
2015) 
PKM902 PAO1 ∆mifSR (PA5511-PA5512) 
PAOΔmifSR 
(Tatke et al., 
2015) 
Plasmids 
pPSV37  GmR; colE1  oriT lacIq PlacUV5  
(Lee et al., 
2010) 
pGDT004 pPSV37 
GmR; The mifR ORF 
subcloned from pGDT002 as 
an NheI-SacI fragment into 
pPSV37  
(Tatke et 
al., 2015) 
pGDT005 pPSV37 
GmR; A ~3.0-kb NheI-SacI 
fragment containing mifSR 
(PA5511-PA5512) ORFs 
amplified from PAO1 
genome using HK_mifSF1 
and GDT_mifRR1 primers 
and cloned directly into NheI-
SacI-cut in pPSV37  
(Tatke et 
al., 2015) 
pGDT006 pPSV37 
GmR; A ~1.3-kb NheI-SacI 
fragment containing PA5530 
ORF amplified from PAO1 
genome using 
GDT_PA5530F1 and 
GDT_PA5530R1 primers 
(Tatke et 
al., 2015) 
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and cloned directly into NheI-
SacI-cut in pPSV37 
pGDT007 pPSV37 
GmR; A ~1.3-kb NheI-SacI 
fragment containing pcaT 
(PA0229) ORF amplified 
from PAO1 genome using 
GDT_pcaTF1 and 
GDT_pcaTR1 primers and 
cloned directly into NheI-
SacI-cut in pPSV37 
This study 
 
 
 
Table 3.2: Primers used in this study. 
Primer Name Sequence 
GDT_pcaTF1 
5’-
GCTAGCAGAAGGAGATATACCATGACTGCCCCTG
TTCAC-3’ 
GDT_pcaTR1 5’-TTTGAGCTCCCGTCAGGGCTCGTCGTT-3’ 
GDT_p37_SeqF 5’-GACCCGTTTAGAGGCCCCAA-3’ 
GDT_p37_SeqR 5’-CGTGCTTTACACTTTATGCTTCCGG-3’ 
pcaT_seqF 5’-TTCGTGATCGGCGCGATC -3’ 
pcaT_seqR 5’-CAGCCAGAGGGCGATCAC-3’ 
DBS_qRT_clpXF 5'- TGCGATTACGATGTGGAGA -3' 
DBS_qRT_clpXR 5'- CCCTCGATGAGCTTCAGCA -3' 
GDT_qRT_pcaTF 5'- TGCGATTACGATGTGGAGA -3' 
GDT_qRT_pcaTR 5'- CCCTCGATGAGCTTCAGCA -3' 
GDT_qRT_PA5530F 5'-CGCAACGCATCAAGTCGAT-3' 
GDT_qRT_PA5530R 5'-AGTCGTACCACTCGACCAGGTT-3' 
qRT_phzA1F 5'- GGCACAACGTGCGGATCT -3' 
qRT_phzA2R 5'- CGCACTCGACCCAGAAGTG-3' 
qRT_phzA2F 5'- GCCCTGCGCGAATACG -3' 
qRT_phzA2R 5'- CCATTCCTCTTTTTCCCGTTCT -3' 
qRT_phzSF 5'- GCCCTGCGCGAATACG -3' 
qRT_phzSR 5'- CCATTCCTCTTTTTCCCGTTCT -3' 
qRT_phzMF 5'- GAGCGCATCCATCGACTGAT -3' 
qRT_phzMR 5'- GGTATCGCCCTGGAAGATCTC -3' 
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Results and Discussion 
Acquisition of energetically favorable carbon and energy sources from the 
extracellular milieu of nutrients is of paramount importance to bacterial survival and 
disease progression. The C5-dicarboxylate α-KG is a key intermediate of the 
energy-generating TCA cycle and plays an important role in regulating the cellular 
carbon and nitrogen metabolism (Doucette et al., 2011). An important aspect of 
the nutrient acquisition process is their transport from the environment into the cells 
via the transporter proteins. The transport of α-KG has been studied in only a 
handful of bacteria including P. aeruginosa (Lundgren et al., 2014, Tatke et al., 
2015),  E. coli (Seol & Shatkin, 1991, Cai et al., 2013), R. trpopici (Batista et al., 
2009), X. oryzae (Guo et al., 2012) and Staphylococcus aureus (Tynecka et al., 
2001). In P. aeruginosa, E. coli and R. tropici extracellular α-KG transport is 
arbitrated by TCS proteins MifS/MifR (Tatke et al., 2015), KguS/KguR (Cai et al., 
2013) and KgtS/KgtR (Batista et al., 2009), respectively. The present study further 
explores the role of P. aeruginosa mifSR encoding the sensor kinase MifS and 
response regulator MifR in regulating α-KG transport. Furthermore, using the 
PAOΔmifS, PAOΔmifR and PAOΔmifSR mutants and their derivatives, we 
additionally investigated the role of MifSR TCS and the C5-dicarboxylate α-KG in 
regulating P. aeruginosa virulence.  
P. aeruginosa possess multiple α-KG transport proteins 
The E. coli transporter KgtP is the most extensively studied α-KG permease 
(Seol & Shatkin, 1991, Seol & Shatkin, 1992, Seol & Shatkin, 1993). A homology 
search in P. aeruginosa PAO1 genome revealed the presence of two ORFs 
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PA0229 (pcaT) and PA5530 encoding the putative dicarboxylic acid transport 
proteins that are homologs of E. coli α-KG permease KgtP. After here we name P. 
aeruginosa PA5530 as KgtP. In recent studies, KgtP has been characterized and 
identified as the functional α-KG transporter, whose expression is regulated by the 
MifSR TCS in coordination with the alternate sigma factor RpoN (σ54) (Lundgren 
et al., 2014, Tatke et al., 2015). In P. puitda, PcaT has been implicated in the 
transport of β-ketoadipate (Ondrako & Ornston, 1980). However, in P. aeruginosa 
PcaT function was not previously explored. 
Our sequence analyses of P. aeruginosa PcaT and KgtP with E. coli KgtP 
using BLASTP revealed that P. aeruginosa PcaT (PA0229) is the closest E. coli 
KgtP homolog with 88% similarity and 70% identity, suggesting a similar function. 
P. aeruginosa PcaT and KgtP share 72% similarity and 55% identity, and have the 
conserved protein domain family PRK10406 implicated in α-KG transport 
(Marchler-Bauer et al., 2015). This data strongly suggests that P. aeruginosa PcaT 
is capable of transporting α-KG into the cells. To confirm the role of P. aeruginosa 
pcaT in α-KG uptake, pcaT was amplified and subcloned downstream of the 
inducible PlacUV5 promoter to generate the plasmid pPcaT. The plasmid pPcaT was 
then introduced into the wild-type PAO1 and its isogenic mifSR mutant strains. The 
PAOΔmifS, PAOΔmifR and PAOΔmifSR mutants exhibit an α-KG-dependent 
growth defect due to the deficiency in the transport of extracellular α-KG (Tatke et 
al., 2015). Expression of pcaT in trans in the mifSR mutants restored their growth 
to a level comparable to the wild-type PAO1 in M9 minimal media with α-KG (30 
mM) as the sole carbon source (Figure 3.1).  
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Table 3.3: Growth Properties of the mifSR mutants and its 
derivatives in the presence of α-KG  
 PAO1 ∆mifR ∆mifS ∆mifSR 
EV +++ --- --- --- 
pPcaT +++ +++ +++ +++ 
pPA5530 +++ +++ +++ +++ 
Figure 3.1: Growth of mifSR mutants in the presence of α-KG and pPcaT. 
Growth curves of P. aeruginosa wildtype PAO1 and mifSR mutants expressing 
pcaT, encoding the putative carboxylic acid transporter in trans in M9 minimal 
media with α-KG (30 mM). Results shown are mean with standard deviation of 
three biological replicates. 
94	
	 	 	
Furthermore, growth of the wild-type PAO1 was not affected by the expression of 
an extra copy of the pcaT gene (Figure 3.1). This finding confirms the role and 
ability of P. aeruginosa PcaT in transporting extracellular α-KG into the cells. 
Biochemical studies have hinted to the presence of inducible α-KG 
transporters in Pseudomonas spp (Campbell & Stokes, 1951, Edwards et al., 
1979). This was supported by our recent findings where the expression of P. 
aeruginosa kgtP gene encoding the α-KG permease was significantly induced by 
α-KG (Tatke et al., 2015). To test if the expression of pcaT gene is induced by the 
presence of extracellular α-KG, qRT-PCR analysis was performed. Expression of 
pcaT was tested in the wild-type PAO1 grown with varying amounts of α-KG (1 – 
80 mM). The presence of α-KG resulted in the activation of pcaT expression in a 
concentration independent manner (Figure 3.2). This data suggests that pcaT 
expression is induced by α-KG.  
The mifSR mutants failure to grow in the presence of α-KG is the result of 
a defect in the expression of α-KG transporter proteins (Tatke et al., 2015). This 
growth deficient phenotype can be rescued by uncoupling the MifSR regulatory 
control over pcaT and kgtP by expressing these genes under a regulatable 
promoter (Table 3.3). This suggests that MifSR TCS, similar to kgtP, regulates 
pcaT expression. To determine if this is true, we looked at the pcaT and kgtP RNA 
levels in the ΔmifS, ΔmifR and ΔmifSR mutant strains. Corroborating our previous 
findings (Tatke et al., 2015), expression of kgtP was downregulated in the mifSR 
deficient strains (Figure 3.3). However, surprisingly, pcaT expression was 
upregulated in the absence of mifSR and the presence of α-KG (Figure 3.3). This 
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suggests that MifSR TCS negatively regulates pcaT expression. In the 
experimental set up, the regulatory control of pcaT was uncoupled by expressing 
it under PlacUV5. In the mifSR mutants, there is an intact pcaT, however it is unable 
to rescue the a-KG dependent growth defect (Table 3.3), despite the increased 
expression (Figure 3.3). This implies that perhaps pcaT expression is controlled 
post-transcriptionally by an un-identified factor which requires intact MifSR. These 
findings strongly suggests that MifSR TCS inversely regulates the expression of 
P. aeruginosa pcaT and kgtP.  
Our sequence analysis of the pcaT upstream promoter (PpcaT) region 
revealed the presence of a putative weak RpoN (σ54) sigma factor binding -24/-12 
sequence: TGGCAC-N7-TCGCC (Barrios et al., 1999) and an A-rich motif 
adjacent to the ribosome binding site with a signature sequence (AAc/uAAc/A) for 
the catabolite repression control (Crc) protein (Figure 3.4) (Sonnleitner et al., 2009, 
Browne et al., 2010). Crc is a post- transcriptional inhibitor that prevents translation 
initiation by binding to the mRNA (Moreno et al., 2007, Sonnleitner et al., 2009). In 
addition, we identified four putative GGA trinucleotide motifs in the PpcaT, a 
characteristic binding site recognized by the post-transcriptional control RsmA 
family of proteins (Brencic & Lory, 2009). Also, in the predicted secondary structure 
of the pcaT leader sequence using Mfold we found that the GGA motifs are 
exposed in the steam-loop structures which could acts as a substrate for RsmA 
binding, as has been observed for several known RsmA targets (Figure 3.4). 
Though the role of Crc and RsmA in α-KG transport has to be verified 
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experimentally, it suggests an additional layer of regulation controlling pcaT 
expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: pcaT gene expression in response to α-KG. qRT-PCR was used 
to measure the relative quantities of pcaT mRNA after P. aeruginosa PAO1 
cells were induced for an hour with varying concentration of α-KG (1 to 80 mM). 
Bars above or below the line represents up- and down-regulation, respectively, 
and the error bars indicate standard errors. Data were normalized to expression 
in PAO1 uninduced cells. The clpX gene (PA1802) was used as the 
housekeeping control. Statistically significant difference as determined by one-
way ANOVA with Bonferroni’s post-hoc test, ** p-value < 0.001 compared with 
expression in the uninduced condition. 
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MifS/MifR TCS regulates P. aeruginosa virulence  
Success of P. aeruginosa as a recalcitrant pathogen relies significantly on 
its metabolic flexibility, which is exhibited by its ability to utilize a myriad of organic 
compounds as carbon and energy source for its survival and growth.  Furthermore, 
P. aeruginosa is conspicuous for its ability to cause both acute and chronic 
infections in immunocompromised patients (Bodey et al., 1983). This versatility is 
manifested in part by expression of a vast array of virulence determinants, both 
cell-associated and secretory, that are capable of overpowering the host cell 
defenses and catabolizing macromolecules (Gellatly & Hancock, 2013). It is 
therefore not surprising that the synthesis and regulation of multiple virulence 
factors is controlled by nutrient availability. Carbon and nitrogen sources have 
been shown to influence several virulence related phenotypes in P. aeruginosa 
including biofilm development (Klausen et al., 2003(a), Shrout et al., 2006), motility 
(Kohler et al., 2000), pigment production (Palmer et al., 2007, Dandekar et al., 
2012) and cell cytotoxicity (Bains et al., 2012). To date, very little is known of the 
physiology of P. aeruginosa when provided with α-KG as the sole carbon source 
and its role in virulence. Importantly, it is now known that extracellular α-KG is a 
primary carbon source for some pathogenic bacteria during infection (Guo et al., 
2012, Cai et al., 2013). Considering these findings, we further explored if a-KG has 
a more profound physiological role in regulating P. aeruginosa virulence and if 
MifSR TCS play any role. An impediment in performing experiments with mifSR 
mutants in the presence of α-KG was there in#ability to grow in media with α-KG 
as the sole carbon source (Table 3.3). To circumvent the problem, all the virulence 
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related phenotypic assays were performed using ΔmifS, ΔmifR and ΔmifSR 
mutants harboring pPcaT plasmid, unless specified otherwise. Thus, in the mifSR 
mutants, in trans expression of the α-KG transporter PcaT ensures the influx of 
extracellular α-KG into the cells while manifesting the effect of mifSR deletions on 
P. aeruginosa virulence phenotypes.  
Enhanced biofilm formation in the absence of mifSR 
Biofilm mode of growth is one of the hallmark of P. aeruginosa chronic 
infections (Tolker-Nielsen, 2014). Subsequently, biofilm infections are difficult to 
eradicate as a result of biofilm’s inherited tolerance to clinically significant 
antibiotics (Costerton et al., 1999). It has been long known that TCS signaling 
proteins play a crucial role in modulating P. aeruginosa biofilm formation 
(Mikkelsen et al., 2011). The response regulator MifR, has been implicated in 
regulating P. aeruginosa biofilm formation, as mifR-deficient strains failed to form 
mature biofilms due to a defect in microcolony formation (Petrova & Sauer, 2009).  
Furthermore, previous studies have reported the interdependence of pyruvate 
fermentation and requirement of functional MifR in supporting microcolony 
formation (Petrova et al., 2012). Considering the above results in the light of 
previous findings (Tatke et al., 2015) we investigated the impact of MifSR TCS on 
P. aeruginosa biofilm formation in the presence of α-KG (30 mM) as the sole 
carbon source. As mentioned before, because of the inability of the PAO∆mifR, 
PAO∆mifS and PAO∆mifSR mutants to grow in the presence of α-KG (Table 3.3) 
(Tatke et al., 2015), biofilm formation was assessed using mifSR mutant strains 
harboring the pPcaT plasmid, unless otherwise specified. Also, to rule out the 
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possible role of pPcaT affecting biofilm formation, the wild-type strain PAO1 
expressing PcaT in trans was used as a control.   
Compared to the wild-type PAO1 strain, PAO∆mifR(pPcaT), 
PAO∆mifS(pPcaT) and PAO∆mifSR(pPcaT) mutants exhibited an increase in 
biofilm formation in the presence of α-KG as carbon source (Figure 3.5A). The 
difference was significant at all time points (P-value > 0.005) tested over a period 
of 72 hours. Importantly, expression of the wild-type mifR and mifSR genes in trans 
in the PAO∆mifR and PAO∆mifSR mutants restored the biofilm formation to the 
wild-type PAO1 levels (Figure 3.5A). Furthermore, the presence of pPcaT itself did 
not have any adverse effect on biofilm formation, as PAO1(pPcaT) formed 
comparable level of biofilm as that of the wild-type PAO1 without pPcaT (Figure 
3.5A). Additionally, our positive control PAOΔretS a hyper biofilm forming strain 
and the negative control PAOΔpelΔpslΔalgD that forms no biofilms showed the 
expected results (Figure 3.5).   
We have previously shown that MifSR TCS is specific for regulating P. 
aeruginosa α-KG transport, as mifS, mifR and mifSR mutants exhibited no growth 
difference compared to the wild-type PAO1 in the presence of TCA cycle C4-
dicarboxylate (succinate, fumarate, malate) and/or the C6-tricarboxylate (citrate) 
intermediates (Tatke et al., 2015).  It was of interest to investigate if the enhanced 
biofilm formation phenotype of mifSR(pPcaT) mutants is α-KG specific. To test 
this, biofilm formation ability of the mifSR(pPcaT) mutants was evaluated in the 
presence of citrate and/or succinate (30 mM each) as the sole carbon source. No 
difference in biofilm formation between the mifSR(pPcaT) mutant strains and the 
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wild-type PAO1 was observed over a period of 72 hours in the presence of 
succinate (Figure 3.5B) or citrate (Figure 3.5C) as a carbon source. These findings 
suggests that MifSR TCS negatively regulates biofilm formation in an α-KG 
dependent manner.  
It is now well established that the type and availability of nutrients 
significantly impact biofilm development and composition (Bowden & Li, 1997, 
Sauer et al., 2004). In P. aeruginosa, biofilm formation and development 
progresses distinctly in the presence of different carbon and nitrogen sources 
(Klausen et al., 2003(a), Klausen et al., 2003(b), Shrout et al., 2006). Most of the 
studies to date have looked at the influence of citrate, succinate, pyruvate, 
glutamate, casaminoacids, and sugars on the formation of P. aeruginosa biofilms 
(De Kievit et al., 2001, Klausen et al., 2003(a), Klausen et al., 2003(b), Shrout et 
al., 2006, Petrova et al., 2012). The present study is one of the first to report α-KG 
mediated two-component signaling in regulating P. aeruginosa biofilm formation.  
 
 
 
 
 
 
 
 
 
103	
	 	 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: α-KG dependent regulation of biofilm formation by mifSR 
mutants. Biofilm formation of the wild-type PAO1 and mifSR mutants 
expressing pcaT in trans, hyperbiofilm producing PAOΔretS (positive control), 
and less biofilm producing PAOΔpelΔpslΔalgD (negative control) in M9 minimal 
media with α-KG (A), succinate (B) and citrate (C) at 30 mM each, as a sole 
carbon source. The data shown is the relative biofilm formation of each mutant 
and complementing strain as compared to that of the wild type PAO1 as 
described in material and methods. Each result represents the mean with 
standard deviation of three biological replicates. The inset, taken at 72 hours, 
demonstrates the superior biofilm formation capacity of PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) mutants compared to PAO1 in the 
presence of α-KG (D). Statistically significant difference between the wild type 
and mutants as determined by one-way ANOVA with Bonferroni’s post-hoc test, 
** p-value < 0.001. 
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mifSR deletion mutants are defective in swarming motility 
In pathogenic bacteria including P. aeruginosa, motility facilitates 
successful invasion, survival and colonization within a host, increases nutrient 
acquisition efficiency and helps challenging or evading the host defenses, thus 
playing an indispensable role in its virulence (Kazmierczak et al., 2015). 
Depending on the growth conditions and medium, P. aeruginosa exhibits three 
types of motility, namely swimming, swarming and twitching (Rashid & Kornberg, 
2000). The motility is controlled by two cell-surface appendages, a single polar 
flagellum and type-IV pili (Harshey, 2003). The flagellum enables swimming in 
liquid environments (Toutain et al., 2005) whereas type-IV pili mediates twitching 
across solid surfaces (Burrows, 2012). Swarming is a coordinated rapid movement 
over semi-solid or viscous surfaces requiring both flagella and type-IV pili (Kohler 
et al., 2000). In P. aeruginosa, motility plays a crucial role in facilitating the 
transition from a free-living planktonic growth to the more sessile biofilm mode of 
growth (Sauer et al., 2002). 
On the basis of our findings that P. aeruginosa mifSR-deficient strains form 
hyper-biofilms in the presence of α-KG, we hypothesized that MifSR TCS is 
involved in regulating motility. To test this, we compared swimming, swarming and 
twitching on 0.3%, 0.6% and 1% agar in the wild-type PAO1 and PAO∆mifR, 
PAO∆mifS and PAO∆mifSR mutants harboring the pPcaT plasmid, in the presence 
of α-KG (30 mM) as the sole carbon source. The mifSR(pPcaT) mutants 
demonstrated no significant defect in the flagellum-mediated swimming and type-
IV pili mediated twitching motilities in the presence of α-KG (Figure 3.6).  
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Figure 3.6: Swimming and twitching motility of mifSR mutants in the 
presence of α-KG.  Swimming and twitching motility of the wild-type PAO1, 
PAOΔmifS(pPcaT), PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) was assessed on 
media supplemented with α-KG (30 mM). The experiment was repeated 
multiple times with biological replicates.    
Figure 3.7: α-KG specific swarming motility in mifSR mutants.  Swarming 
motility of the wild-type PAO1, PAO1(pPcaT), PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) mutants and the pMifR and pMifSR 
complementing clones was assessed on media supplemented with α-KG or 
citrate (30 mM each). The experiment was repeated multiple times with 
biological replicates.    
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However, compared to P. aeruginosa wild-type PAO1, the ability of ∆mifS(pPcaT), 
∆mifR(pPcaT) and ∆mifSR(pPcaT) mutants to swarm was completely abolished in 
the presence of α-KG (Figure 3.7A). The swarming defect exhibited by these 
mutants could be restored to that of the wild-type PAO1 by expressing mifR and 
mifSR in trans in the ∆mifR and ∆mifSR mutants (Figure 3.7C). Furthermore, no 
difference in swarming motility was observed in the PAO1(pPcaT) control strain 
suggesting that the swarming motility defect in ∆mifS(pPcaT), ∆mifR(pPcaT) and 
∆mifSR(pPcaT) mutants is pPcaT-independent and MifSR-dependent.  
In our previous study using rich media, such as LB, no role of MifSR TCS 
was established in regulating P. aeruginosa motility (Tatke et al., 2015). The above 
data further supports the argument that the swarming defect is α-KG dependent. 
To further investigate, if the inability of mifSR mutants to swarm was α-KG-specific, 
we tested the ability of these mutants to swarm on other TCA cycle intermediates 
including succinate and citrate. Interestingly, P. aeruginosa wild-type PAO1 and 
the mifSR mutants with or without pPcaT exhibited identical swarming phenotypes 
in the presence of succinate or citrate (Figure 3.7B). Also, no difference in 
swimming and twitching motility was observed in presence of citrate or succinate 
as a carbon source. Together, these findings clearly argues for the requirement of 
a functional MifSR in modulating P. aeruginosa swarming motility exclusively in the 
presence of α-KG.  
Swarming motility in P. aeruginosa is often regulated in response to 
rhamnolipid production (Kohler et al., 2000, Caiazza et al., 2005). Rhamnolipids 
are surface-active agents that help in reducing surface tension to drive flagellum-
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mediated translocation over semi-solid surfaces (Kohler et al., 2000). In addition, 
rhamnolipids have been recovered from CF patient sputa and are involved in 
inactivation of mammalian tracheal cells and erythrocyte destruction, indicating 
their importance as virulence factors (Hastie et al., 1986, Kownatzki et al., 1987, 
Jensen et al., 2007). Lack of swarming in the ∆mifS(pPcaT), ∆mifR(pPcaT) and 
∆mifSR(pPcaT) mutants can be attributed to a difference  in rhamnolipid 
production in the presence of α-KG. To test if the swarming defect in the mifSR 
mutants is concomitant with rhamnolipid production we performed the rhamnolipid 
plate assay with α-KG as a carbon source. No significant difference was observed 
in rhamnolipid production in the ∆mifS(pPcaT), ∆mifR(pPcaT) and ∆mifSR(pPcaT) 
mutants as compared to the wild-type PAO1 with or without pPcaT in the presence 
of α-KG (Figure 3.8). Although interesting, this is not surprising as similar findings 
have been reported in P. aeruginosa where swarming phenotype was independent 
of rhamnolipid production (Yeung et al., 2011, Guo et al., 2014). 
Swarming motility by itself is a complex surface associated behavior 
controlled by multiple physical factors (flagella, type IV pili and rhamnolipid) (Kohler 
et al., 2000, Deziel et al., 2003) and transcriptional regulatory networks (Yeung et 
al., 2009) . Additionally, swarming motility is also dependent on the availability of 
specific nutrients (Rashid & Kornberg, 2000, Harshey, 2003, Bains et al., 2012). In 
P. aeruginosa, swarming motility is influenced by the presence of specific carbon 
and nitrogen sources (Kohler et al., 2000, Bernier et al., 2011). Swarming is 
augmented in response to nitrogen limitation, and in the presence of certain amino 
acid such as glutamate, histidine, proline and aspartate (Kohler et al., 2000). 
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Interestingly α-KG is central to both these processes, it is a well-established signal 
for nitrogen starvation (Leigh & Dodsworth, 2007) and is also a precursor for the 
synthesis of amino acids glutamate, histidine and proline (Owen et al., 2002). 
Together, our finding suggests a more intricate network of metabolic control 
exerted by α-KG on P. aeruginosa swarming motility that still needs to be further 
explored. Furthermore, in P. aeruginosa swarming motility and biofilm mode of 
growth are inversely regulated i.e., strains that are deficient in swarming motility 
produce more biofilm while strains that exhibit increased swarming motility produce 
less biofilms (Caiazza et al., 2007). This is achieved by a complex interplay 
between several regulatory mechanisms including TCSs and the seconder 
messenger molecule cyclic-di-GMP (Goodman et al., 2004, Caiazza et al., 2007, 
Kuchma et al., 2007, Merritt et al., 2007, Merritt et al., 2010). It has been shown 
that the intracellular levels of cyclic-di-GMP influence a wide array of bacterial 
behaviors, with the common trend being that an increase in the levels of cyclic-di-
GMP encourages sessile behaviors, such as biofilm formation, while the 
degradation of cyclic-di-GMP favors motile behaviors, such as swarming. As the 
mifSR mutant exhibits a swarming defect and a hyperbiofilm phenotype, it will be 
of interest to examine if MifSR TCS plays a role in regulating the levels of cellular 
cyclic-di-GMP in the presence of α-KG. Regardless, our data is reminiscent of 
these findings that shows an inverse relationship between biofilm formation and 
swarming motility modulated through the MifSR signaling cascade. However, at 
this point, the precise transcriptional regulatory control exerted by MifS/MifR TCS 
proteins on biofilm formation and swarming motility in the presence of α-KG 
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remains to be elucidated.  Our study shows that MifSR TCS positively regulates 
swarming motility and negatively regulates biofilm formation in an α-KG dependent 
manner.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Rhamnolipid production in the presence of α-KG.  Rhamnolipid 
production of the wild-type PAO1 (Vector), PAO1 (pPcaT), PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) was assessed using the  
cetyltrimethylammonium bromide (CTAB) methylene blue agar plate (A) and 
the diameter of the blue halo around the colonies was measured as a mark of 
rhamnolipid production (B) 
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Pyocyanin production is negatively regulated by mifSR 
One of the hallmarks of P. aeruginosa infections is the production of 
extracellular, redox-active phenazine compounds. Pyocyanin, a nitrogen-
containing heterocyclic blue-green pigment is the major phenazine-derived 
compound produced by P. aeruginosa (Pierson & Pierson, 2010). Pyocyanin 
functions both as a crucial virulence factor (Lau et al., 2004) and as a signaling 
molecule (Dietrich et al., 2006). Furthermore, pyocyanin exhibits antibiotic 
properties that allow P. aeruginosa to gain dominance over other competing 
microorganisms, including bacteria and fungi, during infection (Baron & Rowe, 
1981, Kerr et al., 1999, Price-Whelan et al., 2006).  Importantly, both in vitro and 
in vivo studies have revealed that pyocyanin plays an pivotal role in establishing 
P. aeruginosa infections and is essential for its full virulence (Mahajan-Miklos et 
al., 1999, Ran et al., 2003, Lau et al., 2004, Allen et al., 2005, Cezairliyan et al., 
2013). In our earlier experiments when pPcaT was introduced in the ΔmifS, ΔmifR 
and ΔmifSR mutants, a visual difference in the pigment production was observed 
in the presence of α-KG (Figure 3.9). In particular, there was a difference in the 
production of the blue-green color, a characteristic of pyocyanin (Frank & Demoss, 
1959). This prompted us to ask if pyocyanin production is α-KG dependent and if 
it is regulated by the MifSR TCS. To test this, we compared the amount of 
pyocyanin made by ΔmifS(pPcaT), ΔmifR(pPcaT) and ΔmifSR(pPcaT) mutants to 
that of wild-type PAO1 strain in the presence of TCA cycle intermediates including 
α-KG, citrate and succinate (30 mM each), as a carbon source. There was no 
significant difference in the amount of pyocyanin (ug/ml) produced in the presence 
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of citrate and/or succinate between the wild-type PAO1 and the mifSR mutant 
derivatives (Figure 3.9). However, as compared to the parent PAO1, the 
mifSR(pPcaT) mutants produced significantly (p-value < 0.0005) higher amount (a 
five-fold increase) of pyocyanin in the presence of α-KG (Figure 3.9). This 
phenotype was rescued by complementing the mifR and mifSR mutant strains with 
the wild-type mifR and mifSR genes (Figure 3.9). Also, the comparable amount of 
pyocyanin produced by the wild-type PAO1 and PAO1(pPcaT) suggests, that the 
presence of an extra copy of pcaT does not influence this phenotype. Furthermore, 
absorbance spectra analysis of the overnight cell free culture supernatants showed 
a characteristic peak of pyocyanin at 310-325 nm (Mavrodi et al., 2001, Reszka et 
al., 2004). The absorbance peak intensity of the ΔmifS(pPcaT), ΔmifR(pPcaT) and 
ΔmifSR(pPcaT) mutants was significantly higher as compared to the wild-type 
PAO1 strain indicative of more pyocyanin production in the mifSR mutant 
derivatives (Figure 3.12).These findings strongly suggests an α-KG dependent 
regulation of P. aeruginosa pyocyanin production by the MifSR TCS proteins.  
Pyocyanin production in P. aeruginosa involves a complex pathway 
consisting of two homologous operons phzA1B1C1D1E1F1G1 (phzA1) and 
phzA2B2C2D2E2F2G2 (phzA2) and two additional genes phzM and phzS 
encoding phenazine modifying enzymes (Mavrodi et al., 2001). To determine if the 
difference in pyocyanin production in the presence of α-KG is a function of change 
in gene expression, qRT-PCR was performed to assess the transcript levels of 
phzA1, phzA2, phzM and phzS genes in the PAO1(pPcaT) and the mifSR(pPcaT) 
mutants. For the qRT-PCR analysis PAO1(pPcaT) was used as the reference 
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strain since it exhibited the same pyocyanin phenotype as that of the wild-type 
PAO1 strain without pPcaT. In the PAO1(pPcaT) strain, presence of α-KG appears 
to inhibit the expression of the phz genes namely, phzA1, phzA2, phzM and phzS 
(Figure 3.10). The above data suggests that α-KG is a repressor of pyocyanin 
synthesis in P. aeruginosa.  In the mifSR(pPcaT) mutant derivatives the expression 
of phzA1 was significantly induced in the presence of α-KG as compared to the 
wild-type PAO1(pPcaT). However, the second phzA2 operon and, phzS and phzM 
genes did not show a significant increase in expression.  Pyocyanin production is 
a characteristic of P. aeruginosa stationary growth phase. Here the cells were 
induced with α-KG for an hour, we suspect that prolong induction of the cells with 
α-KG might result in a differential expression of the other genes involved in 
pyocyanin synthesis in the mifSR(pPcaT) mutants. In P. aeruginosa PAO1, the 
expression of phzA1 accounts for majority of phenazine production (Liang et al., 
2008), and our qRT-PCR findings suggests that the hyper-production of pyocyanin 
could be accounted for by an increased expression of phzA1 in the mifSR(pPcaT) 
mutant strains. Together these findings indicate that MifSR TCS is negatively 
regulating P. aeruginosa pyocyanin production in the presence of α-KG.  
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Figure 3.9: Pyocyanin production in mifSR mutants in the presence of       
α-KG. Pyocyanin production was measured quantitatively from the overnight 
culture supernatants of the wild-type PAO1, PAO1(pPcaT), PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT), PAOΔmifSR(pPcaT) mutants and the pMifR and pMifSR 
complementing clones in M9 minimal media supplemented with α-KG, and/or 
succinate (30 mM each) , using the chloroform and HCL method, as described 
in materials and methods. Results shown are mean with standard deviation of 
three biological replicates. Statistically significant difference between the wild 
type and mutants as determined by one-way ANOVA with Bonferroni’s post-
hoc test, ** p-value < 0.001. 
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mifSR positively regulates pyoverdine production 
P. aeruginosa produces several siderophores that play a pivotal role in 
scavenging iron from the host, a vital process required for bacterial growth and 
infection (Bullen, 1981, Poole & McKay, 2003, Skaar, 2010). Amongst these, 
pyoverdine, a yellow-green fluorescent pigment is the primary siderophore 
produced by P. aeruginosa (Meyer, 2000, Lamont et al., 2009).  Pyoverdine is not 
only an efficient iron scavenger and transporter during P. aeruginosa infection and 
biofilm formation (Banin et al., 2005, Visca et al., 2007) but also, a signaling 
molecule established in regulating multiple virulence-associated traits (Beare et 
al., 2003, Visca et al., 2007). Indeed, several in vivo studies in animal and 
nematode models demonstrated the requirement of pyoverdine as an important 
virulence factor essential for successful P. aeruginosa infections (Meyer et al., 
1996, Takase et al., 2000, Kirienko et al., 2013).  Considering the fact that P. 
aeruginosa MifSR TCS is involved in modulating P. aeruginosa virulence 
associated pigment production in the presence of α-KG, we investigated its role in 
pyoverdine production. To test this, we compared the amount of pyoverdine made 
by ΔmifS(pPcaT), ΔmifR(pPcaT) and ΔmifSR(pPcaT) mutants to that of wild-type 
PAO1 strain in the presence of TCA cycle intermediates including α-KG and 
succinate (30 mM each), as a carbon source. As compared to the parent PAO1, 
the mifSR(pPcaT) mutants produced significantly (p-value < 0.005) less 
pyoverdine in the presence of α-KG (Figure 3.11). This phenotype was rescued by 
complementing the mifR and mifSR mutant strains with the wild-type mifR and 
mifSR genes (Figure 3.11). No difference in pyoverdine production was observed 
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when succinate was provided as the sole carbon source (Figure 3.11) suggesting 
an α-KG dependent regulation. Also, the comparable amount of pyoverdine 
produced by the wild-type PAO1 and PAO1(pPcaT) suggests, that the presence 
of an extra copy of pcaT does not influence this phenotype. These findings strongly 
suggests an α-KG dependent regulation of P. aeruginosa pyoverdine production 
by the MifSR TCS proteins.  
Furthermore, absorbance spectra analysis of the overnight cell free culture 
supernatants showed a characteristic peak of pyoverdine at 400-405 nm 
(Vandenende et al., 2004). The absorbance peak intensity of the ΔmifS(pPcaT), 
ΔmifR(pPcaT) and ΔmifSR(pPcaT) mutants was lower as compared to the wild-
type PAO1 strain indicative of less pyoverdine production in the mifSR mutant 
derivatives (Figure 3.12). Together the data suggest that MifSR TCS positively 
regulates pyoverdine production in the presence of α-KG, as the sole carbon 
source.  
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Figure 3.11: Pyoverdin production in mifSR mutants in the presence of       
α-KG. Pyoverdin levels of wild-type PAO1, PAO1(pPcaT), PAOΔmifS(pPcaT), 
PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) mutants and the pMifR and pMifSR 
complementing clones in M9 minimal media supplemented with α-KG and/or 
succinate (30 mM each) was quantitated by measuring the absorbance A405. 
Values are normalized with respect to culture density and A405/A600 ratio 
expressed the pyoverdin levels. Each result represents the mean with standard 
deviation of three biological replicates. Statistically significant difference 
between the wild type and mutants as determined by one-way ANOVA with 
Bonferroni’s post-hoc test, ** p-value < 0.001. 
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Loss of mifR increases cell cytotoxicity  
P. aeruginosa expresses and utilizes an arsenal of virulence mechanisms 
to gain competitive advantage over its host in-order to establish acute and chronic 
infections. Most of these mechanisms rely on numerous virulence factors and/or 
exoproteins, which are intentionally released by this pathogen via diverse and 
complex secretion machinery.  Most of the secreted virulence factors are toxins 
and hydrolytic enzymes that induce cell cytotoxicity thus causing damage and 
annihilation of the host cells. Moreover, in a previous microarray gene expression 
study significant alteration in expression of genes encoding secreted virulence 
factors was observed in mifR mutant compared to its wild-type PAO1 (Petrova et 
al., 2012). Since our data indicated that MifSR TCS proteins regulated the 
transport of extracellular α-KG, and modulate different virulence determinants, we 
examined the ability of mifSR mutant derivatives to infect and destroy A549 lung 
fibroblast cell cultures in the presence of α-KG.  
Since all the virulence related phenotypes exhibited by the ∆mifS(pPcaT), 
∆mifR(pPcaT), ∆mifSR(pPcaT) mutants were α-KG dependent, bacterial cells 
were grown overnight and sub-cultured in M9 minimal media with α-KG (30 mM) 
before infecting the respective cell cultures. Release of lactate dehydrogenase 
(LDH) was measured as a function of cell damage using colorimetric LDH activity 
assay (Hauser & Engel, 1999). The ∆mifR(pPcaT) and ∆mifSR(pPcaT) mutants 
exhibited two-fold increase (P-value < 0.005) in cytotoxicity compared to the wild-
type PAO1 in the presence or absence pcaT (Figure 3.13A). Interestingly no 
difference in cytotoxicity was observed in case of ∆mifS(pPcaT) compared to the 
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parent strain PAO1. This could be the result of a potential crosstalk between MifR 
and other noncognate HKs that needs to be verified. Furthermore, introduction of 
the wild type mifR and mifSR genes into ∆mifR and ∆mifSR mutants restored 
cytotoxicity to the wild-type PAO1 levels. In-order to rule out the cytotoxicity seen 
is not specific to A549 lung fibroblast, HeLA and J774-Eclone cells were assessed. 
All three cell-lines exhibited the same phenotype (Figure 3.14) suggesting 
increased virulence of mifR and mifSR mutants leading to higher cytotoxicity. 
Subsequently, when α-KG was replaced with succinate as the carbon source, no 
discernable difference in cell cytotoxicity was observed between the mifSR(pPcaT) 
mutants and the parent PAO1 strains (Figure 3.13B). The data suggests that MifR 
independent of MifS, negatively regulates P. aeruginosa cell cytotoxicity. 
Bacterial pathogens are one of the most portentous infiltrators of the host 
system, causing significant damage leading to cellular aberrations and injury. In 
the mammalian cells TCA cycle intermediates including α-KG are mainly found in 
cytoplasm and mitochondria. Cell injury, results in the efflux of intracellular 
metabolites leading to an increase in their extracellular concentrations. It is known 
that TCA cycle intermediates (C4, C5, and C6 dicarboxylates) are present at 
micromolar (μM) concentrations in blood that increase with tissues damaged (He 
et al., 2004, Hebert, 2004).Therefore it is possible that α-KG might act as a marker 
of the intensity and level of cellular damage that signals P. aeruginosa to 
downregulate its cytotoxic determinants via mifR regulatory circuit. This is one of 
the first report of α-KG mediated two-component signaling in regulating P. 
aeruginosa cell cytotoxicity. 
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MifSR TCS and α-KG dependent regulation of P. aeruginosa virulence. 
To confirm that the expression of α-KG transporter PcaT itself in the mifSR 
mutants had no effect on P. aeruginosa α-KG-dependent virulence phenotypes, 
we performed pigment (pyocyanin and pyoverdine) production, absorbance 
spectra analysis and cell cytotoxicity assays with the wild type PAO1 and mifSR 
mutants in the presence of PA5530 (KgtP) (the previously reported α-KG 
transporter) (Tatke et al., 2015). Similar to the mifSR(pPcaT) mutants, 
mifSR(pKgtP) mutants produced significantly (p-value < 0.0005) higher and lower 
amounts of pyocyanin and pyoverdine in the presence of α-KG, as compared to 
the parent PAO1 strain with and/or without pKgtP (Figure 3.15A and 3.15B). 
Furthermore, absorbance spectra analysis of the cell free culture supernatants 
showed the characteristic peak of pyocyanin at 310-325 nm and pyoverdine at 
400-405 nm. The absorbance peak intensity of the ∆mifS(pKgtP), ∆mifR(pKgtP) 
and ∆mifSR(pKgtP) mutants was higher for pyocyanin and lower for pyoverdine as 
compared to the wild-type PAO1 strain (Figure 3.15C). In addition, in the presence 
of α-KG, similar to the mifSR(pPcaT) mutants, ∆mifR(pKgtP) and ∆mifSR(pKgtP) 
exhibited increased cell cytotoxicity, and no difference in cell-cytotoxicity was 
observed in the case of mifS(pKgtP) compared to the parent PAO1 strain (Figure 
3.15D). The mifSR(pKgtP) results corroborates with our mifSR(pPcaT) data, 
suggesting that mifSR mutant exhibited phenotypes are  transporter independent 
and α-KG-dependent. 
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Figure 3.15: mifSR(pKgtP) virulence assays in the presence of α-KG.  
Pyocyanin production (A), pyoverdine production (B), absorbance spectra (C) 
and cell cytotoxicity (D) of PAO1, PAO1(pKgtP), mifS(pKgtP), mifR(pKgtP), 
mifSR(pKgtP) mutants in the presence of α-KG (30 mM). 
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Conclusion 
P. aeruginosa is one of the most formidable, opportunistic human pathogen 
infamous for its ability to cause several localized and systemic infections (Tummler 
et al., 2014).  Its ability to colonize different host niches is largely dependent on its 
metabolic flexibility and environmental adaptability dictated by genetic versatility 
(Mathee et al., 2008). P. aeruginosa preferentially utilizes TCA cycle intermediates 
as carbon and energy source over other compounds (Collier et al., 1996), and α-
KG is a key intermediate of the TCA cycle (Krebs, 1940). α-KG plays a crucial role 
in regulating carbon-nitrogen metabolism (Doucette et al., 2011) and importantly, 
α-KG is considered to be a signaling molecule in both prokaryotes (Ninfa & Jiang, 
2005) and eukaryotes (Lancien et al., 2000, He et al., 2004). Furthermore, recent 
studies have reported preferential utilization of extracellular a-KG as a principle 
carbon source during infection by pathogenic bacteria (Guo et al., 2012, Cai et al., 
2013). The data together suggests a profound role of α-KG in regulating bacterial 
physiology and metabolism. However, limited analysis of the physiological roles of 
α-KG in bacteria, including P. aeruginosa, has left its role in pathogenesis unclear. 
The present study provides a novel insight into the role of α-KG and MifSR TCS in 
regulating P. aeruginosa pathogenesis. 
Our findings, suggests a complex regulatory cascade in modulating P. 
aeruginosa C5-dicarboxylate, α-KG uptake involving a combined action of multiple 
α-KG transporters namely PcaT (PA0229) and KgtP (PA5530), the MifS/MifR TCS 
and the sigma factor RpoN (Figure 3.16). It appears that MifS senses the presence 
of α-KG and signals MifR. The activated-MifR along with the sigma factor RpoN 
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initiate the transcription of α-KG transporter genes pcaT and kgtP. Interestingly, 
our findings suggests that the MifSR TCS inversely regulates the expression of 
pcaT and KgtP genes (Figure 3). Furthermore, sequence analysis of pcaT 
promoter (PpcaT) and our previous published PkgtP findings (Tatke et al., 2015) 
together indicates that the expression of both pcaT and kgtP genes is under 
several layers of transcriptional and post-transcriptional controls, suggesting a 
complex regulatory mechanism involved in modulating P. aeruginosa α-KG 
uptake. The presence of two α-KG transporters regulated in an opposite fashion 
in P. aeruginosa is of interest due to their possible function in responding to 
nutritional cues. Furthermore, it is also possible that the presence of two α-KG 
transporters is due to a difference in their substrate affinities and may indicate a 
role for each in changing gene expression based upon environmental α-KG 
concentrations. Future studies will determine if P. aeruginosa α-KG transporters 
are preferentially or hierarchically regulated depending on the carbon source. 
In addition to the role of MifSR TCS in modulating extracellular α-KG 
transport, in this study we illustrate the interdependence of MifSR TCS and the C5-
dicarboxylate α-KG in regulating the expression of P. aeruginosa’s key virulence 
determinants. The results presented here show that MifSR TCS in an α-KG specific 
manner positively regulates swarming motility and pyoverdine production while 
negatively regulates biofilm formation and pyocyanin production. Interestingly, α-
KG dependent cell cytotoxicity was found to be MifS-independent and MifR-
dependent, suggesting a potential crosstalk between MifR and other noncognate 
HKs. Together, these findings strongly suggest a complex mechanism of MifSR 
127	
	 	 	
action involving multiple regulatory controls that are achieved by modulating 
expression of numerous genes in α-KG-dependent manner. Identifying the α-KG 
dependent members of MifSR regulon will significantly help in delineating the role 
of MifSR signaling pathway in P. aeruginosa pathogenesis.  
Successful adaptation of P. aeruginosa to different niches depends 
extensively on its ability to regulate gene expression as specified by the 
environmental cues. Although a plethora of TCSs have been identified in P. 
aeruginosa (Winsor et al., 2011) that warrants its adaptability, only a handful of 
TCS signaling molecules are known to date. Recent research progresses show 
that, TCA cycle metabolites in-addition to their canonical role in metabolism are 
increasingly been recognized as a bacterial TCS activating signals (Janausch et 
al., 2002, Sevvana et al., 2008, Zhou et al., 2008, Brocker et al., 2009, Cai et al., 
2013, Valentini & Lapouge, 2013, Tatke et al., 2015). Our data indicates that the 
TCA cycle C5-dicarboxylate α-KG is the signaling molecule activating P. 
aeruginosa MifSR TCS. This is one of the first reports to answer fundamental 
questions pertaining to α-KG utilization in P. aeruginosa and its role as a 
messenger in MifSR regulatory mechanism. Metabolic processes and virulence 
mechanisms are closely interconnected and are hallmarks of P. aeruginosa 
infections. Hopefully, this and future studies on this regulatory system and 
metabolism pathway will add significantly to the understanding of an intricate link 
between virulence and metabolism in pathogens that would provide a better 
stratagem to fight the often indomitable infections.  
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Figure 3.16: Proposed model for α-KG-dependent MifS and MifR TCS 
signal perception mechanism. HK-MifS senses the extracellular α-KG to 
undergo phosphorylation. The phosphate is transferred to the RR-MifR. The 
phosphorylated MifR in coordination with RpoN (σ54) activates the expression 
of α-KG specific transporter gene PA5530. PA5530 thus enables the influx of 
α-KG to meet the metabolic and energy demands of the cells. Also, activated 
MifR, directly or indirectly represses the expression of pcaT gene. pcaT 
promoter (PpcaT) region has a Crc binding site, suggesting that it is under the 
catabolite repression control by Crc/CrcZ. The (PpcaT) also shows the presence 
RsmA binding site indicating a multilayered and complex regulation of the α-KG 
transport system. Further, in the presence of α-KG as a carbon source MifR 
positively regulates swarming motility and pyoverdine production while 
negatively regulates biofilm formation, pyocyanin and cell cytotoxicity.  
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Overview 
Pseudomonas aeruginosa is a metabolically versatile, Gram-negative ϒ-
proteobacteria that is well known for its widespread spatiotemporal distribution 
(Ramos, 2004). Although, a primary inhabitant of soil and water, it has an 
extraordinary ability to survive and thrive in a myriad of natural and artificial 
environments (Walker et al., 2004, Gellatly & Hancock, 2013). Importantly, P. 
aeruginosa is a dominant nosocomial pathogen and an epitome of opportunistic 
infections in humans (Bodey et al., 1983, Lyczak et al., 2000, de Bentzmann & 
Plesiat, 2011). It is the fourth most commonly-isolated nosocomial pathogen and 
accounts for 10 percent of all hospital-acquired infections (Gaynes et al., 2005). P. 
aeruginosa is infamous for its ability to cause wide range of human infections that 
can vary from acute to chronic, local to systemic and self-limiting to life-threatening 
(Campa et al., 1993, Sousa & Pereira, 2014, Tummler et al., 2014). In particular, 
P. aeruginosa pose a high risk to individuals with impaired immunity and those 
suffering from the recessive genetic disorder, cystic fibrosis (Ratjen & Doring, 
2003). In patients with CF, chronic and recurrent pulmonary infections by P. 
aeruginosa are a leading cause of morbidity and mortality (Sorde et al., 2011, 
Winstanley et al., 2016). P. aeruginosa produces multi-determinant virulence 
factors, both cell associated and secretory, which modulate its pathogenicity and 
ensures its success as a pathogen (Balasubramanian et al., 2013). Despite 
extensive efforts in the development of new anti-pseudomonal drugs, therapeutic 
intervention in the treatment of P. aeruginosa infections has not been very 
effective, particularly due its extraordinary intrinsic and acquired resistance to a 
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repertoire of clinically significant antibiotics (Hancock & Speert, 2000, Falagas & 
Bliziotis, 2007, Lister et al., 2009) . Thus, the pathogenesis of P. aeruginosa 
infections is multifactorial, and is manifested by its diverse metabolic capabilities, 
expression of virulence factors and antibiotic resistance.  
Another key factor accounting for the success of P. aeruginosa as an 
invincible pathogen is its environmental and metabolic adaptability. This flexibility 
allows survival, growth and rapid colonization of different host milieus, leading to 
successful infection and disease progression (Silby et al., 2011). In human host, 
since the environmental conditions are highly variable and erratic, pathogenic 
bacteria need a dedicated regulatory system that supports their adaptation to 
perpetual changes.	To perform these adaptations, P. aeruginosa has evolved an 
intricate and dynamic array of signaling networks that in addition to modulating the 
basic housekeeping functions, coordinate the temporal expression of various 
genes in response to both inter- and intracellular signaling molecules and 
environmental cues (Rodrigue et al., 2000, Ventre et al., 2006, Gooderham & 
Hancock, 2009, Williams & Camara, 2009, Haussler, 2010, Jimenez et al., 2012). 
Of the many signaling mechanisms elucidated in P. aeruginosa, two-component 
system (TCS) mediated signal perception play a pivotal role in sensing diverse 
environmental stimuli and elicit a pertinent and rapid adaptive response (Rodrigue 
et al., 2000, Stock et al., 2000, Alm et al., 2006).   
TCSs in P. aeruginosa have been shown to regulate many physiological 
aspects of its lifestyle, including global responses to stress (Wood et al., 2006, 
Leech et al., 2008), chemotaxis (Gooderham & Hancock, 2009), antibiotic 
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resistance (Gooderham & Hancock, 2009), carbon/nitrogen metabolism (Nishijyo 
et al., 2001, Li & Lu, 2007), nutrient uptake (McPhee et al., 2006, Valentini et al., 
2011, Tatke et al., 2015), expression of virulence factors (Gooderham & Hancock, 
2009, Mikkelsen et al., 2011, Okkotsu et al., 2014) and transition from free living 
planktonic to sessile biofilm mode of growth (Mikkelsen et al., 2011). While a 
plethora of TCS signaling proteins (135) have been identified in P. aeruginosa only 
a few have been extensively characterized and the regulatory targets for many 
TCS systems are still unknown (Rodrigue et al., 2000, Barakat et al., 2009, Winsor 
et al., 2011). Furthermore, in most of the cases, the environmental signals that 
influence TCS pathways remains obscure (Mascher et al., 2006, Mitrophanov & 
Groisman, 2008). Though the environmental cues sensed by TCSs are poorly 
understood, they are largely accountable for determining the outcome of P. 
aeruginosa infections and pathogenesis. Also, in many instances TCSs are known 
to work in tandem with other signal transduction pathways, thus forming a complex 
network allowing P. aeruginosa to assimilate numerous external cues into a 
cohesive regulatory circuit that modulates a lifestyle continuum (Coggan & 
Wolfgang, 2012).  Understanding the complexities of TCS signaling is the key to 
understanding P. aeruginosa pathogenesis.  
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Summary  
MifSR TCS regulates P. aeruginosa α-KG transport and virulence 
P. aeruginosa genome encodes one of the largest groups of TCS proteins 
identified in any sequenced bacterial species (Barakat et al., 2009, Winsor et al., 
2011).  Amongst these, only few TCSs have been completely characterized. This 
dissertation investigated the role of a previously uncharacterized TCS protein pair 
MifS and MifR in regulating P. aeruginosa pathogenesis. MifS is a sensor histidine 
kinase (HK) and MifR is the response regulator (RR). During the course of the 
dissertation, the RR MifR was reported to have a dual function, in regulating the 
maturation stage of biofilm formation (virulence) and in pyruvate fermentation 
(metabolism) (Petrova & Sauer, 2009, Petrova et al., 2012).  However, the 
mechanism by which MifR is activated in this process remains obscure and no 
relation with the histidine kinase MifS has been established. Our work identified a 
novel role of the MifS-MifR TCS proteins in regulating P. aeruginosa metabolism 
by exclusively modulating the utilization of a key tricarboxylic acid (TCA) cycle 
intermediate, α-Ketoglutarate (Chapter 2) (Tatke et al., 2015).  Specifically, we 
show that MifSR TCS regulates the uptake of extracellular α-KG by positively 
regulating the expression P. aeruginosa PA5530 (kgtP) gene encoding a putative 
α-KG permease (Chapter 2, Figure 2.11). Additionally, we show that the transport 
of extracellular α-KG in P. aeruginosa is a consequence of an orchestrated 
interplay between the MifSR TCS and the alternate sigma factor RpoN (σ54) 
(Chapter 2, Figure 2.14). To date, this work is one of the first to establish the role 
of P. aeruginosa MifS/MifR TCS in regulates α-KG transport in association with the 
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sigma factor RpoN (Tatke et al., 2015). In addition, we identified that besides KgtP, 
P. aeruginosa genome encodes a second α-KG permease PcaT (PA0229) whose 
expression is independent of MifSR TCS, suggesting an additional layer of 
regulation involved in P. aeruginosa α-KG uptake (Chapter 3).  Lastly, our 
phenotypic assay revealed the α-KG specific exclusivity of MifSR TCS in 
modulating P. aeruginosa virulence mechanism (Chapter 3). We show that MifSR 
TCS in the presence of α-KG as a sole carbon source regulates the expression of 
P. aeruginosa biofilm formation, swarming motility, pigment production (pyocyanin 
and pyoverdine) and cell cytotoxicity (Chapter 3 and Figure 4.1). Simultaneous 
regulation of multiple mechanisms involved in P. aeruginosa pathogenesis 
suggests a complex mechanism of MifSR action. To date, to our knowledge, this 
is one of the first report of α-KG mediated two-component signaling in regulating 
P. aeruginosa metabolism and virulence. Together, this work established the role 
of α-KG as a signaling molecule and that MifSR TCS system is a master regulator 
of α-KG transport in P. aeruginosa. Here we propose a model for α-KG dependent 
MifSR TCS signaling in P. aeruginosa (Figure 4.2). 
 
 
 
 
 
136	
	 	 	
 
	  
Fi
gu
re
 4
.1
: 
O
ve
rv
ie
w
 o
f 
P
. 
ae
ru
gi
no
sa
 v
iru
le
nc
e 
ph
en
ot
yp
es
 d
iff
er
en
tia
lly
 r
eg
ul
at
ed
 b
y 
M
ifS
R
 T
C
S 
in
 th
e 
pr
es
en
ce
 o
f α
-K
G
. 
137	
	 	 	
	  
Figure 4.2: Proposed model for α-KG dependent MifSR TCS 
signaling in P. aeruginosa. Sensor MifS senses the extracellular α-
KG as an environmental cue to undergo phosphorylation. The 
phosphate is then transferred to the response regulator MifR. The 
phosphorylated MifR together with the alternate sigma factor RpoN 
activates the expression of α-KG specific transporter gene kgtP. KgtP 
then enables the influx of extracellular α-KG to meet the metabolic 
demands of the cells. In addition, MifSR TCS in the presence of α-KG 
as a carbon source differentially regulates P. aeruginosa key virulence 
determinants including biofilm formation, swarming motility, cell 
cytotoxicity and the production of pyocyanin and pyoverdine.  
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Future Directions 
Two-component signal perception mechanisms that rely on 
phosphotransfer from histidine kinase (HK) to the response regulator (RR) is one 
of the predominant strategy used by bacteria for coupling environmental signal to 
adaptive responses. Bacterial TCS signal transduction mechanisms have always 
been a subject of extensive research because of the versatility of its components 
(HK and RR) to probe the environmental conditions and decide how best to 
respond by orchestrating the expression of several desired genes. In the recent 
years, with the advent of new biochemical and molecular biology techniques, 
substantial advances have been made in understanding the molecular 
mechanisms regulated by TCS signaling pathways. While the work in this 
dissertation using high-throughput phenotypic microarray studies and molecular 
and biochemical techniques have helped significantly to get an insight into a novel 
role of α-KG mediated signaling via the MifS and MifR TCS proteins in P. 
aeruginosa, there remains many unanswered questions.  
Outlined below are some ideas and avenues for further research that are 
based on the results published in this dissertation and/or are based on my 
preliminary data mentioned in this section. 
• Determine the α-KG dependent MifR regulon  
• Elucidate the role of RpoN (σ54) and TCS signaling in regulating P. aeruginosa 
TCA cycle intermediate transport and pathogenesis   
 (Each future research direction is strengthen with a brief discussion) 
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Determine the α-KG dependent MifR regulon  
P. aeruginosa response regulator MifR is a part of the signal transduction 
MifS/MifR TCS. MifR on average is 60-65% similar to the known P. aeruginosa 
NtrC superfamily of TCS response regulators including DctD, CbrB, AauR, NtrC, 
AlgB, FleR and PilR, suggesting similar functions (Winsor et al., 2011). These 
transcriptional regulators are known to regulate a myriad of functions in P. 
aeruginosa including carbon assimilation, nitrogen metabolism, nutrient uptake, 
motility, antibiotic resistance (Ritchings et al., 1995, Arora et al., 1997, Gooderham 
& Hancock, 2009) and alginate synthesis (Wozniak & Ohman, 1991, Ma et al., 
1998, Leech et al., 2008). Our phenotypic assays under nutrient rich conditions 
indicated no role of MifR in regulating P. aeruginosa antibiotic resistance (Figure 
4.3) or other virulence related characteristics (Figure 4.4) (Tatke et al., 2015). 
Therefore, we performed a high throughput phenotypic microarray (BioLOG) with 
mifR deletion mutant and the wild-type PAO1 strains where numerous metabolic 
and chemical sensitivity phenotypes were tested simultaneously (Chapter 2, 
Figure 2.5). Our phenotypic microarray data indicated the role of RR MifR in 
regulating P. aeruginosa metabolism by modulating the utilization of C5-
dicarboxylate α-KG, a key TCA cycle intermediate as a carbon and energy source. 
Subsequently, our growth profile, genetic complementation and qRT-PCR 
expression studies showed that MifR in concert with the sigma factor RpoN (σ54) 
regulate extracellular α-KG transport by modulating the expression of P. 
aeruginosa α-KG-specific permease PA5530 (KgtP) (Chapter 2) (Tatke et al., 
2015).    
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Figure 4.4: Effect of mifSR deletion on P. aeruginosa virulence. Overview 
of P. aeruginosa virulence phenotypes under nutrient rich conditions. 
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In P. aeruginosa, TCA cycle intermediates, including α-KG is known to 
trigger carbon catabolite repression (CCR), a mechanism by which cells facilitate 
hierarchical uptake and utilization of carbon substrates for efficient growth (Wolff 
et al., 1991, collier 1996). Subsequent studies have showed that, CCR in 
Pseudomonas Spp. is mediated by the catabolite repression control (Crc) protein, 
a translational repressor (Rojo 2010). Our in silico analysis of the kgtP promoter 
region revealed the presence of a CA-rich motif with a signature sequence 
(AAc/uAAc/uAA) for the Crc protein (Chapter 2, Figure 2.13) (Tatke el al 2015). It 
is now well established that the expression of crc gene encoding the Crc protein is 
modulated by RpoN (σ54) dependent small non-coding RNA CrcZ and the 
CbrA/CbrB TCS (sonnleitner 2009).  Also, our analyses indicates that the kgtP 
promoter is under a small non-coding antisense RNA (asRNA) regulation (Chapter 
2, Figure 2.13) (Tatke et al., 2015). This suggests additional layers of regulation 
superimposed on the need for MifR in regulating P. aeruginosa α-KG transport.  
Subsequently, we also identified a second chromosomally encoded α-KG 
permease in P. aeruginosa namely, PA0229 (PcaT) (Chapter 3). Interestingly, our 
qRT-PCR expression data and complementation studies suggests that the 
expression of pcaT gene is independent of the MifS-MifR TCS signaling cascade. 
(Chapter 3, Figure 3.3). Furthermore, in silico analysis of the pcaT promoter region 
revealed the presence of a weak RpoN (σ54) binding site, the signature sequence 
(AAc/uAAc/uAA) for the translational repressor Crc protein and four putative GGA 
trinucleotide motifs, that are the characteristic binding sites for the post-
transcriptional control RsmA family of proteins (Chapter 3, Figure 3.3). Presence, 
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of shared common motifs (RpoN (σ54) and Crc binding sites) in the kgtP and pcaT 
promoter regions indicates an overlapping regulatory control. Though the role of 
asRNA, CrcZ, Crc and RsmA in P. aeruginosa α-KG transport and utilization is 
currently unknown, it suggest a more profound and complex mechanism of MifR 
controlled α-KG transport. This is one of the first study to report the role of a TCS 
response regulator in regulating bacterial α-KG assimilation.  
Furthermore, efficient utilization and catabolism of extracellular nutrients is 
a primary requirement for all pathogenic bacteria to manifest their full virulence 
potential during the course of infection. Metabolic processes and virulence 
mechanisms are closely interconnected and are hallmarks of P. aeruginosa 
infections. Therefore, it is not surprising that the regulation of many virulence 
determinates is controlled by nutrient availability. In P. aeruginosa, specific carbon 
and nitrogen sources have been known to influence several clinically relevant 
virulence phenotypes such as motility (Kohler et al., 2000), pigment production 
(Palmer et al., 2007), biofilm development (Klausen et al., 2003(a), Shrout et al., 
2006) and quorum sensing (Dandekar et al., 2012). In this study we illustrated the 
interdependence of RR MifR and the C5-dicarboxylate α-KG in regulating the 
expression of P. aeruginosa’s key virulence determinants (Chapter 3). We show 
that MifR in the presence of α-KG as the sole carbon source positively regulates 
swarming motility and pyoverdine production while negatively regulates biofilm 
formation, pyocyanin production and cell cytotoxicity (Chapter 3 and Figure 4.1). 
Furthermore, a previous microarray transcriptome study of the parent PAO1 and 
mifR deficient mutant cultivated under biofilm-specific condition exhibited 
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significant alteration in the expression of genes encoding transporter proteins, 
secretion factors, type II and type III secretion systems (Petrova et al., 2012). 
Hyper pyocyanin production and increased cell cytotoxicity of the mifSR mutants 
suggested an overall increase in the concentration of extracellular proteins. Using 
the Bradford assay (Bradford, 1976) we quantitated the amount of total proteins 
present in the culture supernatant of the mifSR mutants grown overnight in the 
presence of α-KG and/or succinate (30 mM each), as a sole carbon source.  The 
results obtained were intriguing as the concentrations of extracellular proteins in 
the culture supernatant were significant lower in the miSR mutants as compared 
to the wild-type PAO1 strains in the presence of α-KG (Figure 4.5). In addition, 
when cells were grown in the presence of succinate no difference was observed 
in the extracellular protein concentration in mifSR mutants compared to the wild-
type PAO1 (Figure 4.5). Together, this data indicates that MifR in the presence of 
α-KG affects numerous transport and virulence associated mechanisms in P. 
aeruginosa. However, at this point, the transcription regulatory network and the 
gene expression pattern regulated by MifR that manifest these phenotypic effects 
are unclear.  
There are numerous previously described signaling pathways in P. 
aeruginosa that independently or in association are capable of positively regulating 
swarming motility and negatively regulating biofilm formation and pyocyanin 
production. These pathways include the cell density dependent quorum sensing 
(Las, Rhl and PQS) signaling system, GacS/GacA two-component system and 
cyclic-di-GMP signaling (Goodman et al., 2004, Caiazza et al., 2007, Kuchma et 
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al., 2007, Merritt et al., 2007, Merritt et al., 2010). In a recent study, Pertova and 
co-workers reported that, mifR overexpression in the P. aeruginosa parent PAO1 
strain positively affects cyclic-di-GMP levels in a biofilm-specific manner (Petrova 
et al., 2012). At this point it is not clear if any of these pathways are regulated by 
MifR in the presence of α-KG, either directly or indirectly. Future work focused on 
elucidating the α-KG dependent members of MifR regulon using the high 
throughput RNA-seq approach will provide a new perspective to decode and better 
understand the correlations between P. aeruginosa metabolism and virulence. 
These studies will also substantially impact our understanding of the profound role 
played by the metabolite α-KG as a messenger in regulating molecular 
pathogenesis of the intractable pathogen P. aeruginosa. I have finished the 
required RNA-Seq experiments using the wild-type PAO1 and PAOΔmifR mutant 
derivatives expressing pcaT in trans in the presence and absence of α-KG. The 
RNA-seq was performed using the Next-generation sequencing Illumina Platform 
and the RAW FASTQ data has been generated. Currently, I am analyzing and 
validating the RNA-seq data using CLC Genomic Workbench, Python 
programming and qRT-PCR expression studies. Future work focused on validation 
of RNA-seq data using phenotypic assays will help to better understand the role of 
RR MifR and the metabolite α-KG in regulating P. aeruginosa physiology.  
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Figure 4.5: Effect of mifSR deletion on extracellular protein concentration. 
The extracellular proteins were quantitated using the Bradford assay from the 
culture supernatant of mifSR mutants grown over night in the presence of α-KG 
and succinate (30 mM each), as the sole carbon source.  
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Elucidate the role of RpoN (σ54) and TCS signaling in regulating                            
P. aeruginosa TCA cycle intermediate transport and pathogenesis 
Success of P. aeruginosa as a recalcitrant pathogen can be largely 
attributed to the repertoire of transcriptional regulators encoded by its genome. 
These regulators form an intricate and dynamic networks to exquisitely tune the 
expression of genes responsible for phenotypic adaptation and virulence during 
infection. P. aeruginosa has one of the largest genome amongst sequenced 
bacteria and transcriptional regulators encompass about 10% of the genome 
(Galan-Vasquez et al., 2011).  Amongst transcriptional regulators, sigma (σ) 
factors are the indispensable global regulators of gene expression. They confer 
promoter recognition specificity to the RNA polymerase core enzyme (Borukhov & 
Severinov, 2002, Campbell et al., 2002, Murakami & Darst, 2003) in order to 
orchestrate the process of transcription initiation (Burgess et al., 1969), a key step 
in gene regulation (Browning & Busby, 2004) . To date, the regulatory machinery 
predicted in P. aeruginosa prototypic strain PAO1 comprises of approximately 550 
transcriptional regulators and 26 putative sigma factors (one RpoN (σ54), eight 
RpoD (σ70), and 17 of extra cytoplasmic function (ECF) family (Potvin et al., 2008, 
Perez-Rueda et al., 2009, Galan-Vasquez et al., 2011). Amongst these of special 
interest is the alternate sigma factor RpoN (σ54) which is a global regulator involved 
in P. aeruginosa nitrogen metabolism, motility, carbon assimilation, nutrient 
transport, quorum sensing and virulence (Potvin et al., 2008).  
Our comparative growth curve analyses of P. aeruginosa wild-type PAO1 
and the PAOΔrpoN mutant strains in the presence of TCA cycle C4, C5 and C6 di- 
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and tricarboxylic acid intermediates exhibited intriguing results (Figure 4.6). The 
PAOΔrpoN mutant failed to grow in the presence of all the TCA cycle intermediates 
including succinate (C4), α-KG (C5) and citrate (C6) as the sole carbon source 
(Figure 4.6). Furthermore, the growth defect exhibited by PAOΔrpoN could be 
restored to the parent strain PAO1 levels by introducing the wild-type rpoN in the 
PAOΔrpoN mutant (Figure 4.6). This data strongly hints at the role of RpoN (σ54) 
as the master regulator of TCA cycle C4, C5 and C6 di- and tricarboxylic acid 
intermediate transport in P. aeruginosa. A unique feature of the RpoN (σ54) 
dependent transcription activation of genes is the requirement of an additional 
transcriptional regulatory protein called the RpoN (σ54) binding protein that aids in 
transcription initiation (Thony & Hennecke, 1989, Potvin et al., 2008). In P. 
aeruginosa, to date, 22 RpoN (σ54) binding proteins have been predicted of which 
nine (close to 41%) belong to the signal transduction TCS. In the extensively 
studied Rhizobium meliloti and Rhizobium leguminosarum, RpoN (σ54) together 
with the RR DctD, a part of the DctB/DctD TCS pair, is reported to regulate the 
transport of C4-dicarboxylates succinate, fumarate and malate (Ronson et al., 
1987, Watson, 1990, Janausch et al., 2002). 
In P. aeruginosa, three TCS protein pairs namely, DctB/DctD, MifS/MifR 
and PA1336/PA1335 have been identified to be homologous to the Rhizobium 
RpoN dependent C4-dicarboxylate transport regulatory DctB/DctD TCS (Tatke et 
al., 2015). The response regulator proteins of these TCS pairs namely, DctD, MifR 
and PA1335 share 67%, 69% and 68% identity to the R. meliloti RR DctD (Winsor 
et al., 2011), suggesting a similar function. During the course of the dissertation, 
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Valentini et al. showed that, P. aeruginosa DctD in concert with RpoN (σ54) 
regulates the transport of C4-dicarboxylate succinate, fumarate and malate by 
initiating the transcription of dctA and dctPQM genes encoding the C4-
dicarboxylate transporters (Valentini et al., 2011). Also, we recently reported a key 
finding that the assimilation of extracellular C5-dicarboxylate α-KG requires a 
functional RpoN (σ54) to work in tandem with the RR MifR in order to activate the 
expression of P. aeruginosa α-KG permease encoding kgtP (PA5530) gene 
(Chapter 2) (Tatke et al., 2015). Interestingly, P. aeruginosa RRs DctD and MifR 
are functionally exclusive with the only shared feature being the requirement of 
RpoN (Valentini et al., 2011, Tatke et al., 2015). This suggests that P. aeruginosa 
has a dedicated sensory-response mechanism to facilitate the assimilation of 
specific class of TCA cycle intermediates (C4, C5 and C6), respectively.   While the 
role of P. aeruginosa RpoN in the transport of C4 (succinate, fumarate, malate) 
(Valentini et al., 2011) and C5 di-carboxylates (α-KG) (Tatke et al., 2015) is 
reported, its role in the transport of C6-tricarboxylate (citrate) is unclear. Also, the 
role of PA1336/PA1335 TCS in P. aeruginosa is unknown. 
Our sequence analysis of P. aeruginosa PAO1 genome revealed the 
presence of two ORFs PA5476 (citA) and PA5468 encoding the putative C6-
tricarboxylate citrate transport proteins (Winsor et al., 2011). The promoter for citA 
and PA5468 genes have the putative -12/-24 RpoN (σ54) binding signature 
sequences (Thony & Hennecke, 1989, Winsor et al., 2011). Furthermore, the RR 
PA1335 has the conserved domains found among NtrC family of regulators, an N-
terminal regulatory, a central RpoN (σ54) activation and a C-terminal DNA binding 
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domains (Winsor et al., 2011). Since PA1335 exhibits high identity to RpoN (σ54) 
dependent transcriptional regulators, it is possible that the RR PA1335, part of the 
PA1336/1335 TCS in concert with RpoN facilitate extracellular citrate transport by 
regulating the expression of citA and PA5468 genes. Future studies aimed at 
characterizing the role of RpoN and PA1336/PA1335 TCS in citrate transport will 
provide a vital missing link in our understanding of the fundamental aspects of P. 
aeruginosa di- and tri carboxylate transport (Figure 4.7).   
It is worth mentioning that P. aeruginosa utilizes TCA cycle intermediates 
as the preferred carbon, nitrogen and energy source (Wolff et al., 1991, Collier et 
al., 1996). The involvement of RpoN (σ54) in regulating the uptake of TCA cycle 
intermediates strongly suggests its role as a protagonist that decides the fate of 
carbon and energy utilization patterns in P. aeruginosa. Recently, amongst all 
sigma factors, RpoN has been recognized as a central player having the largest 
impact on P. aeruginosa global gene expression that ensures its pathogenic 
success (Schulz et al., 2015). Future studies using comparative transcriptome 
profiling approaches should elucidate the function-specific molecular mechanisms 
manifested by RpoN in concert with DctB/DctD, MifS/MifR and PA1336/PA1335 
TCS regulatory proteins. Furthermore, it would be interesting to determine if RpoN 
and the DctB/DctD, MifS/MifR and PA1336/PA1335 function together in any 
capacity to regulate P. aeruginosa virulence in a nutrient source specific manner. 
These studies will significantly contribute to a greater understanding of P. 
aeruginosa’s complex metabolic networks and will provide a reliable scaffold for 
elucidating the transcriptional network of this portentous pathogen. 
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Figure 4.7: P. aeruginosa RpoN and TCS mediated TCA cycle 
intermediate transport. Model representing P. aeruginosa RpoN and TCS 
response regulator mediated transport mechanism of TCA cycle C4 (yellow), 
C5 (blue) and C6 (purple) di- and tri-carboxylates. The response regulators are 
represented in orange. Green and red arrows represent positive regulation 
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Concluding Remarks 
Due to the rapid emergence of antibiotic resistance in bacterial pathogens, 
researchers are relentless search for new targets for drug discovery. Although, 
TCSs have been identified in lower eukaryotes such as yeast and plants, no 
reports on the presence of TCS in mammalian cells have been reported (Gotoh et 
al., 2010). This has made TCS proteins an attractive drug target (Schreiber et al., 
2009, Gotoh et al., 2010, Bem et al., 2015). Furthermore, the metabolite α-KG itself 
has been considered to have significant therapeutic potential in mammals 
(Grzesiak et al., 2016, Zdzisinska et al., 2016). Our results indicates that α-KG is 
a repressor of P. aeruginosa acute (pyocyanin and cell cytotoxicity) and chronic 
infection (biofilm formation) phenotypes. Understanding the physiological effects 
of α-KG on P. aeruginosa and its effect manifested through MifR transcriptional 
control will help significantly in development of new therapeutic options.  
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Abstract 
In the last 70 years, we have seen a radical change in our perception and 
understanding of the microbial world.  During this period, we learned from Woese 
and Fox there exists a third kingdom called “Archea” based on the phylogenetic 
studies of the 16S ribosomal RNA that revolutionized microbiology (Woese & Fox, 
1977, Woese et al., 1978).  Further, we were forced to reckon with the fact that 
Koch and Pasteur’s way of growing cells in test-tubes or flasks planktonically does 
not necessarily translate to the real-life scenario of bacterial life style, where they 
prefer to live and function as a closely knit microbial community called biofilm. 
Thanks are due to Costerton, who led the crusade on the concept of biofilms and 
expanded its scope of inquiry, which forced scientists and clinicians worldwide to 
rethink how we evaluate and apply the data. Then progressively, disbelief turned 
into belief, and now it is universally accepted that the micro-organisms hobnob with 
the members of their community to communicate and coordinate their behavior, 
especially in regards to growth patterns and virulence traits via signaling 
molecules. Just when we thought that we were losing the battle against bacteria, 
antimicrobials were discovered. We then witnessed the rise and fall of antibiotics 
and development of antibiotic resistance. Due to space and choice limitation, we 
will focus on the three areas that caused this major paradigm shift (i) antimicrobial 
resistance (AMR), (ii) biofilm and (iii) quorum sensing (QS), and how the Journal 
of Medical Microbiology played a major role in advancing the shift. 
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Antimicrobial resistance (AMR) 
It is notable that this 70th anniversary collection for the journal coincides 
with the 70th anniversary of the Nobel Prize to Florey and Chain for their work on 
penicillin, a β-lactam antibiotic. It was first used to treat a patient in 1942, which 
revolutionized medicine and ushered in the age of antibiotics. Yet, resistance 
mechanisms that could inactivate penicillin, the β-lactamases, were already 
present among bacteria (Abraham & Chain, 1988). As has been uncovered over 
the years, the origins of most drug-specific antibiotic resistance mechanisms are 
genetically encoded functions that predate the introduction of the antibiotics. These 
mechanisms have been derived from the antibiotic-producing organisms, from the 
pathogens themselves or from commensals or environmental bacteria.  Selective 
pressure by antibiotics has led to horizontal transmission of these resistance genes 
and further optimization (evolution) of the mechanisms (Davies, 1994, Davies & 
Davies, 2010).  
The Journal of Medical Microbiology has published many insightful reviews 
on AMR, and important laboratory and epidemiological studies of the prevalence 
and spread of specific resistance mechanisms.  A 1973 paper (Anderson et al., 
1973) presented a study of antibiotic-resistance transfer in the intestines of human 
volunteers, finding that Resistance-factors (R-factors) were successfully 
transferred when treated with antibiotics, and not in the absence of treatment.  A 
later review of plasmid-mediated, horizontally-transmitted, enzymatic resistance to 
ampicillin and trimethoprim was the subject of an Oakley Lecture (Amyes, 1989). 
This lecture acknowledged the growing numbers of resistance determinants to 
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each antibiotic, but emphasized evolutionary patterns showing that the enzymes 
fell into a small number of groups.  The metallo-β-lactamases, which can hydrolyze 
the carbapenems, were flagged more than 20 years ago as an emerging medical 
challenge (Payne, 1993).  That challenge was realized recently with the advent of 
the NDM-1 metallo-β-lactamase.  A recent review uses the rapid global spread of 
the NDM-1 β-lactamase as an example – and a warning – of the looming public 
health problem of antibiotic resistance that may only be controlled through 
international cooperation (Johnson & Woodford, 2013).   
It is not only transmissible factors that are responsible for AMR.  Especially 
in Gram-negative pathogens, intrinsic impermeability of the cell envelope and 
efflux mechanisms also plays a role. Mutational changes in these factors can lead 
to decreased susceptibility.  Pseudomonas aeruginosa is a particularly problematic 
pathogen because it utilizes a variety of these mechanisms to put up a formidable 
barrier, limiting greatly the number of classes of chemotherapeutics that can 
overcome those mechanisms, to β-lactams, aminoglycosides, fluoroquinolones 
and colistin.  A recent review in the Journal of Medical Microbiology describes this 
phenomenon (Strateva & Yordanov, 2009).  In addition to permeability barriers and 
efflux, certain antibiotics, such as fluoroquinolones, can select mutations in the 
genes encoding their molecular targets.  For the commonly used systemic 
monotherapeutic agents, resistance does not occur via single mutations in the 
target as they are generally not single proteins but are, rather, the products of 
multiple genes or a pathway (Silver, 2007).  It is clear that new antimicrobial 
therapies are needed to bolster the diminishing antibacterial armamentarium, but 
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this is a difficult undertaking  (Silver, 2011).  AMR has become a real and proximate 
threat that requires constant monitoring - and the Journal of Medical Microbiology 
remains at the forefront of the undertaking. 
Biofilm  
The notion that microorganisms, in nature, exist as a sessile, systematized, 
multicellular communities was first described in the late 17th century by Van 
Leeuwenhoek. He examined plaque samples from his own teeth and found them 
to be a complex aggregation of micro-organisms, which he then referred to as 
“animalcules”. Even though the biofilm mode of bacterial existence was known for 
several centuries, the concept was not promulgated until the late 20th century. The 
late 1980s and 1990s saw an increased recognition of the fact that bacteria in their 
natural habitat survive and function as organized communities, encapsulated 
within a polymeric matrix - a crusade led by Costerton, the pioneer and father of 
biofilm research (Costerton et al., 1987, Lappin-Scott et al., 2014). 
In the years that followed, P. aeruginosa emerged as the model organism 
to glean information on the various aspects of biofilm mode of bacterial lifestyle. 
Our appreciation for this lifestyle was facilitated by the advent of non-destructive 
investigation techniques, especially the use of live-monitor systems with confocal 
laser scanning microscopy. This provided an unprecedented ability to see (and 
almost feel) the beautiful architectural formations held together by an extracellular 
matrix. This also led us to question many aspects of biofilm that were accepted as 
a fact, especially where repetition has led to persuasion – the illusory truth effect.  
At that point, it was well established that P. aeruginosa secretes alginate, a 
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complex exopolysaccharide made of guluronic and mannuronic acid that provides 
selective advantage for its survival in lungs of patients with cystic fibrosis (Song et 
al., 2003). The scientific community was persuaded that alginate was the matrix in 
P. aeruginosa biofilms. The Journal of Medical Microbiology was bold enough to 
publish the paper by Stapper et al that questioned the “illusion of truth” (Stapper et 
al., 2004). Notwithstanding the importance of alginate in infection, this paper 
alluded to the potential contribution of other polysaccharides, which turned out to 
be Psl and Pel polysaccharides (Ma et al., 2012, Jennings et al., 2015). 
Micro-organisms coexist in a complex society that includes bacteria, fungi, 
archaea and viruses, forming the multifaceted polymicrobial or mixed species 
biofilm communities. This provides the communities a competitive advantage such 
as AMR, metabolic cooperation, quorum sensing (QS), and many other synergies. 
It is only in the last few years that we have begun to fathom the complex nature of 
the mixed-species biofilm phenotype and its physiological role during infection. 
Adam et al presented a study on mixed fungal-bacterial biofilms using Candida 
albicans and Staphylococcus epidermidis, organisms that are frequently 
implicated in catheter-associated infections (Adam et al., 2002). Their findings 
highlighted the coexistence of different microbial species, and their 
interdependence in the biofilm formation and AMR. In a follow-up study, the same 
group focused on the composition of Candida’s polymeric matrix, which contains 
carbohydrates, proteins, hexosamine, phosphorous and uronic acid, and its 
importance in promoting AMR (Al-Fattani & Douglas, 2006). Their work provided a 
critical insight into the complex biofilm phenotype. Following a series of articles in 
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the journal, Wilson published an insightful review that highlighted the antimicrobial 
sensitivity in oral biofilms (Wilson, 1996). This review summarized studies 
pertaining to the susceptibility of oral bacteria to antimicrobials, based on the type 
of biofilm models used. The author also emphasized the need for research in 
studying the resistance profile of oral biofilm communities, which can be crucial in 
developing an efficient therapeutic regimen. The Journal of Medical Microbiology 
has been instrumental in advancing biofilm research by publishing these studies, 
first of their kind to focus on the mixed-species biofilm and its contribution to AMR.  
More importantly, the recognition of mixed biofilms in nature was the 
precursor to the microbiome studies that were facilitated by metagenomic 
analyses.  Now, one could look at the potential relationship between groups of 
organisms within a single niche that makes a bacterial social network (Fernandez 
et al., 2015). This was clearly facilitated by metagenomic analysis heralded by 
polymerase chain reaction (PCR) that has become a breastwork in all laboratories, 
replacing traditional techniques. This has revolutionized how we view ourselves, 
realizing that the number of bacteria exceeds the number of human cells by 10:1. 
The ease with which DNA is being sequenced and the rapid growth of DNA 
databases, and the development of eubacterial-specific, fungal-specific and 
species-specific primers, will enable rapid detection of micro-organisms that will 
become a mainstay in clinical laboratories. Although we borrowed the knowledge 
of soil microbiologists who developed bacterial-specific primers over 20 years ago, 
we have to thank the human microbiome project (HMP) launched in 1990, which 
truly contributed to the refinement of many bacterial-specific DNA primers (Jaric et 
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al., 2013).  The Journal of Medical Microbiology contributed to this revolution by 
publishing two articles, one that focuses on fungal-specific (Makimura et al., 1994) 
and the other on bacterial-specific (Harris & Hartley, 2003) analyses. The latter 
compared molecular diagnostics with standard culture techniques and offers a 
broad-range 16S rDNA PCR optimized to obtain the highest level of sensitivity for 
the detection of bacteria in clinical specimens.  The future of rapid detection and 
diagnosis of infection truly rests on adopting molecular tools as part of routine 
clinical work. 
The HMP studies have contributed significantly to our knowledge of the 
human microbiome (Turnbaugh et al., 2007). It is now known that the human 
gastrointestinal tract alone harbors a diverse array of microbes that are critical to 
host nutrition, regulation of intestinal angiogenesis, and development of the 
immune response. Alterations in the composition of the intestinal microbiota have 
been associated with various disease states (Larson & Welch, 1993, Masseret et 
al., 2001). A leading example of this is Clostridium difficile-associated diarrhea 
(CDAD), an infection caused by the Gram-positive C. difficile. CDAD occurs 
primarily in patients whose colonic microbiotas have been functionally altered by 
antibiotic therapy (Kelly & LaMont, 2008). C. difficile was identified in 1935 in a 
stool sample from a healthy neonate (Hall & O'Toole, 1935). However, it was not 
until 1976, just over four decades after its identification, that it was successfully 
cultured using the reinforced clostridial medium (Hafiz & Oakley, 1976). The 
Journal of Medical Microbiology took the lead in publishing the findings at a time 
when C. difficile was still considered a human commensal and was not associated 
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with any disease. It was later in 1978 that C. difficile was first reported to be a 
human pathogen (Larson et al., 1978). In the recent years CDAD has become 
rampant, with morbidity and mortality increased over the decades past (Kelly & 
LaMont, 2008, Britton & Young, 2014). Colonic dysbiosis due to the use of 
antibiotics favors C. difficile germination and growth, as it is resistant to most of the 
antibiotics (Knecht et al., 2014, Theriot et al., 2014).  Following the HMP, many 
studies have targeted alternative therapeutic regimens against C. difficile, 
including fecal transplantation. The Journal of Medical Microbiology has always 
been in the vanguard even before the HMP published data pertaining to the fecal 
microbial load (Stephen & Cummings, 1980) and the effect of C. difficile infection 
on fecal microbiome (Hopkins & Macfarlane, 2002).  
Quorum sensing (QS) 
In the 1960s and 70s, scientists decried the notion that bacteria have the 
ability to communicate. In the 1990s this notion was christened as QS, by which 
bacteria can sense bacterial numbers (cell density), integrate and process the 
environmental cues, and coordinately modify their behavior by expressing target 
genes (Nealson & Hastings, 1979, Greenberg, 2003). Now, ample evidence exists 
for inter-species, inter-genera and inter-kingdom communications using largely 
diffusible small molecules called quoromones or autoinducers (Williams, 2007). In 
Gram negative, these molecules are largely made of small chemicals, whereas 
Gram positive tend to use oligopeptides. These signaling molecules interact with 
cognate receptors. It became clear that bacteria employ QS to coordinate the 
expression of virulence factors critical for initiation and establishment of infection. 
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It was also shown that the QS molecules themselves acted as virulence factors by 
being potent stimulators of multiple eukaryotic cells (Smith & Iglewski, 2003). 
Subsequently, a flurry of activities began in this area with everyone looking to link 
their pet system to QS. A significant publication in Science using the P. aeruginosa 
PAO1, which had seen many passages and its isogenic QS mutants, argued the 
complete dependence on QS for biofilm formation (Davies et al., 1998). Once 
again, the Journal of Medical Microbiology led the way in debunking this story. In 
2007, Schaber and colleagues were able to isolate QS-deficient clinical isolates 
and demonstrate their ability to form biofilms, although the quality of the biofilm 
varies (Schaber et al., 2007).  This seriously questioned whether QS was critical 
for biofilm formation and infection. In fact, recent work by Greenberg’s team 
showed that within a colonizing community, one could have social cheaters who 
can coexist and that QS plays a role in policing this cooperation (Wang et al., 
2015). 
With the emergence of AMR it seems natural that research turn towards 
finding anti-QS molecules as an alternative therapy. With the first report of 
furanones as anti-QS molecules (Manefield et al., 1999), there was a slew of 
articles that focused on everything from natural products to synthetic compounds. 
Once again, the opportunistic pathogen P. aeruginosa became the protagonist in 
the search for anti-QS molecules, but investigations also included Gram-positives 
such as Staphylococcus spp. (Nostro et al., 2007). Some researchers randomly 
looked at herbs, including ancient remedies such as ginseng (Schneper et al., 
2011), and others took an ethnobotanic approach by looking at natural products 
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that are used by local communities for medicinal value (Adonizio et al., 2006). The 
latter identified various medicinal plants that had anti-QS activities which 
attenuated bacterial pathogenic virulence factor production, and could rescue 
Caenorhabditis elegans from P. aeruginosa-induced death (Adonizio et al., 2008). 
However, with over 15 years of searching, an anti-QS panacea has not emerged. 
This is, in part, due to the ability of the QS and the anti-QS molecules to elicit an 
immune response that can lead to inflammation. 
Though the focus has largely been on looking at the infecting organism for 
drug targets, we tend to forget that the host contributes to the bacterial 
shenanigans.  It was well known that in the lungs of cystic fibrosis patients, P. 
aeruginosa lives in a novel biofilm lifestyle as aggregates (Sriramulu et al., 2005) 
surrounded by “frustrated” phagocytes (Høiby et al., 1993), and accumulate 
mutations (Oliver et al., 2000). However, it was in the late 1990s that the role of 
neutrophils in the critical phenotypic conversion contributing to poor prognosis for 
the patient was demonstrated (Mathee et al., 1999). This study suggested anti-
oxidants and anti-inflammatory agents as potential therapeutic measures. In 2009, 
a paper by Parks and colleagues not only explored the role of neutrophil in the 
quality and quantity of biofilm, but also proposed neutrophil necrosis as a potential 
drug target (Parks et al., 2009). 
 In this 70 year journey, the Journal of Medical Microbiology has been one 
of the torch bearers in advancing scientific research by critically reviewing and 
publishing articles related to the diverse medical microbiology field. The journal 
has never shied away from thinking outside the box, allowing it to embrace new 
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viewpoints. This will substantially benefit basic research and will help in solving the 
mysteries of the microbial world, whether they be antibiotic resistance, biofilm 
formation, QS or the more advanced microbiome studies.  
  
167	
	 	 	
Appendix 2 
 
 
 
 
 
 
 
 
 
 
Rapid Detection of Mucoid Pseudomonas aeruginosa using 
Microextraction of Volatiles 
 
 
 
 
 
 
 
 
Wen Fan*, Gorakh Tatke*, Mimy Young, Kalai Mathee and José Almirall 
* Equal Contribution (Being Submitted) 
 
168	
	 	 	
Abstract 
Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium with 
remarkable abilities to adapt to environmental challenges. A primary pathogen 
responsible for all Gram negative infections in clinical settings, it is associated with 
lung decline and the untimely demise of people with cystic fibrosis (CF). One of 
the hallmarks of P. aeruginosa chronic infection in CF patients is the presence of 
mucoid isolates that spells poor prognosis. Here we report a rapid detection 
technique for P. aeruginosa based on capillary microextraction of volatiles (CMV) 
using the newly invented dynamic headspace sampling device. The method is 
composed of a one min dynamic sampling followed by 17 min GC-MS analysis 
time. The simple, sensitive and rapid method identified 2-aminoacetophenoe and 
1-undecene as biomarkers for the presence of P. aeruginosa. The comparison 
results between the mucoid and non-mucoid strains show potential use of 1-
undecene for differentiation of acute and chronic infection of P. aeruginosa using 
the non-invasive CMV-based breath analyzer.	  
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Introduction 
Pseudomonas aeruginosa is a Gram negative opportunistic pathogen 
implicated in causing systemic infections in immunocompromised and 
immunosuppressed individuals (Bodey et al., 1983, Ramos, 2004). Its metabolic 
versatility and adaptability has significantly contributed to its ubiquity (Ramos, 
2004). It has increasingly been recognized as a major cause of morbidity and 
mortality in many clinical settings accounting for 1 in every 10 hospital-acquired 
infections (Abraham & Chain) (Giamarellou, 2000). From 1975 to 2003, the percent 
of HAI pneumonias caused by P. aeruginosa nearly doubled in the US, from 9.6 to 
18.1% (Gaynes & Edwards, 2005, Talbot et al., 2006). Unfortunately, the prognosis 
for these patients is often poor. Beyond high infection rate, P. aeruginosa also 
contributes to the highest case fatality rate of all Gram-negative infections (Aliaga 
et al., 2002). It is the primary pathogen responsible for lung decline and mortality 
in patients with cystic fibrosis (CF) (Doggett, 1969, Lyczak et al., 2002). In the CF 
lungs, transition from acute to chronic infections is marked by the development of 
resistance to antibiotics (Workentine et al., 2013), and conversion to a mucoid 
phenotype (Penketh et al., 1983, Govan & Nelson, 1992). The mucoid phenotype 
is due to constitutive production of alginate (Alg), a component of extracellular 
polymeric (EPS) matrix (Flemming et al., 2007). Mucoidy protects the bacteria from 
opsonization, phagocytosis, reactive oxygen species and antibiotics (Mathee et al., 
1999, Pritt et al., 2007). Thus, early detection of P. aeruginosa infections plays a 
major role in the treatment stratagem and clinical outcome. 
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For early and precise detection of P. aeruginosa, numerous culture, 
biochemical, Polymerase Chain Reaction (PCR) and serology based approaches 
have been developed (Qin et al., 2003, Xu et al., 2004, Tramper-Stranders et al., 
2005, Tramper-Stranders et al., 2006, Daines et al., 2014). In particular, during the 
last decade, there has been a substantial upsurge in PCR-based approaches for 
early detection of P. aeruginosa in the respiratory samples of CF patients 
(Deschaght et al., 2011).  However, in spite of the fact that PCR amplifications 
have been successfully used as a routine technique for identification of viruses in 
clinical samples (Niesters, 2002), their use in bacterial diagnostics including P. 
aeruginosa, is still limited. This is mostly due to the questionable specificity and 
sensitivity of these techniques. To date, P. aeruginosa detection and identification 
greatly relies on culture-based approaches which are time consuming, influenced 
by testing conditions and subject to physician interpretation which may lead to 
misinterpretation and misidentification (Deschaght et al., 2011). This together 
strongly suggests the need for development of new diagnostic tools that will help 
pave the way for a more efficient and specific P. aeruginosa detection techniques.  
Breath analysis is a potential revolution in disease diagnostics since the 
collection of exhaled breath is a safe, non-invasive, easy and simple procedure, 
and each individual contains information regarding their own internal state 
(Cepelak & Dodig, 2007, Hunter & Dweik, 2008). Urea breath test (UBT) has been 
effectively used to detect Helicobacter pylori infections with a success rate of 90% 
(Gisbert & Pajares, 2004). Breath analyses have also been widely tested in 
experimental studies to identify biomarkers that can be correlated to various 
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diseases (Dent et al., 2013, Koutsokera et al., 2013, Sarbach et al., 2013). Bulk 
matrix of breath is largely composed of nitrogen, oxygen, carbon dioxide, water, 
and inert gases. However, the breath condensate contains trace amounts (parts 
per billion (ppb) to parts per trillion (ppt)) of inorganic gases, volatile organic 
compounds (VOCs), and other normally nonvolatile substances that can serve as 
biomarkers (Miekisch et al., 2004). For example, nitric oxide (NO) gas was 
reported with an increased concentration in patients with airway inflammation such 
as asthma and bronchiectasis (Kharitonov et al., 1997); and the odor of acetone in 
the breath was a characteristic feature of diabetic coma (Crofford et al., 1977). 
P. aeruginosa has been reported to produce a “grape-like” odor. The 
compound responsible for this peculiar odor has been identified as 2-
aminoacetophenone (2-AA) by Mann in 1966 (Mann, 1966). Importantly, 2-AA was 
not detected in any other respiratory pathogens and thus was used as a biomarker 
for P. aeruginosa infection and/or colonization in the lung (Groenewold et al., 
2011). Although specific for P. aeruginosa infections, 2-AA has also been identified 
in certain foods including corn, dairy, honey products and wine (Karagul-Yuceer et 
al., 2002, Fan et al., 2007, Schmarr et al., 2007, Scott-Thomas et al., 2010). Breath 
sample analysis of uninfected individuals shortly after eating these foods may give 
a false positive which could limit the diagnostic procedures (Scott-Thomas et al., 
2010). In addition to 2-AA, spontaneously expectorated sputum containing P. 
aeruginosa show the presence of 2-nonanone, 2,4-dimethyl-1-heptene, 1-
heptene, isopentanol, and limonene (Savelev et al., 2011); and P. aeruginosa 
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stationary growth culture releases dimethyl sulfide, 1-undecene, and 2-nonanone 
(Zscheppank et al., 2014, Briard et al., 2016).  
In this study, a novel, fast, dynamic headspace sampling device, capillary 
microextraction of volatiles (CMV), was used to capture volatile compounds 
released by P. aeruginosa on standard culture plates. The analytical method 
consists of sampling the headspace above the culture plates for 1 min using the 
CMV device followed by inserting it into a thermal probe that is connected to a GC 
split/splitless (S/SL) injection port, followed by ~17 min chromatographic program 
of GC-MS analysis after thermal desorption of the absorbed analytes from CMV. 
The CMV tube (Figure A2.1) performs similarly to commercial sorbent tubes in 
terms of extraction efficiency, sensitivity, breakthrough and recovery. However, it 
does not require the complicated thermal desorption accessory normally 
associated with sorbent tubes. Due to its extremely high surface area and phase 
volume, small volume sampling (~ 1 L) results in sub-ng absolute detection limits 
for the analytes of interest, making the CMV technique capable of detecting ppb 
concentrations of VOCs in air. In this study, we report the presence of the 
biomarkers 1-undecene and 2-AA among others from the P. aeruginosa. 
Moreover, we report that the presence of 1-undecene can be used for the 
differentiation between mucoid and nonmucoid strains of P. aeruginosa. Compare 
to previously described method, this is one of the first reporting of an inexpensive, 
fast and ultra-sensitive technique for the detection of P. aeruginosa that is 
accessible to a moderately equipped analytical laboratory requiring only GC-MS 
instrumentation (Table A2.1).  
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Table A2.1. Comparison of extraction and analytical parameters between this 
work and previous reports of biomarker detection from pathogens. 
 (Savelev et al., 2011) 
(Zscheppank 
et al., 2014) This Report 
(Scott-Thomas 
et al., 2010) 
Extraction 
Method 
SPME (DVB-
Carboxen-
PDMS), 
closed 
system 
NT, closed 
system 
CMV, semi-
closed 
system 
SPME 
(Carbowax/PEG), 
closed system 
Setup Easy - Moderate Moderate Easy  
Extraction 
Time 50 min 12 min 1 min 5 min 
Extraction 
Temperature 37 °C  RT  
Injection 
Port Split/Splitless  TDU PTV-1079 
Mode 
Pulsed 
Splitless 
Mode 
 Split/splitless Split (50:1) 
Detector EI, 70 eV, full-scan    
Column 
ZB-Wax, 30 
m x 0.25 mm 
x 0.25 um 
Optima 1, 30 
m x 0.32 um 
x 1 um 
DB-5ms, 8 
m x 0.25 mm 
x 0.25 um 
ZB-Wax, 30 m x 
0.25 mm x 0.25 
um 
Initial temp 40 °C, 5 min 35 °C 40 °C, 1 min 60 °C, 2 min 
Ramp 5 °C/min to 100 °C 
1 °C/min to 
53 °C, 3 min 
15 °C/min to 
115 °C, 1 
min 
10 °C/min to 250 
°C, 2 min 
Ramp 
5 °C/min to 
150 °C, 2 
min 
15 °C/min to 
120 °C 
25 °C/min to 
280 °C, 3 
min 
 
Ramp 5 °C/min to 230 °C 
5 °C/min to 
160 °C   
Ramp  2.5 °C/min to 180°C   
Ramp  2 °C/min to 200 °C   
Run Time 44 min 51 min 16.6 min 21 min 
He 1 mL/min 1.5 mL/min 1 mL/min 1.2 mL/min 
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Materials and Methods 
Bacteria strains, media and growth conditions 
Bacterial strains used in this study are listed in Table A2.2. Luria-Bertani 
(LB) (Fisher Scientific) broth was used for routine cultivation of bacterial cultures 
and was supplemented with 1.5% agar when needed, unless specified otherwise. 
All cultures were grown overnight in LB broth with shaking at 200 rpm, at 37˚C for 
Pseudomonas aeruginosa (Mucoid/Non-mucoid), Staphylococcus aureus, 
Escherichia coli, 26˚C for Serratia marcescens, Chromobacterium violaceum and 
30˚C for Bacillus strains. Briefly, overnight cultures were diluted to obtain equal 
optical densities. Culture densities were normalized to a final A600 of 0.05-0.08 
before inoculating on LB agar plates by swabbing the surface with adjusted culture 
suspensions. Plates were allowed to dry before incubating overnight for 12 to 16 
h at 37˚C, 30˚C and/or 26˚C depending on the culture. In addition, mixed culture 
suspension of P. aeruginosa prototypic PAO1, E. coli (DH5α), S. marcescens, B. 
cereus and S. aureus in different combination were used. For mixed bacterial 
cultures, the plates were incubated overnight at 30˚C. In total, 280 culture plates 
were sampled, and each strain was analyzed at least three times. All the sampling 
and analyses were accomplished using blind study method. The culture plates 
containing all the bacteria, including the negative controls, were labeled with 
reference IDs to minimize any bias during the headspace sampling. The LB agar 
plate with no culture was used as a negative control. 
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Dynamic headspace sampling using CMV devices 
The CMV devices were recently developed and reported as an efficient way 
to detect trace amounts of explosives (Fan & Almirall, 2014). Fabrication of the 
CMV devices has been described elsewhere (Fan & Almirall, 2014). These 2-cm 
length open-ended sampling devices allow for fast dynamic headspace sampling. 
The CMV devices were conditioned in an oven at 250 °C for an hour prior to use, 
cooled to room temperature and connected to a hand-held air monitoring vacuum 
pump (Escort Elf Air Sampling Pump, Zefon International Inc., Ocala, FL) that 
provides a flow through the CMV device at the rate of 1.5 liters per min (LPM). For 
the culture plates sampling, the LB agar culture plates were popped open with a 
small opening where the CMV devices were simply inserted into the plates for 1 
min dynamic sampling at a flow rate of 1.5 L/min (Figure A2.2). The CMV sampling 
device capable of sub-nanogram detection of VOCs, when coupled to GC-MS (Fan 
& Almirall, 2014, Tarifa & Almirall, 2015) (Air Chemistry, Inc, Miami, FL). 
Sample analysis using GC-MS 
After 1 min sampling, the CMV device was disconnected from the tubing 
and inserted into a probe for thermal desorption into an Agilent Technologies 
7890A GC S/SL injector that was connected to thermal separation probe adaptor 
from Agilent Technologies Inc., Santa Clara, CA. The injector was set to 180 °C. 
The Agilent Technologies 7890A GC system was equipped with a 5975C inert XL 
mass spectrometer detector (MSD). The GC column used in this research was a 
DB-5ms Ultra Inert, 8 m × 0.25 mm × 0.25 µm column. For the initial study, the GC 
oven temperature ramp started at 40 °C, was held for 1 min and ramped at 15 
177	
	 	 	
°C/min to 200 °C and held for 1 min, ramped again at 15 °C/min to 240 °C, held 
for 6.5 min and ramped at 25 °C/min to 270 °C, ramped at 5 °C/min to a final 
temperature of 280 °C and held for 4 min. The total analyses time was 29.33 min 
that provided with a high resolution for detection of various volatile organic 
compounds in the headspace over the culture plates. Once biomarkers were 
identified for P. aeruginosa strains, a fast GC oven temperature program was used 
to reduce the analyses time.  The oven temperature started at 40 °C for 1 min, and 
ramped to 115 °C at 15 °C/min and held for 1 min, and ramped to final temperature 
of 280 °C at 25 °C/min and held for 3 min. The total analyses time was reduced to 
16.6 min.  	
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Results  
Identification of VOCs in the Headspace of P. aeruginosa  
The VOCs present in the prototypic P. aeruginosa strain PAO1 were differentiated 
from other bacteria, E. coli DH5α and C. violaceum, in this particular study and 
characteristic VOCs were found in the P aeruginosa strains using the 1-min. 
headspace sampling method. After 24 hours of incubation, the headspace of the 
plates were sampled with the CMV for 1 min. 1-Undecene and 2-
aminoacetophenone (2-AA) were detected in P. aeruginosa, and indoles were 
detected in E. coli (Figure A2.3). After 48 hours of incubation at room temperature, 
limonene was also detected in both the P. aeruginosa and C. violaceum plates; 
thus, limonene wasn’t chosen as a biomarker along with 1-undecene and 2-AA in 
this research.  
Differentiation of P. aeruginosa from Other Bacterial Species 
The 1-min. headspace sampling using CMV resulted in the differentiation of the 
199 plates containing P. aeruginosa strains from the 66 plates containing other 
bacteria using blind sampling studies. The compounds 1-undecene and 2-AA were 
found only in the headspace of the P. aeruginosa strains (see Table A2.3) and 
these results are consistent with previous workers who also reported finding these 
compounds as biomarkers of P. aeruginosa.  Almost every plate containing the P. 
aeruginosa strain resulted in the detection of one or both of these biomarkers. 
Additionally, none of the plates containing the other bacteria resulted in the 
presence of either or both of the biomarkers. A confusion matrix was built (Table 
A2.3) in which the theoretical biomarker present is equivalent to P. aeruginosa 
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plate and the theoretical biomarker absence is equivalent to a plate containing 
other bacteria. Based on this confusion matrix, two observations can be made. 
First, where the true negative rate equals to 1.00 indicates that the two biomarkers 
chosen are not found in the other bacterial strains tested in this study. Second, the 
false negative rate of 0.12 indicates that a few P. aeruginosa strains do not emit 
either 1-undecene or 2-AA. Mucoid strains may be retaining the VOCs better than 
the non-mucoid strains and therefore the biomarkers are more difficult to detect. 
Detection of 2-AA and 1-undecene is specific for P. aeruginosa 
To determine if this detection method is specific and sensitive, several 
mixtures of species were made (Table A2.4). The headspace of each mixture was 
also sampled and the chromatograms were overlaid (Figure A2.4). As predicted, 
the two compounds, 1-undecene and 2-AA were detected in Group 1 (P. 
aeruginosa, S. marcescens, and S. aureus) and 4 (P. aeruginosa alone), and 
indole was found in Group 2 (E. coli, S. marcescens, and B. cereus UW85), 3 (E. 
coli, S. marcescens, and S. aureus) and 5 (E.coli alone). Thus, the test method for 
1 min fast dynamic sampling followed by analysis in GC-MS is suitable even when 
a complex mixture is present.  
Differentiation between mucoid and non-mucoid P. aeruginosa strains 
P. aeruginosa strains often transition from acute to chronic infections in 
patients with CF. The transition is marked by development of resistance to 
antibiotics and conversion to mucoid phenotype. The mucoid phenotype is due to 
overproduction of alginate (Figure A2.5). The mucoid strains are referred to as 
Alg+. Thus we hypothesized that the transition will lead to concomitant change in 
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odor the profile. To test this hypothesis, eight non-mucoid and 10 mucoid strains 
were tested (Figure A2.6). 
For the eight mucoid strains analyzed, 1-undecene was detected in all 83 
plates (100% detection rate); while 2-AA was found in 80 plates (96.4% detection 
rate) (Figure A2.6). The only strain that didn’t have 2-AA in headspace is strain 
CDN118, which is a pan-resistant bacterimic isolate from Nigeria. The absence of 
2-AA in this single strain needs further study.  
The 2-AA biomarker was detected in 85 of 116 (73.3%) of the mucoid strains 
(Figure 2A.6). The plates that failed to have detectable 2-AA in the headspace 
included strain ZW77 (3 plates), PAO1 (3 plates), and PDO300 (17 plates). The 1-
undecene was detected in all of the non-mucoid (Alg-) strains whereas only 41.3 
% of the mucoid isolates presented 1-undecene in the headspace (Figure 2A.6). 
The mucoid strains may not produce appreciable amounts of 1-undecene. The 
presence of 1-undecene in some of the plates could result from the presence of 
non-mucoid strains in the plates due to their ability to transition during the 
incubation process. In fact, the Alg+ phenotype of PDO300 is unstable and up to 
80% of the isolates can revert to non-mucoid phenotype (Sautter et al., 2012). To 
test this hypothesis, volatiles from three stable mucoid strains PA2192 (12 plates), 
FRD39 (13 plates), were compared with the Alg- PAO1 (6 plates) strains. As 
expected, only 2-AA was found in all 31 plates. The stable mucoid strains were 
differentiated from the non-mucoid strains by only the presence of these two 
biomarkers using the CMV headspace test described.  
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Figure A2.6. The detection frequency of 1-undecene and 2-aminoacetophenone 
(2-AA) in mucoid and non-mucoid P.  aeruginosa strains. 1-Undecene was 100% 
detectable in non-mucoid P. aeruginosa strains, while only 43% detectable in mucoid 
strains. The significant drop in detection frequency led to the hypothesis of using 1-
undecene as a biomarker for separation of mucoid and non-mucoid strains.  
Figure A2.5. Non-mucoid (Alg-) and mucoid (Alg+) P. aeruginosa. The 
prototypic P. aeruginosa such as PAO1 are non-mucoid. The conversion seen 
during chronic infection, especially in patients with cystic fibrosis is due to a 
mutation in mucA encoding an anti-sigma factor. The mucoid phenotype reverts 
back to non-mucoidy in the absence of selection due to second site suppressors 
strain (Sautter et al., 2012). 
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Table A2.2. Bacterial strains used in this study 
Strain ID Strain Background Relevant characteristics Source 
P. aeruginosa strains 
PAO1 PAO1 Alg
-; Prototypic wild type, a 
wound isolate 
(Stover et al., 
2000) 
PDO300 PAO1 Alg
+; PAOmucA22, 
constitutively mucoid 
(Mathee et al., 
1999) 
PKM315 PAO1 Alg-; PAO∆ampR (Balasubramanian et al., 2012) 
PKM816 PDO300 
Alg-; PDO300 revertant, non-
mucoid; 
PAOlagO96 mucA22 
sap26; Mathee 
Lab 
PKM831 PDO300 Alg
-; PDO300 revertant, non-
mucoid; PAOmucP451 mucA22 
sap21; Mathee 
Lab 
PKM900 PAO1 Alg
-; PAO∆mifR; in-frame 
deletion of mifS  
(Tatke et al., 
2015) 
PKM901 PAO1 Alg
-; PAO∆mifS; In-frame 
deletion of mifS  
(Tatke et al., 
2015) 
PKM902 PAO1 Alg
-; PAO∆mifSR; in-frame 
deletion of mifS and mifR 
(Tatke et al., 
2015) 
CDN118  Alg
-; Panresistant clinical isolate 
from Nigeria C.D. Nkwonta 
PA2192 2192 Alg
+; Mucoid cystic fibrosis (CF) 
clinical isolate  (Pier et al., 1983) 
FRD1 FRD1 Alg+; Mucoid CF clinical isolate  
(Ohman & 
Chakrabarty, 
1981) 
FRD39 FRD1 Alg+; Mucoid isolate 
(Ohman & 
Chakrabarty, 
1981) 
ZW77  Alg+; poxB15, CF throat swab, London, UK, 1997 
(Kong et al., 
2005) 
ZW98  Alg
-; CF throat swab, The 
Hague, Netherlands, 1997 
(Kong et al., 
2005) 
PT22   Alg
-; Water, Mühlheim, 
Germany, 1992 
(Kong et al., 
2005) 
641 HD   Alg
-; poxB22; Water, Mühlheim, 
Germany, 1992 
(Kong et al., 
2005) 
PKM122 PAO1 
Alg+; PAOmucA22; mucoid 
strain isolated from PAO1 
biofilm after PMN exposure  
(Mathee et al., 
1999) 
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PKM123 PAO1 
Alg+; PAOmucA22; mucoid 
strain isolated from PAO1 
biofilm after PMN exposure  
(Mathee et al., 
1999) 
Bacillus strains 
ATCC 
35866 
B. 
thuringiensis  NRRL B4488 [HD73] ATCC 
ATCC 
23857 B. subtilis  ind- tyr+ ATCC 
ATCC 
14581 B. megaterium    ATCC 
ATCC 
53522 
B. cereus 
UW85    ATCC 
Other bacterial strains 
CV026 Chromobacterium violaceum Violaceum negative mutant (Pier et al., 1983) 
DH5α Escherichia coli  
F- Φ80lacZΔM15 Δ (lacZYA-
argF)U169 deoR recA1 
endA1 hsdR17 (rk- mk+) 
phoA supE44 λ- thi-1 gyrA96 
relA1 
New England 
Biolabs 
ATCC 
13880 
Serratia 
marcescens  Isolated from pond water ATCC 
KM1000 Staphylococcus aureus  Wild type Mathee Lab 
 
Table A2.3. Confusion matrix built upon the blind study. 
Confusion Matrix  
Theoretical 
Biomarker 
Present 
Biomarker not 
Present 
Experimental  
Biomarker Present 176 (TP=0.88) 0 (FP=0) 
Biomarker not 
Present 23 (FN=0.12) 66 (TN=1.00) 
TP: True Positive Rate; FP: False Positive Rate; FN: False Negative Rate; TN: 
True Negative Rate 
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Table A2.4. Mixture of bacterial cultures 
  Strain Background Strain IDs 
Mixture 1 
P. aeruginosa PAO1 
S. marcescens ATCC 13880 
S. aureus KM1000 
Mixture 2 
E. coli DH5α 
S. marcescens ATCC 13880 
B. cereus UW85 ATCC 53522 
Mixture 3 
E. coli DH5α 
S. marcescens ATCC 13880 
S. aureus KM1000 
Mixture 4 P. aeruginosa PAO1 
Mixture 5 E. coli DH5α 
 
 
 
 
 
 
 
 
188	
	 	 	
Discussion  
The rapid sampling technique using CMV devices coupled to GC-MS for 
sample analysis is an effective method to differentiate P. aeruginosa strains from 
the other bacterial pathogens. The two biomarkers used in this study, 2-AA and 1-
undecene, are only found in the headspace of P. aeruginosa strains, in comparison 
to the headspace of several other pathogen strains. No significant levels of 
biomarkers were found for the other bacterial pathogens except that indole was 
found in the headspace of DH5α (E. coli). Beyond this, when multiple bacteria were 
mixed together, the method doesn’t show any interference and is specific in 
identifying the two biomarkers only from the mixtures that contained the P. 
aeruginosa strains.  
In addition, to differentiate P. aeruginosa strains from the other bacterial 
pathogens, the method could also be used for separation of P. aeruginosa mucoid 
and non-mucoid strains. In the analysis of 8 mucoid strains, the 1-undecene 
detection rate dropped significantly from 100% to 41.3%, when compared to the 
analysis of 10 non-mucoid strains. These results suggest that either the mucoid 
strains do not produce 1-undecene in the headspace as a biomarker or the 
mucoidy prevents the release (absorbs) the 1-undecene. The headspace analysis 
of the three stable mucoid strains shows that 2-AA was the only biomarker 
detected in the headspace. Previously, solid phase microextraction (SPME) has 
been used for studying the headspace of P. aeruginosa (Scott-Thomas et al., 
2010, Savelev et al., 2011). Because of the static sampling nature of the SPME 
device and its limited surface area and phase volume, the static sampling SPME 
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methods required longer analysis times. In addition, the SPME glass fiber is very 
fragile and thus not suitable for field applications. In this study, the newly 
developed method is rugged, dynamic, fast, and has comparable or better 
sensitivity as SPME. However, in the analysis of about 300 culture plates, a 
relatively low true positive rate (88%) was found which resulted from three out of 
eight mucoid strains. As discussed above, the mucoid strains may have the 
polysaccharide cover to prevent the release of biomarkers into the headspace; 
thus, culturing the plates under a condition to prevent conversion from mucoid to 
non-mucoid might be useful for successful detection that can lead to a higher true 
positive rate. Additionally, both stable and unstable mucoid strains should be 
analyzed. Further experiments should also include quantitative analysis that 
addresses the number of bacteria on the culture plate versus the headspace 
biomarker signals. These studies may provide further insights into the 
concentration of biomarker compounds that can differentiate the mucoid and 
nonmucoid strains of P. aeruginosa. 
	
	  
190	
	 	 	
Conclusions 
The newly reported CMV device for dynamic headspace sampling of VOCs 
over bacteria culture plates provides for a simple and inexpensive extraction setup. 
The 1 min sampling time significantly increases the sampling throughput and the 
direct introduction of the CMV into a port of a GC-MS followed by thermal 
desorption produces a VOC profile in ~ 17 min for each plate. 1-undecene and 2-
AA were identified as the biomarkers for P. aeruginosa in these studies. In further 
screening test, 265 plates were sampled and no false positive was generated with 
a total number of 66 other bacteria (not containing P. aeruginosa) plates analyzed. 
In the analysis of non-mucoid strains, the clinical isolate CDN118 did not produce 
2-AA in the headspace, but 1-undecene was found in all plates; thus, 1-undecene 
can be used as the primary biomarker while 2-AA as a secondary marker for 
confirmation. In addition, 1-undecene might be used as the biomarker to 
differentiate mucoid and non-mucoid P. aeruginosa isolates. The method was also 
successfully applied to the culture plates with multiple bacteria (mixtures). The 
detection results showed the method is sensitive and effective even with a relative 
complex matrix. In conclusion, the simple and fast sampling method developed in 
this research is effective in screening bacteria culture plates to identify P. 
aeruginosa strains. Additional developmental research may lead to rapid, non-
invasive detection of P. aeruginosa in the breath of patients that are susceptible to 
P. aeruginosa infection such as potential cystic fibrosis patients.		 	
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